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Abstract 
 
In the blood stream the merozoite is the invasive form of the malaria parasite that must 
enter a new erythrocyte.  Merozoites lack structure for locomotion such as cilia and 
flagella, but use an actomyosin motor complex that provides the force to drive them into 
the cell.  This molecular motor is located at the pellicle membrane of the parasite.  The 
motor protein complex or glideosome includes a class XIV myosin heavy chain 
(MyoA), Myosin Tail Interacting Protein (MTIP) and two anchoring proteins known as 
Glideosome Associated Protein 45 (GAP45) and GAP50.  A ternary complex of MyoA-
MTIP-GAP45 is first formed and this later associates with GAP50.  Using a GFP-
tagged MyoA transgenic parasite line the expression of MyoA was examined in both 
Plasmodium falciparum and P. knowlesi.  The protein was expressed at the periphery of 
the parasite and associates with MTIP, GAP45 and GAP50.  In time course studies it 
was shown that recruitment of GAP50 to the complex occurs late relative to the onset of 
GAP50 synthesis, likely reflecting a role for GAP50 in cellular processes prior to host 
cell invasion.  A second class XIV myosin, Myosin B (MyoB) was also tagged with 
GFP in a transgenic parasite line.  Whilst the timing of MyoB expression followed that 
of MyoA, with clearly detectable protein in segmenting schizonts at 40 hours post 
invasion, MyoB did not associates with MyoA or any of the other invasion complex 
proteins.  The localisation of MyoB-GFP in P. falciparum was at the apical end of the 
merozoite, in front of other apical organelle markers such as Rhoptry neck protein 4 
(RON4).  During erythrocyte invasion, MyoB -GFP remained in the same location, 
whilst RON4 moved out onto the parasite surface as part of the moving junction and 
migrated to the rear of the parasite.  Although the exact role of MyoB is unknown, it is 
suggested that it  may be involved in the invasion process but within its own protein 
complex that is distinct from the glideosome. 
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Chapter 1 
Introduction 
 
1.1 Introduction to malaria 
 
1.1.1 The burden 
Malaria is a preventable and treatable disease.  Latest WHO estimates can be 
summarised as 219 million cases reported in 2010 with 660, 000 estimated deaths 
especially in African children (~90%).  These estimated malaria cases were received 
from 104 malaria endemic countries and territories in 2011 with 99 of these countries 
having on-going malaria transmission.  An estimated 80% of the total malaria cases 
occur within the 17 most affected countries and the African Region alone gave 47% of 
cases. However, malaria mortality rates fell by 26% around the world between 2000 and 
2010, and remarkable decreases of 33% were reported from the WHO Africa region.  
During this period, an estimated 1.1 million malaria deaths were averted globally 
(WHO, 2012).   
 Recently, a large cluster of human infections caused by P. knowlesi has 
been identified in South East Asian countries including Malaysia (Cox-Singh et al., 
2008; Singh et al., 2004),  Singapore (Ng et al., 2008), The Philippines (Luchavez et al., 
2008), Thailand (Sermwittayawong et al., 2012), the Thai-Myanmar border 
(Jongwutiwes et al., 2004) and Cambodia (Khim et al., 2011). Other than in South-East 
Asia P. knowlesi cases have only been reported as imported cases where the patient 
acquired the infection during a vacation in the region.   The infections were usually 
acquired during jungle trekking as a part of eco-tourism activity.  The cases reported are 
from  Dutch (Link et al., 2012), New Zealander (Hoosen and Shaw, 2011), French 
(Berry et al., 2011), Spanish (Ta et al., 2010), Australian (Figtree et al., 2010), and 
Swedish (Brossier et al., 2003) travelers.   Perhaps malaria is a more difficult disease to 
curtail compared to HIV or tuberculosis owing to the fact of multiple distinct life cycle 
stages as well as its genetic complexity, which allows Plasmodium to adapt rapidly to 
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drug pressure and challenges by the immune system.  In hyperendemic areas, the most 
affected groups are children under five, pregnant women and other non-immune 
individuals (Sachs and Malaney, 2002). 
 
 
1.1.2   The disease 
  The clinical features are caused by the asexual blood stage of the parasite.   
These symptoms appear during the parasite’s maturation in the blood with the release of 
antigens during rupture of the host cell (Trampuz et al., 2003).  Cases of malaria can be 
divided into uncomplicated or mild and severe forms.   Symptoms of uncomplicated 
malaria include headache, myalgia and coughing that precedes a typical sequence of 
shaking chills, fever and sweating for which accurate diagnosis is often difficult. 
However, uncomplicated malaria can lead to a more severe condition (Weatherall et al., 
2002). Severe malaria is a life threatening disease because of the dysfunction of vital 
organs, i.e. the lungs, kidneys, liver and brain. Further complication such as 
enlargement of the spleen can occur in untreated cases associated with the increased 
capacity of the spleen to clear red cells from the circulation (Carter and Mendis, 2002). 
Cerebral malaria is characterised by deep coma and severe neurological symptoms, 
seizures, and hypoglycaemia especially in children and has been linked to the 
sequestration of parasitized erythrocytes in post capillary venules of the cerebral 
circulation (Weatherall et al., 2002).  Severe malarial anemia, including ‘black water 
fever’ due to the appearance of haemoglobin in the urine indicating severe intravascular 
hemolysis leading to hemoglobinuria and hemoglobinemia (White, 2004), and placental 
malaria causing abortion, premature death of the foetus and maternal death (Weatherall 
et al., 2002) are two further complications of malaria parasite infection. 
 
 
1.1.3  The parasite  
 
Malaria is caused by Plasmodium species of the phylum Apicomplexa, protozoa 
that are capable of infecting a variety or organisms including certain reptiles, birds and 
mammals. Malaria species are host specific, however several simian malaria species can 
be transmitted to man (Coatney, 1971; Escalante et al., 1998; Waters et al., 1993).  
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There are six species of Plasmodium responsible for human malaria: Plasmodium 
falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale  curtisi and 
Plasmodium ovale walikeri, as well as Plasmodium knowlesi  (Coatney, 1971; 
Sutherland et al., 2010).  
 
Other than the Plasmodium spp., the Apicomplexa include Toxoplasma gondii, a 
causative agent of complications in pregnancy and the immunocompromised; 
Cryptosporidium spp., a causative agent of gastroenteritis; Theileria spp. a tick-borne 
parasite of cattle in Africa and Eimeria spp. the causative agent of coccidiosis in 
livestock (Morrissette and Sibley, 2002).   Apicomplexan parasites shares common and 
unique structures known as the apical complex in the motile and invasive stages, which 
are usually call ‘zoites’  (Menard, 2001).  Zoites are polarized and elongated cells and 
the integrity of the cell shape is maintained by a set of microtubules anchored to the  
anterior polar ring and extending longitudinally under the parasite pellicle, which is 
composed of the plasma membrane (PM) and the inner membrane complex (IMC) 
(Morrissette and Sibley, 2002).   
 
 
1.2 The Plasmodium life cycle  
 
1.2.1 The zoites 
 
Zoites are motile forms that can be found in the lumen of the mosquito mid-gut  
(ookinete), in mosquito salivary gland and hepatocyte invasion (sporozoites) and in the 
red blood cell cycle (merozoites).  Although they invade different cells during the 
different life cycle stages, they share a similar overall morphology.  The zoites; the 
ookinete (~10-13µm long), the sporozoite (~12-15µm long) and the merozoite (~1.5µm 
long) possess apical secretory organelles namely micronemes, dense granules and 
rhoptries (only in the sporozoite and merozoite forms) (Figure 1.1).  These organelles 
are only seen in the zoites, secrete their contents at the anterior tip of the zoite during 
attachment, and invasion of the host cell. Following invasion the parasite resides within 
a parasitophorous vacuole (PV).  The PV is a parasite-derived vacuole formed during 
infection, primarily by secretion of the lipid-rich rhoptries and partly from later 
secretion of the dense granules (Baum et al., 2008a; Opitz and Soldati, 2002).  
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The ookinete’s lack of rhoptries is thought to correlate with its special role in 
traversing the mosquito mid-gut epithelium and the absence of PV formation (Vlachou 
et al., 2006). Having large rhoptries (club-shaped or elongated) and numerous 
micronemes, the sporozoites are able to glide, and traverse and infect hepatocytes.  On 
the other hand, the merozoite has large rhoptries and fewer micronemes, shows no 
gliding motility or cell traversal, but is able to rapidly invade the host cell powered by 
the  conserved gliding machinery (the glideosome) (Cowman and Crabb, 2006).  These 
apical secretory organelles are also present in T. gondii tachyzoites (the invasive stage) 
which suggested that they are conserved across Apicomplexa although the composition 
of their content differs which is a direct consequence of host cell type specificity (Baum 
et al., 2008a). Except for Cryptosporidium, these parasites  also contain  a non-
photosynthetic plastid (of algal origin) known as the  apicopalst to play important roles 
in metabolic activity and possibly in the establishment of the PV (Kim and Weiss, 
2004).   
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Figure 1.1:  The invasive stages of Plasmodium falciparum and Toxoplasma gondii.  
Conserved organelles at the apical prominence mainly involved in motility and host cell 
invasion are the rhoptries, micronemes and dense granules.  Ookinetes lack rhoptries.   
Both Plasmodium falciparum and Toxoplasma gondii belong to the genus Apicomplexa. 
Despite the conservation of apical organelles, differences such as the presence of the 
conoid (only in T. gondii) are also depicted here. (A) Ookinete (~10-13µM); (B) 
Sporozoite (~12-15µM); (C) merozoite (~1.5µM); (D) T. gondii tachyzoite (~7.5µM).  
Panels (A) and (D) taken from (Baum et al., 2008a); Panel (B) from (Frevert, 2004) and 
Panel (C) from (Bannister et al., 2000b) 
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1.2.2  The life cycle 
The life cycle involves two hosts one being the insect  (mosquito stage) and the 
other the human (vertebrate) host.  The life cycle involves two hosts one being the 
insect  (mosquito stage) and the other the human (vertebrate) host.  During a blood 
meal, a malaria-infected female Anopheles mosquito inoculates sporozoites into the 
human host.  Sporozoites infect liver cells and mature into merosomes, which rupture 
and release merozoites into the blood circulation.  After this initial replication in the 
liver (exo-erythrocytic schizogony), the parasites undergo asexual multiplication in the 
erythrocytes (erythrocytic schizogony). In continuous cycles merozoites infect red blood 
cells: the initial ring stage develops into a trophozoite and nuclear and cell division 
leads to a  mature schizont, which then ruptures releasing more merozoites. The cycle 
continues, but some parasites differentiate into sexual erythrocytic stages (gametocytes). 
The gametocytes, male (microgametocytes) and female (macrogametocytes) are 
ingested by an Anopheles mosquito during a blood meal. In the mosquito's midgut, 
gametogenesis  produces male and female gametes and the microgamete fuses with the 
macrogamete generating a zygote. The zygote in turn becomes motile and elongated  in 
a form now called an ookinete, which invades the mid-gut wall of the mosquito where it 
develops into an oocyst. The parasite's multiplication in the mosquito is known as the 
sporogonic cycle. The oocyst grows and sporogony results in oocyst rupture and release 
of sporozoites into the hemocoel. The oocyst-derived sporozoites migrate to and infect 
the mosquito's salivary glands.  Inoculation of the sporozoites into a new human host 
during a blood meal perpetuates the malaria life cycle (Bannister and Mitchell, 2003; 
Cowman and Crabb, 2006) (Figure 1.2).   
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Figure 1.2:  The malaria parasite life cycle.  Infection of humans occurs by 
inoculation of sporozoites by the bite of a female infected mosquito.  In humans, the 
sporozoites get carried with the blood stream to the liver where they invade hepatocytes 
starting the exo-erythrocytic liver stage cycle.  In the hepatocyte, the parasite grows 
through schizogony into a merosome which contains merozoites which then release into 
the blood circulation starting the asexual erythrocyte cycle.  The newly invaded 
merozoite forms the ring stage, progressing to a trophozoite and following schizogony 
to a schizont which releases merozoites into the blood circulation.  This starts a new 
asexual erythrocytic cycle.  Some of the merozoites after invasion develop into 
gametocytes which are taken up by feeding mosquitoes and start the sporogonic cycle 
resulting in the development of infective sporozoites.  Diagram adapted from (Bannister 
and Mitchell, 2003). 
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1.2.3 The mosquito stage 
The gametocytes are the only stages within the life cycle of the malaria parasite 
that are able to mediate the transition from the human host to the insect host.  
Gametocytogenesis starts in the erythrocyte cycle 9-12 days after the appearance of the 
parasite in the human blood and can be influenced by different kinds of stress, including 
parasite density, anemia, host immune response or drug treatment.   When the parasite 
becomes committed to change from the asexual pathway to the sexual pathway it will 
involve all merozoites from this schizont and it will result in the production of only one 
sex (male or female) per schizont (Bruce et al., 1990).   This was proven by using 
female and male-specific markers (pfg377 and α-tubulin II respectively) which showed 
that the siblings from one schizont were committed to female or male gametocytes 
exclusively. The switch is believed to have occurred the previous cycle before 
gametocyte manifestation (Silvestrini et al., 2000).  The cellular events of 
gametogenesis have been described in detailed (Carter and Miller, 1979; Sinden, 1983a, 
b).  During the blood meal from an infected human, the female mosquito takes up 
gametocytes.  By entering the mosquito mid-gut, the gametocytes become activated and 
round up before egress from their enveloping host cell erythrocyte. Here in the mid-gut 
the parasite receives environmental signals to switch from a warm blooded host to an 
insect vector. This extreme change includes sudden drop in temperature (10-15oC) , a 
pH decrease and the presence of mosquito-derived factors (xanthurenic acid), which  
trigger the  initiation and development of gametes (Billker et al., 1998; Kooij and 
Matuschewski, 2007).  The female macrogametocyte transforms into a macrogamete 
and the male microgametocyte develops into eight microgametes forming a rosette 
called an exflagellation center. The microgametes finally detach from the residual body 
as activated microgametes.  Within approximately 20 minutes post-activation, motile 
microgametes can fertilize macrogametes resulting in a zygote which then transforms 
into an ookinete within 24 hours (Figure 1.3)  (Kuehn and Pradel, 2010).   
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Figure 1.3: Gametocytogenesis and gametogenesis. (a) Giemsa-stained parasites 
depicting stages of gametocyte development in human blood. (b) schematic of 
gametogenesis both in human host and in mosquito. Stage-I: oat grain shape of ring 
stages with simple plasma membrane and small nucleus; Stage-II: D-shaped stage with 
8-15 microtubules and an inner pellicle membrane vacuole on the ‘straight’ side of the 
cell and a small nucleus with some spindles; Stage II-III: D-shaped parasites and the 
erythrocyte is distorted; contains 15-40 microtubules,and the inner pellicle membrane 
vacuole extends around the entire circumference; the nucleus becomes lobed; Stage III-
IV: spindle shaped and distorted erythrocyte with microtubules and membrane pellicle 
surrounding the cell; Stage V or mature stage shows a crescent shape parasite with 
blunt/ rounded ends within a distorted erythrocyte. The microtubules depolymerise and 
the inner membrane remains.  Females will stained blue, whereas, the male gametocyte 
is stained pink when using the Giemsa staining technique.  Pigmentation of hemozoin 
differs with a more compact form in the female and a dispersed form in male 
gametocytes.  In the midgut of the mosquito, female gametocytes transform into one 
macrogamete, meanwhile the male gametocyte forms eight microgametes by  
exflagellation (Dixon et al., 2008).  
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1.2.4 The liver stage 
The invasive stages of Plasmodium, Toxoplasma and Eimeria have two 
characteristics to ensure continuity of their life cycle: the capability of cell traversal and 
invasion  by gliding motility (at 1-10µm per second (Sibley et al., 1998). Malarial 
transmission to the human host is established by sporozoite infection, travelling through 
the skin in order to reach a blood vessel where they breach the endothelial barrier to 
enter the circulation and travel to the liver (Garnham, 1966). The circumsporozoite 
protein (CSP) and thrombospondin-related anonymous protein (TRAP) are essential 
membrane proteins required for sporozoite motility as well as attachment and invasion 
of the salivary gland (Baum et al., 2006b).  The cytoplasmic domain of TRAP has a 
penultimate tryptophan residue which is essential to sporozoite motility. TRAP has been 
shown to be crucial for the sporozoite’s ability to infect salivary glands as well as 
hepatocytes. Other thrombospondin domain-containing proteins in other life cycle 
stages appear to support a similar function such as circumsporozoite-TRAP-related 
protein (CTRP: in ookinete stages) (Dessens et al., 1999) and merozoite-TRAP 
(MTRAP: in merozoite stages) (Baum et al., 2006b).  Essential for Kupffer cell 
transversal motility are two sporozoite micronemal proteins named SPECT-1 and 2 
(Ishino et al., 2005; Ishino et al., 2004; Yuda and Ishino, 2004). 
 
 Cell traversal by Apicomplexan parasites involves the rupturing of the cell PM 
resulting in the death of several hepatocytes.  It is currently unknown how sporozites 
choose between traversal versus invasion of hepatocytes. It appears that cell traversal is 
essential for the induction of a cAMP derived signaling mechanism in the sporozoites 
which together with cytosolic Ca2+ levels lead to the secretion of  micronemes and 
rhoptries (Ono et al., 2008).   Sporozoites do not develop within the hepatocytes close to 
space of Disse in the liver, but they migrate through a several hepatocytes before 
invading the final hepatocyte.   The final invasion results in the formation of a PV in the 
selected hepatocyte.   Inside the PV, the sporozoite grows and differentiates into a 
young exoerythrocytic form (EEF).  During the onset of the EEF development cascade, 
the parasite typically lies close to the nucleus of the infected hepatocyte. Within two 
days (in rodent) or six to seven days (in primate), the developing EEF grows 
dramatically resulting in a parasite larger in size than the original host cell.  The final 
step is the release of merozoites into the blood circulation, which occurs not by rupture 
of the hepatocyte but by the formation of merozoite-filled vesicles,  so called 
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merosomes,  which bud off from the infected hepatocytes and release merozoites into 
the blood circulation (Sturm et al., 2006). 
 
1.2.5 The asexual blood stage 
In the blood circulation, the merozoite initially adheres to the erythrocyte surface 
before invasion proceeds. The initial attachment is reversible, then the merozoite re-
orientates to ensure that the apical end which contains the invasion apparatus is 
juxtaposed to the erythrocyte membrane.  The erythrocyte membrane appears thickened 
at the contact site and at this point the merozoite activates the invasion machinery based 
on an acto-myosin motor complex.  In the erythrocyte, the newly invaded merozoite 
undergoes several stages of its asexual development and multiplication within a 
membranous sac called the parasitophorous vacuole (PV).  The intracellular stages are 
named ring, trophozoite, and schizont. Some parasites switch from the asexual pathway 
to the sexual pathway and develop into gametocytes (Bannister and Mitchell, 2003; 
Bannister, 2001; Garnham, 1966).   During this early developmental stage the parasite 
feeds on small amounts of haemoglobin ingested through the cytostome or cell mouth, 
specialised to phagocytose food.   P. falciparum digests more than 80% of the 
erythrocyte’s haemoglobin to support parasite growth (Francis et al., 1997).  The bulk 
of haemoglobin degradation occurs via a semi ordered process of digestion by proteases 
which are contained within the food vacuole (Lazarus et al., 2008).   The haem products 
of the haemoglobin digestion are crystallized into a dark pigment called haemozoin 
which is contained within the food (pigment) vacuole.  Any disruption of the 
haemoglobin degradation process such as that mediated by artemisinin (by damaging 
the food vacuole or haem polymerization) and chloroquine (by inhibiting the 
polymerization of haem released during haemoglobin proteolysis) will result in parasite 
death (Bannister and Mitchell, 2003; Francis et al., 1997). The ring grows more 
rounded, increasing the size of the PV membrane (PVM) and extends finger-like 
projections and membranous blebs into the surrounding erythrocyte (Bannister et al., 
2003; Bannister et al., 2000a). 
Trophozoites are the most metabolically active uni-nucleate stages in asexual 
parasite development.  The numbers of free ribosomes multiply greatly and the ER 
enlarges, marking the increases of protein synthesis.  The parasite feeds on the 
haemoglobin of the erythrocyte and alters significantly the host cell by exporting 
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numerous parasite proteins into its cytoplasm and to its surface, resulting in the 
formation of knobs on the host cell surface. Knobs are relevant to allow sequestration of 
parasitized erythrocytes in blood vessels preventing splenic clearance (Bannister et al., 
2003).  The function of the largely extended cleft network within the host erythrocyte is 
still under debate. Recently using EM, tethers connecting the Maurer’s cleft bodies with 
the erythrocyte membrane have been identified suggesting a role in transport between 
the clefts and the erythrocyte surface, which may aid the vesicle mediated delivery of 
PfEMP1 to the surface (Gruring et al., 2011; Hanssen et al., 2010; Tilley et al., 2007).  
During the development of schizont stages, DNA replication occurs and apical 
organelles (rhoptries, micronemes and dense granules) are formed. Cytoskeletal 
components such as microtubules and the apical polar ring are formed beneath the 
merozoite surfaces which are vital for nuclear segregation and therefore formation of 
daughter merozoites. Cytokinesis takes place during schizont development and starts 
from a cleavage furrow on each merozoite.  Once cytokinesis is completed, marked by 
the end of schizogony, and the merozoites are ready to be released into the blood 
circulation,  the host cell membrane and PVM are lysed in a protease-dependent process  
(Bannister et al., 2000a).  Figure 1.4 shows the complete erythrocyte asexual life cycle. 
Gametogenesis occurs when the parasite switches, changing their pathway from 
producing merozoites to producing gametocytes.  
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Figure 1.4: Asexual stages of Plasmodium. (a) the invasion event starting from 
attachment to post invasion, (b) ring stages. (c) trophozoite stages, (d) dividing schizont, 
and (e) schizont rupture releasing merozoites (Bannister et al., 2003)  
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1.3 The erythrocyte invasion by merozoites  
The invasion of erythrocytes by Plasmodium merozoites starts with the 
attachment to the erythrocyte surface followed by a reorientation process in which the 
apical end of the merozoite is brought to be juxtaposed to the erythrocyte surface. When 
the tight or moving junction (TJ or MJ) is formed the invasion process becomes 
irreversible; the molecular motor engages and drives the invasion. At the same time 
proteases cause the shedding of the surface coat while the parasite is moving into the 
erythrocyte. Lastly the moving junction seals behind the invading merozoite which is 
now found within the PV within the host cell (see review by [(Cowman et al., 2012; 
Cowman and Crabb, 2006)]) (Figure 1.5).   
 
 
 
Figure 1.5: Malaria invasion of the host cell.  Attachment of merozoites to the 
erythrocyte surface occurs following egress from schizonts, andis a reversible process.  
Merozoites then reorientate to bring the apical end in proximity to the erythrocyte 
membrane. The secretion of apical organelles allows the formation of a MJ and makes 
the invasion irreversible.  The MJ is somehow connected with the acto-myosin motor 
resulting in the movement of the junction across the merozoite surface. In the same 
process surface proteins are shed. The PV is formed from the erythrocyte plasmalemma 
and rhoptry secretions and once the MJ reaches the posterior end of the parasite, the 
membrane seals (Cowman et al., 2012). 
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1.3.1 Initial attachment 
A few moments prior to merozoites release, the schizont transforms 
morphologically into a more rounded form. Each merozoite appears defined, tightly 
packed and symmetrically arranged in a flower-like shape around a centrally located 
digestive vacuole with condensed haemozoin.  A few seconds before actual merozoite 
egress, the merozoites are released from the PVM into the host cell and then from the 
erythrocyte, in an explosive event causing the curling of the erythrocyte membrane, into 
the blood stream (Abkarian et al., 2011; Glushakova et al., 2005).  Initial attachment 
(depending on the receptor-ligand interaction) of the merozoite is believed to be 
mediated through the adhesive surface coat. This is the first and crucial step of  invasion 
where the merozoite needs to distinguish an erythrocyte from other cells. At this stage 
the merozoite can detach and re-attach to another erythrocyte (Bannister and Dluzewski, 
1990; Dvorak et al., 1975).   
The attachment to the erythrocyte can occur anywhere on the surface of the 
merozoite. A merozoite surface protein (MSP) binds to the erythrocyte plasma 
membrane and caused adhesion. More than one MSPs, are essential for the erythrocyte 
adhesion, these included members of EBA and Rh families, which are secreted onto the 
surface from the internal apical organelles. These protein bind to specific receptors 
(Tham et al., 2012). Due to the abundance and distribution of MSP1 all over the surface, 
MSP1 may mediate this initial interaction during the invasion process (Holder et al., 
1985). MSP1 processing fragments have been described to bind to erythrocyte 
receptors, such as the C-terminal MSP119 fragment and erythrocyte receptor band 3 
(Goel et al., 2003; Li et al., 2004) or MSP142 and heparin (Boyle et al 2010). EBA175  
binds to Glycophorin A and PfRh4 binds complement receptor (CR)-1 (Tham et al., 
2012).  Gene knockout experiments indicated that the Rh and EBA families function 
cooperatively, such that EBA genes loss of function resulted in increased transcription 
of the PfRhs family (Lopaticki et al., 2011). 
 
1.3.2 Apical orientation 
After initial attachment the merozoite re-orientates such that the apical complex 
is juxtaposed to the erythrocyte membrane so that secretion from the apical organelles 
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(rhoptries and micronemes) can be triggered.  The merozoite wraps itself with the 
erythrocyte to facilitate the reorientation, and AMA1 has been implicated in this 
reorientation process (Mitchell et al 2004). After reorientation of the merozoite, a tight 
interaction between parasite and erythrocyte membrane is formed. This  junction zone is 
marked in EM images by an electron-dense undercoating of the erythrocyte membrane 
and a closer inter-membrane distance of between about 4 nm (Bannister et al., 1986) 
and ~10nm (Aikawa et al., 1978). This junction formation involves more than one 
merozoite protein secreted from the apical organelles (micronemes and rhoptry tip) 
including the rhoptry neck proteins RON2 and RON4 and others such as the  
erythrocyte binding antigen family (Gaur et al., 2004) and the reticulocyte binding 
protein homologue family (Rayner et al., 2000; Triglia et al., 2009).  The exact 
sequence of  protein secretion from different organelles and the exact external signal 
that triggers this release are still unknown.  
 
1.3.3 Moving junction (MJ) formation 
Much of the invasion process itself is organized around a key interface that 
forms between the two cells called the MJ.  The MJ creates a tight molecular seal 
between  the host and parasite membrane  (Aikawa et al., 1978) believed to be 
comprised of RON2 and RON4 (Besteiro et al., 2011) and other proteins including 
AMA1 and MTRAP which span the host and parasite membrane and associate with 
aldolase (on the cytoplasmic face of the parasite PM)  The MJ moves from the apical 
end towards the posterior end of the merozoite, powered by the acto-myosin motor 
(Baum et al., 2006a; Morrissette and Sibley, 2002), driven by Myosin A (MyoA) via 
filamentous actin (F-actin).  F-actin is present at the apical pole of invading merozoites 
and then concentrated at the MJ during invasion (Baum et al., 2008b).   As the MJ 
progresses towards the posterior end of the parasite, ligands mediating the adhesion to 
the host cell must be removed/shed (Cowman and Crabb, 2006).  The erythrocyte 
membrane at the point of attachment is slightly raised and thickened.  As the invasion 
progresses, the indentation deepens and conforms to the curvature of merozoite.   Once, 
the merozoite-erythrocyte junction is initiated, and MJ progresses the thickened, 
electron-dense zone on the erythrocyte membrane is no longer observed at the site of 
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initial attachment (Tyler et al., 2011).   The junction transforms from a localized patch 
to an orifice through which the merozoites penetrates into the deepening, forming PV.  
The PVM is partially derived from the erythrocyte membrane as well as new 
membrane material presumed to be derived from the contents of rhoptries. Not all host 
PM proteins enter the PVM, the MJ sieves some selected proteins (for examples flotilin-
1 and -2 are exclusively internalized into the newly form PVM, although some proteins, 
such as stomatin and nonraft cytoskeletal proteins, are excluded) (Murphy et al., 2007). 
The secretion of the AMA-1/ RON complex is essential not only for establishment of 
the MJ but also for the secretion of the rhoptry bulb contents which then allows the 
establishment of the PV. RON2 is a transmembrane protein which after secretion from 
the rhoptry neck sits in the erythrocyte plasma membrane. It associates with RON4 and 
RON5 secreted into the erythrocyte cytoplasm and connects to the host cell 
cytoskeleton (Tonkin et al., 2011). In Toxoplasma, MJ is constituted by the AMA-1 and 
RON2/4/5 complex, and recent showed the involvement of association with RON8 
(Figure 1.6).  The complex of RON2/4/8 is injected into the MJ tethered by RON2 
(Tonkin et al., 2011). Knockout of the RON8 gene seem to cripple the parasite making 
it unable to establish firm attachment of the MJ (Straub et al., 2011).   AMA-1 is the 
only member on the parasite surface which so far has been identified in the MJ complex 
and the best candidate for anchoring the complex on the parasite site.  Knockout of 
AMA-1 impaired parasite attachment to the host cell,  invasion and affected rhoptry 
secretion (Andenmatten et al., 2013; Mital et al., 2005).  
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Figure 1.6: Moving junction formation and the role of the AMA-RON complex. (a)  
Close up of the apical tip displaying secretory organelles; rhoptries (bulb and neck 
compartment), dense granules and micronemes. Rhoptries are being secreted with the 
RONs embedding themselves in the erythrocyte membrane and connecting to the host 
cell cytoskeleton. (b) Zoite partially invaded.  The MJ coincides with the parasite 
contractile apparatus (Tyler et al., 2011). (c) Overview of  TgAMA1 and the RON 
complex.  This figure depicts the essential TgAMA1-TgRON2 complex that links the 
parasite and host cell.  The proposed extracellular location of the C-terminus of 
TgRON2 is indicated (denoted by [(c)]) (Tonkin et al., 2011).  
 
1.3.4  Sealing and completion of the parasitophorus vacuole 
As the parasite pushes its way into its host cell, it lies within a PV which it 
forms to seal itself from the host cytoplasm and form an environment hospitable for its 
development.  The membrane of the invagination eventually closes at the posterior end 
of the merozoites to form the PV (Cowman and Crabb, 2006) . The sealing process is 
followed by a brief period of echinocytosis of the erythrocyte defined by a 
morphological spiking of the host cell stimulated by the efflux of potassium and 
chloride ions. Within 10 min however the erythrocyte returns to its normal shape 
(Gilson and Crabb, 2009). Progression of the MJ complex over the merozoite, formation 
of the PV and the sealing events can be followed experimentally by using labeled 
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PfRON4 and PfRON2 as markers (Zuccala et al., 2012).   The internalized parasite 
known as a ring stage  then undergoes rapid, dramatic changes in cell shape (Gruring et 
al., 2011). 
 
1.4 The Myosin superfamily 
Myosins can be defined as a diverse superfamily of molecular motor proteins 
capable of translocating actin filaments or vesicle cargo on fixed actin filaments.  
Myosin has the ability to convert energy released by ATP hydrolysis into mechanical 
work (Sellers, 1999).  Even though all myosins have this ability, different myosins 
perform very different types of functions in the cell.  Some myosins are important in 
cell polarisation, cytokinesis, organelle transport and trafficking as well as signal 
transduction (Thompson and Langford, 2002).  Myosins can be classified into several 
classes. Previously 18 different classes were distinguished (Hodge and Cope, 2000; 
Sellers, 2000)  whereas more recently 24 have been described (Foth et al., 2006).  The 
characterisation is based on the molecular structure comprising a heavy chain with a 
conserved head domain, generally near the N-terminus, followed by an alpha-helical 
light chain-binding domain consisting of one or more IQ motifs and a C-terminal 
domain.  N-terminal extensions are also characteristic of a few classes of myosins 
(Coluccio, 2008; Lodish et al., 2008; Sellers, 1999; Thompson and Langford, 2002). 
The more recent classification takes into account similarities of the amino acid sequence 
in the head domains and phylogeny (Foth et al., 2006) (Figure 1.7).  
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Figure 1.7:  Myosin superfamily.  Phylogenetic tree of the myosin superfamily. Class 
XIV contains only Apicomplexan myosins, which are suggested to be similar to classes 
III, XII, XVII and more distantly related to class I (Hodge and Cope, 2000).  
Apicomplexa class XIV is highlighted in the blue circle and includes TgMyoC, 
TgMyoB, TgMyoE, PfMyoA, TgMyoA, TgMyoD and PfMyoB. 
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All type of myosins consists of at least 3 functional domains (Figure 1.9):    
i) the highly conserved head domain or motor domain also known as cross-
bridge, which also contains the ATPase activity.  Crystal structures for type 
I, II, V, and VI have been determined and show conservation in the head 
domain. The head domain consists of a 7-stranded β-sheet surrounded by 
numerous α-helices.  The ATP binding site consists of a P-loop.  The head 
domain also contains the actin binding site which is split by a deep cleft 
allowing the domain to open and close in response to ATP binding.  ATP 
hydrolysis causes structural conformational changes which are transmitted 
from the head domain to the lever arm by a small protein region called the 
converter. This converter region is able to change a linear displacement into 
a rotation.  
ii) the lever arm or neck region which consists of an α-helix of variable length 
carrying a number of characteristic IQ motifs (between 1 and 6) which have 
the consensus calmodulin-binding sequences (IQxxxRGxxxR). Each IQ 
motif serves as a binding site for either a myosin-specific light chain or 
calmodulin 
iii) a tail region of variable length, domain composition and organisation.  The 
cellular localisation and function of the myosins is determined by the tail 
region. Functions range from filament assembly to cargo binding (Figure 
1.8) (Coluccio, 2008; Lodish et al., 2008; Sellers, 1999; Thompson and 
Langford, 2002).   
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Figure 1.8:  Myosin structures. (a) Schematic diagram of myosins. In myosins three 
different domains can be distinguished: the head domain, neck domain and tail domain.  
The head domain or motor domain usually serves as an ATP binding site, contains 
ATPase activity and has the actin binding site.  The neck domain serves as the lever arm 
usually for regulation purposes.  This site binds either myosin-specific light chains or 
calmodulin. The tail domain, defines the specific role of each myosin, serves as a 
receptor for cargo binding and can form dimers. (b)  Schematic diagram of skeletal 
muscle myosin II which can be broken into fragments by proteolysis. LMM (light 
meromyosin), HMM (heavy meromyosin), S1 (subfragment1) and S2 (subfragment 2). 
(c) Crystal structure of myosin II motor domain.  The conformation shown is the post 
rigor state.  N-terminus (green), nucleotide binding P-loop and adjoining helix (yellow), 
upper 50K (red), lower 50K domain (grey), C-terminal long helix (dark blue) with two 
calmodulin-like chains. Diagram (a) and (b) are adapted from Lodish H, Berk A, 
Zipursky SL, et al. Molecular Cell Biology. 4th edition. New York: W.H.Freeman; 
2000. Available from: http://www.ncbi.nlm.nih.gov/books/NBK21475/) and (c) from 
(Coluccio, 2008) 
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Best described myosin belong to classes I, II, V, VI and also XIV, especially important 
in apicomplexan parasites.  
Myosin I is an unconventional myosin with a single head molecular motor due to 
lack of heptapeptide motifs responsible for coiled-coil association in other myosins. The 
neck domain of myosin I of Dictyostelium and Acanthamoeba associates with one or 
two light chain subunits, whereas in vertebrate cell it contains one to six IQ motifs.   
The tail domain is relatively short containing TH1 (tail homology 1) domains 
responsible for membrane binding. Others also contain TH2 domains with are enriched 
with glycine, proline and alanine or glutamine residues, and may contribute to an ATP-
insentive actin-binding site that is believed to serve in anchoring the motor to one actin 
filament so that it can be moved past another actin filament. Others again contain a src 
homology (SH3 or TH3) domain that is found in several membrane cytoskeletal 
proteins.  These myosin exhibit an ATP-independent actin binding site (Coluccio, 2008; 
Sellers, 1999). 
Myosin II is a conventional myosin. Members of the myosin II class are numerous 
and well-studied.  Myosin II is a hexameric polypeptide that is formed of two heavy 
chains which contain the actin and nucleotide binding sites, two light chains and two 
regulatory light chains.  Myosin II binds to actin filaments for a short period only. The 
two heads appear to act independently at the N-terminus which contains the actin and 
nucleotide binding site.  At the C-terminus of two heavy chains, between the two 
globular head regions and highly elongated coiled-coil α-helical rod lies the binding site 
for two light chains.  Each head is associated with an essential and a regulatory type 
light chain.  The tail region is long and contains α-helical coiled-coil  regions that self-
assemble and form a variety of filament structures such as in skeletal myosin (Coluccio, 
2008; Sellers, 1999).   
Myosin V consists of two heavy chains which dimerise via their coiled-coil regions 
in their tails.  The neck domain is extended comparable to that of myosin II and contains 
six IQ motifs. This allows the association with multiple calmodulins and specific light 
chains. Myosin V is a cargo-transporting molecule which walks processively along 
actin filaments in a hand-over-hand mechanism. The dimer is functionally essential and 
the two heads interact strongly through actin binding. The long range movement occurs 
outwards towards the plasma membrane and is tightly associated with the short-range 
40 
 
movement of endocytic vesicles achieved via myosin VI (Coluccio, 2008; Sellers, 
1999). 
Myosin VI is an unusual myosin because it moves backwards toward the minus end 
of the actin filament.  It can be found in distinct locations and is implicated in a wide 
range of processes such as endocytosis, exocytosis, and maintenance of Golgi 
morphology and cell migration.  The head domain contains a unique insertion of 25 
residues which can be found within a surface loop within the 50kDa domain (Kellerman 
and Miller, 1992).  In addition, myosin VI has 50 amino acid inserted N-terminal to the 
single IQ domain, which is a characterising feature for this class of myosins.  The tail 
domain consists of a short 200 amino acid sequence and is predicted to form coiled-coil 
structures. (Coluccio, 2008; Sellers, 1999). 
Myosin XIV is found only in Apicomplexa and ciliates.  Myosin XIV appears to 
have evolved from myosin I in the alveolate protist lineage.  The appearance of myosin 
XIV was coincident with the disappearances of myosin I from alveolates, in accordance 
with the myosin family tree by Hodge and Cope (2000).  Myosin XIV was grouped into 
a  separate class although there is a similarity in the head domain between myosin I and 
myosin XIV (Thompson and Langford, 2002).  The class XIV myosins have been 
described in ciliates and in Theileiria, Toxoplasma, Plasmodium, Cryptosporidium and 
Eimeria.  In P. falciparum six class XIV myosins can be distinguished named PfmyoA 
to F (Chaparro-Olaya et al., 2003; Vale, 2003). PfmyoA was first identified (Pinder et 
al., 1998) before identification of PfmyoB, PfmyoC and PfmyoD orthologues in T. 
gondii (Heintzelman and Schwartzman, 2001; Hettmann et al., 2000). Recently PfmyoE 
and F have been described following on from the P. falciparum genome project 
(Chaparro-Olaya et al., 2005; Gardner et al., 2002). Relative transcript abundance of 
these six myosins was analysed in blood stage parasites and showed that MyoA, MyoB,  
MyoE and MyoF (currently known as MyoK) are maximally expressed in schizont 
stages to approximately equal levels (Chaparro-Olaya et al., 2005).  Apicomplexan 
myosins were further divided into two subclasses called  XIVa and XIVb (Chaparro-
Olaya et al., 2005), and even more recently ino four subclasses (Foth et al., 2006).  
Reclassification of the subclasses resulted from a ‘Naming Convention of 
Apicomplexan Myosins’ to aid consistency between species.  A systematic naming was 
proposed so that the same letter denotes homologous myosins across taxa.  The naming 
system was based on homology to T. gondii myosins since T. gondii has the largest 
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identified myosin repertoire (11 myosins) of any Apicomplexan. (Heintzelman and 
Schwartzman, 1997, 2001; Hettmann et al., 2000). Thus the previously named PfMyoC, 
PfMyoD and PfMyoE of Plasmodium were changed to PfMyoF (~240kDa), PfMyoJ 
and PfMyoK   respectively. MyoB of Babesia and Theileria was changed to MyoH.  
During this reclassification, MyoH was regrouped into a new subclass XIVc.  The 
existing 12 ciliate myosins were grouped into subclass XIVd.   
Phylogenic comparisons that include P. falciparum myosins are difficult due to 
the A/T rich genome and the insertion of low sequence complexity regions. As a result 
some P. falciparum myosins appear on long branches of the phylogenic tree and are 
therefore difficult to classify.  Consequently, three P. falciparum myosins (PfMyoC, 
PfMyoD and PfMyoF) were excluded from class XIV leaving three sequences in class 
XIV, of which PfMyoA is segregated in subclass XIVa (~93kDa), together with MyoA 
from T. gondii (TgMyoA), P. berghei (PbMyoA), B. bovis (BbMyoA) and C. parvum 
(CpMyoA),  whereas PfMyoB (~93kDa) and PfMyoE do not unambiguously cluster 
with other sequences (Foth et al., 2006). MyoA had been described in other 
Apicomplexan species showing 84% amino acid identity between P. falciparum and 
mouse malaria species P. berghei and P. yoelii and 62% identity with T. gondii 
(Matuschewski et al., 2001). 
The MyoA function in both Toxoplasma and Plasmodium is important for 
gliding motility and host cell invasion by interacting with actin and forming a fast, plus-
end-directed motor (Herm-Gotz et al., 2002).  Only one Plasmodium myosin class XIV 
(PfMyoA) has so far been studied in detail. In Toxoplasma, TgMyoA was implicated in 
cell invasion (Herm-Gotz et al., 2002; Meissner et al., 2002). MyoD with the apparent 
molecular weight of ~91kDa localises to the pellicle of tachyzoites and merozoites 
(Hettmann et al., 2000). Although MyoD is not essential for tachyzoite motility or 
propagation it might still be involved in motility in the bradyzoite stages of the parasite 
(Herm-Gotz et al., 2006; Hettmann et al., 2000).  TgMyoB/C have been implicated in 
parasite cell division (Delbac et al., 2001) and there is speculation that myosins 
belonging to class XIVc are involved in mitosis, cytokinesis or other cell cycle events 
(Coluccio, 2008; Foth et al., 2006). 
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1.5 The inner membrane complex (IMC)  
Apicomplexan parasites such as Plasmodium, Toxoplasma, Cryptosporidium and 
Theileria share unusual cytoskeletal elements that provide a structural framework for 
the cell.  The motile stages are surrounded by the pellicle, a three-layered structure 
composed of the plasma membrane and the inner and outer membrane of the inner 
membrane complex (IMC).  The IMC is formed by one or several flattened vesicles 
underlying the plasma membrane (Morrissette et al., 1997). A group of 2 or 3 
microtubules arranged in parallel run from the third polar ring or MTOC, to the 
merozoite’s posterior, underlying the IMC. This structure is known as the P. falciparum 
merozoite assemblage of subpellicular microtubules (f-MAST) and is thought to act as a 
directional guide, indicating the apical polarity and facilitating a cortical flow of F-actin 
over myosin (Fowler et al., 2001).  The IMC provides stability and shape to the zoite 
(Aikawa et al., 1981; Tremp and Dessens, 2011; Tremp et al., 2008), as well as 
functioning as a scaffold for organellogenesis and cytokinesis (Nishi et al., 2008). The 
IMC also supports the glideosome apparatus that is required for gliding motility and 
host cell invasion (Gaskins et al., 2004).   Deletion of genes for  protein components of 
the IMC such as IMC1 in Toxoplasma (TgIMC1),  or IMC1a and  IMC1b in ookinetes 
and sporozoites of P. berghei, caused altered stability and rigidity of the daughter cell 
subpellicular network,  an abnormal cell shape, reduced speed of motility, decreased 
mechanical resistance and reduced infectivity (Khater et al., 2004; Mann et al., 2002).   
 
1.6 Acto-myosin motor complex in Apicomplexa 
In Apicomplexa generally, the invasive stages use substrate-dependant motility 
to invade the host with an invasion machinery powered by an acto-myosin motor known 
as the glideosome complex (Opitz and Soldati, 2002).  This was established clearly by 
the use of drugs that interfere with actin dynamics such as cytochalasin D, 
jasplakinolide and latrunculin B as well as myosin ATPase function modulators such as 
BDM (2,3–butanedione monoxine) which block invasion (Dobrowolski and Sibley, 
1996; Matuschewski et al., 2001; Siden-Kiamos et al., 2006a; Wetzel et al., 2003).  The 
gliding motility of Toxoplasma and Plasmodium and movement during cell invasion is 
critically dependent on actin polymerization and is powered by a myosin motor 
(MyoA), which is ubiquitously conserved across the phylum (Baum et al., 2006a; Baum 
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et al., 2006b). TgMyoA together with the myosin light chain (TgMLC1) and the integral 
membrane glycoprotein GAP50 (glideosome associated protein 50), which anchors the 
motor firmly in the IMC, and the lipid modified GAP45 (glideosome associate protein 
45) forms the motor in T. gondii. Orthologous proteins have been identified in 
Plasmodium with PfMyoA, PfMTIP (Pf myosin tail domain interacting protein), 
PfGAP45 and PfGAP50, which are conserved across the genus (Gaskins et al., 2004).  
 It is believed that for gliding motility to occur, the MyoA motor complex 
somehow needs to be firmly anchored to the IMC/subpellicular microtubule 
cytoskeleton of the parasite, while actin is firmly attached to a solid substrate outside of 
the cell via an adhesive protein such as TRAP or MTRAP.  It has been established that 
aldolase, a tetrameric glycolytic enzyme, offers a bridge between the acto-myosin motor 
and the host receptor-ligand complex (Buscaglia et al., 2003; Jewett and Sibley, 2003).  
This glycolytic enzyme is unexpectedly able to bind to both the C-terminal domain of a 
transmembranous adhesin and to parasite actin filaments (Baum et al., 2008a; Bosch et 
al., 2007a; Buscaglia et al., 2003; Uchime et al., 2012). Adhesin molecules which are 
able to bind using their cytoplasmic tails to connect via aldolase to actin are TgMIC2, a 
member of the TRAP family; TRAP and TRAP-like protein (TLP) in Plasmodium 
sporozoites; CSP and TRAP related protein (CTRP) in Plasmodium ookinetes, and 
MTRAP in merozoites. This model of motility requires the posterior translocation of the 
F-actin-aldolase complex which is bound to the adhesion protein, moving along the 
myosin track which is firmly anchored in the IMC. This process is able to generate the 
force required for the parasite to move forward.  This chain of interacting components 
of TRAP/MTRAP-aldolase-actin-MyoA-MLC/MTIP-GAP45-GAP50 together forms 
the motor complex. 
 
1.6.1 Plasmodium falciparum myosin A (PfMyoA)  
PfMyoA like TgMyoA (~90-93kDa, 818 amino acids) is a single headed myosin 
with no definitive neck region and a very short tail. TgMyoA has 63% identity to 
chicken skeletal muscle myosin II (Ckn myosin II) with 64% identity in the head alone 
and 32% identity in the tail region. MyoA is peripherally located and shows a 
concentration towards the parasite apex. MyoA is expressed in schizonts but not 
detected in ring stages (Chaparro-Olaya et al., 2005; Foth et al., 2006; Pinder et al., 
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1998).  MyoA was also identified in sporozoites and merozoites of P. berghei 
(PbMyoA) and P. yoelii (PyMyoA) (Matuschewski et al., 2001). MyoA is also present 
in ookinetes where is essential for motility (Siden-Kiamos et al., 2011).   PfMyoA 
consist of a conserved motor and light chain binding region.  The head region displays 
conserved ATP and actin binding sites with which MyoA generates force upon 
attachment to an actin filament.  MyoA binds to actin and is released from actin in an 
ATP-dependent manner.  In comparison to the head region of Ckn myosin II, PfMyoA 
shows the least conservation in the loop-2 (less charge) and loop-3 (similar charge) 
regions with the other elements well conserved (Figure 1.9).  In the relay-helix (SH-1) 
and the converter there is less identity with Ckn myosin II.  In Ckn myosin II, the 
“fulcrum point" (a region that undergoes conformational changes upon actin-myosin-
ATP interaction, which lead to lever arm movements for the power stroke (Liang and 
Spudich, 1998) is where the conserved glycine is replaced by a serine residue (S690 in 
PfMyoA).  However, the glycine at the end of the SH-1 helix is conserved in both 
TgMyoA and PfMyoA (G710 and G701 in Ckn myosin II and PfMyoA respectively).  
This residue is believed to allow rotational movement of the converter of PfMyoA 
(Figure 1.10) (Farrow et al., 2011).  Normally, in other myosins, the neck region 
contains a variable number of IQ motifs, which bind to the EF-hands of calmodulin-like 
light chains which serve to strengthen and extend the myosin lever arm.  In Ckn myosin 
II this region binds to two light chains known as “essential” and “regulatory” light 
chain.   
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Figure 1.9:  Clustal alignment of amino acid sequences of PfMyoA, TgMyoA 
compared to Chicken muscle myosin II (Ckn myoII).  This alignment shows the 
similarities between PfMyoA, TgMyoA and the less similar Ckn MyoII.  The black 
boxes highlight relatively well conserved regions, while poorly conserved regions are 
boxed in red.  The individual substitution of amino acid was highlighted in blue letters.  
Residues which are involved in binding to the light chain (MTIP) are underlined in 
green. A possible degenerate putative IQ motif upstream of the MTIP binding motif is 
underlined in red.  TEDS site, the fulcrum point boxed in blue.  The conserved glycine 
(G699) at the fulcrum point is replaced by serine (S690) in P. falciparum (Farrow et al., 
2011). 
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Figure 1.10:  Putative protein structure of Plasmodium falciparum Myosin A 
(ribbon diagram).  (a) shows the U50K domain (red); L50K domain (yellow); N-
terminal domain (grey); central β-sheet (blue); the SH1 helix and rely helix and 
converter (in green); lever arm (blue); actin binding loop (black).  TEDS site (T416-
green); T587 of the HTIG sequence (red) and pivotal S690 (yellow spheres). (b) the 
highly conserved glycine (at the end of SH1 helix) is replaced with a serine (S690) in 
PfMyoA (Farrow et al., 2011). 
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1.6.2  Interaction of MyoA with its myosin light chain, MTIP 
All class XIV myosins are short motor molecules that contain a neck region 
divergent from other myosins and lack a true, elongated tail domain. The function of the 
myosin motor can either be modulated by phosphorylation of the myosin heavy chain 
(MHC), such as at the TEDS rule site, or via the interaction with the myosin light chain 
(MLC). Normally the TEDS rule site is found in a region of the myosin head which 
contains a consensus site for Ser/Thr phosphorylation and makes significant contact 
with actin, so that this interaction can be altered by increasing/decreasing the negative 
charge. MyoA has been shown to be phosphorylated by CDPK1 and PKA (Lasonder et 
al., 2012).  The TEDS site rule has been deduced from the tendency of many myosins to 
carry a phosphorylatable residue or an acidic residue (T, E, D, S) at position 16 
upstream of the conserved sequence element DALAK. This sequence element however 
is only partially conserved in MyoA molecules. Some myosins do not adhere to the 
TEDS rule and it has been proposed that their interaction with actin is regulated 
differently. MyoA shows unusual features, and therefore it has been a challenge to 
predict the potential mode of regulation for these molecules.   MyoA does not follow 
the TEDS rule and rather is regulated by MLC1/MTIP which bind to an unusual binding 
site in the short neck domain, which is devoid of IQ motifs (consensus 
IQXXXRGXXXR) (Bement and Mooseker, 1995; Foth et al., 2006).   
TgMyoA is not directly bound to the IMC but connects to it through MLC. The 
extreme C-terminus of TgMyoA is important for its peripheral localization. More 
precisely it is a dibasic motif of two arginines  which might be part of a divergent IQ 
motif (known as ‘degenerate’ IQ (IQXXXRGXXXR/K) due to the fact that it does not 
fully conform to the usual IQ motif (Herm-Gotz et al., 2002; Hettmann et al., 2000)), 
that contributes to the association with TgMLC1/MTIP and via this with the IMC 
(Bergman et al., 2003; Herm-Gotz et al., 2002; Hettmann et al., 2000; Jones et al., 
2006).  MLC1 and MTIP contain four degenerate EF-hands  missing the canonical 
calcium-binding motif (Herm-Gotz et al., 2002), and the interaction with MyoA appears 
to be calcium- independent (Bosch et al., 2006; Green et al., 2006b). Therefore both 
TgMLC1 and MTIP resemble an atypical EF-hand in which the Ca2+ binding site 
residues are not conserved. The MyoA binds to MTIP via a short, 15 aa sequence and 
removal of these residues eliminates the MyoA-MTIP interaction.  In Plasmodium, 
double or single substitutions of R and K residues in the divergent IQ motif completely 
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abolish the PfMyoA interaction with PfMTIP (Jones et al., 2006). In addition Bosch et 
al., (2006, 2007), showed that overall correct conformation of MTIP is important for the 
interaction between the MTIP C-terminus and the 15 amino acid region in the MyoA-
tail.  
Phosphorylation occurs at S107 and/or S108 of PfMTIP in vivo and mutations at 
those sites weakens the affinity of MTIP for the C-terminal tail of MyoA.  This 
disruption is likely to have a significant impact on MyoA since the localization to the 
IMC is dependent of the interaction with MTIP (Douse et al., 2012). The N-terminus of 
the MTIP homologue, TgMLC1 has been shown to be involved in the interaction with 
GAP45 (Frenal et al., 2010).  A conditional knockout of TgMyoA using a tetracyclin-
inducible gene expression system showed that MyoA is important for parasite gliding 
motility, host cell invasion and egress (Meissner et al., 2002).  Since the MyoA-
MTIP/MLC1 interaction is important for parasite invasion, any disruption is expected to 
prevent a continuous parasite life cycle. Thus this interaction could be a good target for 
anti-malarial compound development. However more recently, using the DiCre system 
to produce a conditional knockout it was shown that MyoA is not essential for parasite 
survival, and moreover, the localization of other glideosome proteins (such as MLC and 
GAP45) is not affected by deletion of MyoA, suggesting the present of a MyoA-
independent invasion mechanism (Andenmatten et al., 2013).  
 
1.6.3 The glideosome associated proteins (GAPs) 
TgMyoA has been shown to be associated with the IMC as part of a hetero-
oligomeric complex termed the glideosome. TgMyoA binds via MLC1 to TgGAP45 
and TgGAP50. The pre-complex of MyoA-MLC-GAP45 is anchored to the IMC 
through association with GAP50, the IMC integral glycoprotein and through acylation 
of GAP45 (Gaskins et al., 2004; Rees-Channer et al., 2006).  At the N-terminus of 
GAP45 is a predicted myristoylation and palmitoylation site (Rees-Channer et al., 
2006), and another two palmitoylation sites were identified at the C-terminus (Frenal et 
al., 2010).  The N-terminus of GAP45 is anchored to the PM (by acylation) and the C-
terminus is anchored to the IMC via acylation and protein interactions (Frenal et al., 
2010; Ridzuan et al., 2012).  The glideosome complex assembles in two steps: MyoA, 
MLC1 and GAP45 assemble co-translationally prior to transport to the parasite 
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periphery and then bind to GAP50 which is anchored in the IMC.  The complex is also 
conserved in Plasmodium where the assembly occurs in the same manner (Baum et al., 
2006b). GAP50 initially is targeted to the secretory pathway by its signal peptide and 
following insertion into the ER GAP50 is transported to the IMC.  MyoA lacks a signal 
peptide and is translated on ribosomes in the cell cytoplasm before associating with 
MTIP and GAP45 (Fauquenoy et al., 2011). GAP50 firmly immobilises MyoA in the 
IMC. GAP50 itself is immobilised within cholesterol rich detergent resistant domains of 
the IMC not allowing free diffusion and therefore anchoring the whole glideosome 
within the IMC (Johnson et al., 2007). The current model is that the bulk of GAP50 is 
located in the lumen of the IMC and binding to other motor complex components 
occurs via its C-terminal helix extension (Bosch et al., 2012) (Daher and Soldati-Favre, 
2009).  During early stages of parasite development, GAP50 is localized in the ER but 
gets redistributed to the apical cap during the formation of daughter cells. Following 
this GAP50 is incorporated into the IMC and found throughout the parasite 
development (Yeoman et al., 2011).   
Other glideosome associated proteins belong to the GAPM family. These are 
proteins which contain six-pass transmembrane domains, which are highly conserved in 
Plasmodium and Toxoplasma, localize to the IMC and co-purify with cytoskeletal 
alveolin proteins. GAPMs can also associate with the actomyosin motor in pull down 
experiments and are suggested to have a role in IMC-anchoring to the cytoskeleton 
(Bullen et al., 2009).   GAP40 is the most recent GAP identified as part of the 
glideosome motor complex.  This protein is a polytopic IMC protein, conserved across 
the Apicomplexa phylum, and believed to play a role as an anchorage protein together 
with GAP50, although the actual function remains to be investigated (Frenal et al., 
2010).  
 
1.6.4 MyoA-actin interrelationship 
MyoA involvement in binding to parasite actin and generating motility was 
suggested as early as the 1970s and 1980s (King, 1988; Vanderberg, 1974). Myosin A 
haa been described in ookinetes (Siden-Kiamos et al., 2011; Siden-Kiamos et al., 2012; 
Siden-Kiamos et al., 2006b), sporozoites (Bergman et al., 2003; Matuschewski et al., 
2001; Matuschewski et al., 2002) and merozoites (Pinder et al., 1998) and was localized 
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to an area between the IMC and parasite PM towards the apex (Pinder et al., 2000).  
Despite a clear contribution of the actomyosin system to gliding and invasion, parasite 
actin filaments have never been seen formally in the vicinity of the glideosome.  In 
Toxoplasma and Cryptosporidium, actin is represented by a single gene, whereas in 
Plasmodium two genes are present. Pf-actinI is transcribed in both asexual and sexual 
stages, whereas Pf-actinII is only transcribed in sexual stages (Dobrowolski et al., 
1997b; Wesseling et al., 1988; Wesseling et al., 1989). Actin has a predicted molecular 
weight of 42-44 kDa. Actin can exist in two forms, globular or monomeric actin (G 
actin) and filamentous actin (F-actin).   The monomeric form can polymerise in a ‘head-
to-tail’ fashion into a right-handed helical spiral. The assembly of monomeric actin 
usually involves polymerisation into F-actin with addition of monomeric actin onto the 
‘barbed’ (or plus) end and depolymerizes from the ‘pointed’ (minus) end (Dobrowolski 
et al., 1997a; Dobrowolski et al., 1997b).  P. falciparum actin either directly extracted 
from parasites or produced in heterologous systems displays atypical biochemical 
properties by forming remarkably short filaments (~100nm in length) that are less stable 
than those formed by conventional actin (Schmitz et al., 2005). This suggests that 
filamentous actin is found only for short periods and in the precise locations where it is 
needed for motility such as areas close to the MJ (Holder and Veigel, 2009). The 
indication that this is actually the case has been provided by using a Plasmodium 
specific actin antibody, although this antibody does not differentiate between G- and F-
actin (Angrisano et al., 2012).  
Both actin dynamics and microfilament turnover are suggested to arise from an 
interaction with actin binding partners.  Actin polymerization/ depolymerization may be 
controlled by intrinsic structural features but also by stabilizing and destabilizing actin 
associated regulatory proteins.    Short actin filaments seem to be nucleated by a yet 
unknown nucleator from a pool of G-actin sequestered in the cytosol.  In other 
eukaryotes, the ARP2/3 complex nucleates the polymerization of F-actin but 
Apicomplexa lack ARP2/3 and instead use formin to regulate actin polymerization 
(Angrisano et al., 2012; Baum et al., 2006a). P. falciparum formin 1 (PfFormin-1) 
(Baum et al., 2008b; Holder and Veigel, 2009) and PfFormin-2 (Farrow et al., 2011) 
localise beneath the parasite plasma membrane and are concentrated towards the 
parasite apex.  
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The gliding motility or invasion can be disrupt by certain drugs which interfere 
with either actin dynamics such as cytochalasin D (CytD), jasplakinolide (JAS), and 
latrunculin B or interfere with myosin ATPase function  such as 2,3-butanedione 
monoxime (BDM) (Dobrowolski et al., 1997a; Poupel and Tardieux, 1999; Russell and 
Sinden, 1981; Shaw and Tilney, 1999; Siden-Kiamos et al., 2006b; Wetzel et al., 2003).  
This was demonstrated by using T. gondii mutant lines which are resistant to CytD, 
which showed that  host cell invasion by T. gondii tachyzoites was dependent on the 
polymerization of the parasite actin but not that of the host cell (Dobrowolski and 
Sibley, 1996). The gliding motility can be blocked by CytD, however the attachment of 
the parasite to the host cell was unaltered (Dobrowolski and Sibley, 1996; Wetzel et al., 
2005). Recently the involvement of host cell actin in invasion was demonstrated. In T. 
gondii tachyzoites and P. berghei  sporozoites host cell actin participated during 
parasite invasion by inducing the formation of a ring shaped F-actin structure in the host 
cell underneath the MJ which remained stable during the invasion process (Gonzalez et 
al., 2009).  
MyoA binds to actin in an ATP-dependent manner. According to the current 
model of Apicomplexan invasion, myosin grabs onto F-actin filaments and exerts ATP-
dependent power strokes which are transmitted via aldolase to parasite ligand-host cell 
receptor complexes resulting in movement of those to the posterior end of the parasite 
(Hettmann et al., 2000).   PfMyoA moves actin filaments at a speed of 33.3 µm/s and 
produces short lived working strokes of 5 nm as determined by in vitro motility assays 
and single molecule optical trapping methods.  The mechanism of how force is 
generated (the power stroke) in the myosin actin model by association and 
disassociation of the myosin head from the filamentous actin has been widely described. 
In the absence of ATP, the myosin head is firmly attached to the actin filament.  
Although this state is very short-lived in living muscle, it is this state which is 
responsible for muscle stiffness after death (rigor mortis).  On binding ATP, the myosin 
head releases from the actin filament.  The head hydrolyses ATP to ADP and Pi which 
induces a rotation in the head with respect to the neck.  This ‘cocked state’ stores the 
energy released by the ATP hydrolysis as elastic energy, similar to a stretched spring.  
Myosin in the ‘cocked state' binds actin.  When bound to actin the myosin head couples 
the release of Pi with the release of the elastic energy to move the actin filament.  This 
is known as the ‘power stroke’ as it involves moving the actin filament with respect to 
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the end of the myosin neck domain.  The head remains tightly bound to the filament as 
ADP is released (Cooke, 2004; Vale, 2003) (Figure 1.11). 
 
 
 
Figure 1.11: The power stroke during gliding motility.  During the “rigor state”, 
myosin binds tightly to actin (with no bound nucleotide).  (1) Upon ATP binding, the 
cleft of the ATP binding site “opens” which causes the disruption of the actin-binding 
site; the interaction becomes weakened releasing the myosin head from the actin 
filament.  (2) Freed of actin the myosin head hydrolyses ATP to ADP+Pi (phosphate).  
Hydrolysing ATP causes a conformational change in the head.  The neck “cocks” and 
moves to a new position, closer to the (+) end of the actin filament and rebounds the 
actin filament. (3) Pi dissociates from the ATP binding pocket, the myosin head 
undergoes the second conformational change, coming into “rigor state” and producing 
the “power stroke” causing myosin to move the actin filament forward. (4) Myosin head 
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remains tightly bound to actin as ADP is released.  When fresh ATP binds to the 
binding pocket within the head domain the process continues (Lodish H, Berk A, 
Zipursky SL, et al. Molecular Cell Biology. 4th edition. New York: W. H. Freeman; 
2000. Available from: http://www.ncbi.nlm.nih.gov/books/NBK21475/). 
 
The current model of the acto-myosin motor complex (Figure 1.12) was used as 
a starting point in this present studies to further investigated the acto-myosin motor 
complex in Plasmodium.  
 
 
Figure 1.12:  Schematic diagram of acto-myosin motor complex. MyoA is linked to 
the IMC via glideosome associated protein GAP45 (acylated), GAP50 (transmembrane 
protein) as well as myosin tail domain interacting protein (MTIP). GAPM is a 
transmembrane protein which is highly conserved and specific to Apicomplexa.  The 
myosin head moves the actin filament from the (+) end towards the (-) end. G-actin is 
polymerized by formin/profilin.  The force generated by the hydrolysis of ATP in the 
myosin head associates and dissociates the myosin from the actin filament resulting in 
the forward movement of the parasite into the erythrocyte. Nt; N-terminal; Ct: C-
terminal. F-actin (black shape) 
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1.7 Apicomplexan Myosin B 
MyoB like MyoA is classified as a class XIV myosin. As mentioned briefly in 
section 1.6, MyoB belongs to subclass b of the myosin XIV class (Foth et al., 2006). In 
Toxoplasma, TgMyoB/C arre encoded by one gene and different transcripts are 
generated by alternative splicing resulting in different C-termini in the proteins. 
Although both T. gondii  MyoB and MyoC showed distinct cellular localisation with 
MyoB spreading throughout the cytoplasm with concentrated punctuate structures and 
MyoC mostly concentrated at the posterior and weakly at the anterior pole, both 
myosins have been implicated in parasite cell division (Delbac et al., 2001).  In 
Plasmodium, PfMyoB is the smallest myosin in class XIV (88kDa: 801 residues). 
PfMyoB has been shown to be expressed in mature schizonts and merozoites by RT-
PCR, immunobloting and IFA from different stages of the P. falciparum parasite 
(Chaparro-Olaya et al., 2003; Chaparro-Olaya et al., 2005)  The hypothesis that 
PfMyoB might be involved in invasion-related mechanisms was based on the imaging 
data of MyoB which detected this protein only in late stages of the asexual development 
and at the merozoite apex (Chaparro-Olaya et al., 2003; Chaparro-Olaya et al., 2005).  
MyoA and MyoB are also detected in P. berghei.  PbMyoA was detected in mature 
ookinetes, whilst PbMyoB was detected in mixed blood stages (containing mostly 
gametocytes and schizonts), zygotes and mature ookinetes by Western blotting probed 
with  an anti-PfMyoB antiserum, and it shows a punctuated pattern of expression 
around the entire cell periphery by IFA (Siden-Kiamos et al., 2006b).    
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1.9 Aims of this thesis  
MyoA in Apicomplexan parasites is a well studied molecule and it has been 
previously shown to be involved in powering the gliding motility of parasites which is 
important for host cell invasion. Constructing the motor complex is dependent on the 
association of MyoA with an actin filament, the myosin light chain and the glideosome 
associated proteins.  Even though MyoA has been biochemically characterized and 
plays a key role in powering invasion (Pinder et al., 2000; Pinder et al., 1998), detailed 
studies on MyoB which is considered to be structurally similar to MyoA are lacking. In 
this study we aim to address the following: 
 
i) In vitro assembly of the P. falciparum motor complex. Using the wheat 
germ cell free system attempts will be made to express and assemble MyoA, 
MTIP and GAP45 into a complex in vitro in order to examine in detail the 
protein-protein interactions between these molecules. Reconstituition of the 
invasion motor in vitro will also allow functional, biophysical studies of the 
complex, some of which previously were only attempted with parasite 
lysate. Compared to that from parasite lysate, MyoA produced with this 
system can be considered free from other protein components that exist 
together in the parasite and therefore will give us the oppportuity to work 
with MyoA molecules alone in order to clarify their function. 
 
ii) Study of MyoA in vivo.  This study will attempt to produce a transgenic 
MyoA-GFP parasite line by insertion of gfp at the C-terminus of the 
endogenous MyoA locus.  Although the localisation and timing of protein 
expression of MyoA can be predicted as it has been examined in many 
previous studies, GFP-tagging will allow us to follow MyoA throughout the 
life cycle in real time.  Using the transgenic parasite detailed characterisation 
of protein partners in the motor complex such as the newly characterised 
GAP40 (in T. gondii) and GAPMs, and potential novel candidates will be 
attempted.  Overall, a transgenic parasite would allow a better understanding 
of the motor complex in space and time and especially during the process of 
invasion.  
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iii) Characterisation of MyoB and its cellular function.  An identical approach 
as that described for MyoA to GFP-tag MyoB by targetting the endogenous 
PfMyoB locus will be attempted. This part of the thesis will be directed to 
studying MyoB timing of protein expression, localisation and interactions 
with other proteins in order to predict a role and function for MyoB.  As for 
MyoA, efforts will be made to visualise MyoB-GFP during the process of 
invasion. 
 
iv) Characterisation of MyoA and MyoB in other Plasmodium species.  The 
generation of transgenic MyoA-GFP and MyoB-GFP P. knowlesi parasites 
was attempted. P. knowlesi has merozoites which are significantly larger 
than P. falciparum and also viable for longer once released. The aim was to 
generate transgenic parasites to study real time invasion in this fifth human 
malaria parasite. 
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Chapter 2 
Material and Methods 
 
 
2.1 DNA manipulation and transformation  
2.1.1 Oligonucleotides 
Oligonucleotides were purchased from Sigma-Aldrich Company Ltd and used in the in 
vitro expression system (Table 2.1) and to prepare DNA constructs for transfection 
(Table 2.2).  
 2.1.2 Polymerase Chain Reaction (PCR) 
DNA was amplified from plasmid DNA using high fidelity AccuPrime Pfx DNA 
polymerase. The reactions consisted of 50 - 200 ng DNA templates, 2 - 4 mM dNTPs, 
0.1 - 0.3 µM each oligonucleotide, 10 mM MgSO4, 1.0 - 2.5 units of polymerase and 
polymerase buffer (supplied by manufacturer) diluted in dH20 to a final volume of 50 
µl. The PCR reactions were performed in a DNA engine® thermocycler (Eppendorf).  
Amplified DNA was purified using a QIAquick PCR purification kit (Qiagen) 
according to the manufacturer’s instructions. 
2.1.3 Agarose gel electrophoresis 
DNA fragments were analysed using 0.8 - 1.0% agarose gel electrophoresis.  Agarose 
gel was prepared by dissolving agarose powder (BioRad) in 1X TAE buffer (45 mM 
Tris-acetate [pH 8.0], 1 mM EDTA).  For UV detection, 0.5 µg/ml ethidum bromide or 
the same concentration of GelRed (Life Technologies) was added before pouring the 
agarose into the gel cast.  Once cooled, gels were immersed in 1X TAE and DNA 
samples were mixed with 1X DNA loading dye (QIAGEN) before loading into wells. 
Separation was conducted at 80-100V using an EPS 500/400 DC Power Supply 
(Pharmacia).  HyperladderTM I (Bioline) DNA size markers were included for reference. 
If required, DNA was purified from gel pieces using a gel extraction kit (Qiagen) 
according to manufacturer’s instructions. 
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2.1.4 Restriction endonuclease digestion 
In a basic reaction, 1 µg DNA was digested for 2 h at 37°C, in reaction buffer supplied 
with the specific enzyme being used. All enzymes were purchased from New England 
Biolabs, 1 Unit being defined as the amount of enzyme required to digest 1 µg DNA in 
1 h at 37°C, in a 50 µl reaction. Where more than one enzyme was used in any given 
reaction, buffers were chosen in order to retain optimal activity of both enzymes. 
2.1.5 Ligation of DNA fragments 
Where restriction digestion was used in cloning, the resulting cohesive ends were 
ligated using T4 DNA ligase (Promega). Reactions contained 200U enzyme, 50 ng 
vector DNA and a 3:1 molar excess of insert to vector DNA. Samples were incubated at 
16°C overnight, in the supplied buffer.  The vector which was subjected to ligation with 
the DNA fragment of interest was treated with alkaline phosphatase (AP) before 
electrophoresis and gel excision.  Briefly, 5 µl each of 10X AP buffer  and AP were 
added to digestion mixtures, incubated in the 37oC incubator for 1 h, followed by 50oC 
for 30 min and finally 75oC for 10 min or treatment with 5 µl of 0.05 M EDTA. This 
mixture was then electrophoresed and bands were excised and purified. These vectors 
were then used for ligation with the selected purified DNA fragment. 
2.1.6 The propagation and transformation of E. coli by plasmid DNA  
Ligated DNA (1-2 µl or 50 ng) was added and mixed slowly into 25 - 50 µl chemically 
competent E. coli cells (GigaSingle: Novagen). The reaction was then incubated on ice 
for 5 min, heat shocked for exactly 30 sec in a 42oC water-bath, followed by incubation 
on ice for another 2 min, then 250 µl SOC medium at room temperature was added and 
incubated for 1 h at 37°C with agitation at 250 rpm.  About 30 - 50 µl of the 
transformed cells were then plated onto agar plates containing antibiotic for selection 
(100 µg/ml ampicillin) and incubated at 37°C overnight prior to positive colony 
picking. Colonies were picked and grown in LB culture containing 100 µg/ml ampicillin 
at 37°C with agitation at 225 - 250 rpm.  
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2.1.7 Isolation of plasmid DNA 
Plasmid DNA was isolated from E. coli overnight cultures using either the QIAprep 
Spin Miniprep or QIAGEN Plasmid Midi/Maxi kits (Qiagen) following the protocols 
provided in the QIAGEN plasmid purification handbook. If the resulting DNA was to 
be used for transformation or sequencing, 2 - 5ml culture was sufficient and DNA was 
extracted using the Miniprep kit. For electroporation of P. falciparum, larger quantities 
of DNA were required and thus 250 ml cultures were grown and DNA extracted using 
the QIAGEN-tip 500 from the Maxiprep kit. All DNA was eluted and stored in elution 
buffer EB (10 mM Tris-HCL, pH 8.5). 
2.1.8 Sequencing of DNA 
Sequencing reactions were carried out by Cogenic (Beckman Coulter).  Sequencing 
results were aligned and analysed using Sequencher 4.9 (Demo Version). 
 
2.2  In vitro expression and purification of recombinant MyoA, MTIP and GAP45 
protein 
 2.2.1 Construction of recombinant DNA 
Recombinant plasmid DNA was generated for MyoA, MTIP and GAP45 using specific 
primers (Table 2.1) designed for the ENDEXT® Technology (CellFree Sciences), for 
use in their wheat germ cell free protein synthesis system.  The recodonised template 
DNA for MyoA was provided by Rachel Farrow (Physical Biochemistry, NIMR), MTIP 
and GAP45 were from Rob Moon (Parasitology, NIMR).  All vectors used were 
provided by CellFree Sciences Co., Ltd. (Japan).  The DNA was amplified by PCR with 
a combination of primers 1A and 2A, 3M and 4M and 5G and 6G of MyoA, MTIP and 
GAP45 respectively.  The amplified products were cloned into the multiple cloning site 
region of the vectors,which for example, had been cleaved between the XmaI and SpeI 
sites of the pEU-E01H-TEV-N2 (H-pEU) which introduced an N-terminal His-tag. 
Primer combinations of 7A and 8A, 9M and 10M, and 11G and 12G for MyoA, MTIP 
and GAP45 respectively, were used for amplification and the products were inserted 
between the EcoRV and NotI sites of pEU-E01G-TEV-N1 (G-N1) to produceN-
terminal GST-tag constructs (Appendix A). 
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2.2.2. Transcription of DNA to mRNA 
For one reaction of mRNA transcription, 2 µl of 1.0 µg/µl highly pure DNA (with 
A260/A280 ratio ranging  between 1.7-1.85) were used in a reaction with Transcription 
Premix (11.5 µl Nuclease free water, 1 X transcription buffer, 2.5 mM NTP mix, 1 U/µl 
RNase inhibitor, 1 U/µl SP6 RNA Polymerase) in a total volume of 20 µl, mixed and 
incubated at 37oC for 6 h.   The quality of mRNA produced was monitored by gel 
electrophoresis; if RNase degradation was apparent, the plasmid DNA was further 
purified. 
 
2.2.3 Translation of mRNA to protein 
A Bilayer Reaction System method (CellFree Sciences) was used to translate mRNA 
into protein.  mRNA  (10 µl) was added to 10 µl of wheat germ extract (WEPRO® 
1240) with 40 ng/µl Creatine Kinase (CK), then the mixture was mixed gently and 
carefully transferred directly to the bottom of 1 X SUB-AMIX solution (0.3 mM each of 
amino acids [L-Arg/ L-Asn/ L-Asp/ L-Cys/ L-Gln/ L-Glu/ L-Gly/ L-His/ L-Ile / L-Leu/ 
L-Lys/ L-Met/ L-Phe/ L-Pro/ L-Ser/ L-Thr/ L-Trp/ L-Tyr/ L-Val], 100 mM potassium 
acetate, 2.7 mM magnesium acetate, 16 mM disodium creatine phosphate tetrahydrate, 
0.4 mM spermidine, 1.2 mM ATP, 0.25 mM GTP, 4 mM dithiothreitol, and 30 mM 
HEPES-KOH [pH 7.8]).  This will form a bilayer phase with the translation mixture in 
the lower layer and 1 X SUB-AMIX in the upper layer.  The translation process was 
incubated for 20 h at 15-16oC. The expressed proteins were resolved by SDS-PAGE and 
detected by western blot.   
 
2.2.4 Co-translation of proteins 
Two or more proteins can be co-expressed using individually transcribed mRNA. The 
volume of mRNA used and translation mixtures were optimized so that the efficiency of 
protein translation was maximized.  This co-expression was performed to get the best 
yield of protein in the soluble fraction for use in interaction studies. The resulting 
protein concentration was determined using a spectrophotometer (Nanodrop, 
ThermoScientific) with pre-programmed settings for protein absorbance at λ595. 
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2.2.5 SDS-PAGE 
Protein samples were separated using Sodium Dodecyl Sulphate- Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) with Nu-PAGE 10% or 12% pre-cast Bis-Tris gels  and 
an Xcell II Mini Cell gel cassette (Invitrogen) in MOPS (Nu-PAGE 3-[N-
morpholino]-propanesulphonic acid) running buffer at 200 Volts (V) using an EPS 
500/400 DC Power Supply (Pharmacia).  Forty µl of 2X Laemmli sample buffer (100  
mM Tris HCl [pH 6.8], 200 mM dithiothreitol [DTT], 4% sodium dodecyl sulphate 
[SDS], 20% glycerol, 0.2% bromophenol blue) were added to the samples and mixed, 
then the samples were boiled for 5 min. Precision Plus Protein standards (Biorad) 
were used as size markers. The separated proteins were visualised by staining with 
Coomassie blue (0.1% [w/v] Coomassie Brilliant Blue R-250, 45% [v/v] methanol, 10% 
[v/v] acetic acid), or by immunoblot.    
2.2.6 Immunoblot 
A resolved SDS-PAGE gel was transferred onto nitrocellulose membrane for 1-2 hours 
at 30V or overnight at 10V at room temperature. The nitrocellulose membranes 
(Whatman Protran) were immersed in blocking buffer (1% bovine serum albumin 
[BSA] in PBST)  for 30 to 60 min at room temperature or overnight at 4oC with 
constant slow agitation.  The membrane was incubated in the appropriate primary 
antibody (Table 2.3) for 1 h and washed with PBST 3 times at 10 min intervals. The 
membrane was incubated with an appropriate secondary antibody for 1 h and washed as 
before. To visualise protein bands, the membranes were immersed in enhanced 
chemiluminescene substrate solution (ECL, GE Healthcare)  for 1 - 2 min and the 
protein band signal was detected by exposing the blot to Biomax MR film (Kodak) for 
an appropriate amount of time before being developed using a Fuji FPM-3800 AD Film 
developer. 
 
 
 
 
 
 
 
62 
 
2.3  Pull down assay and co-immunoprecipitation assay 
 
2.3.1 GST Pull Down for cell free protein 
Soluble glutathione-S-transferase (GST) fusion protein was purified on glutathione-
Sepharose 4B, prepared by washing in 10 volumes of PBS.  The tubes were inverted 
several times to mix the resin before centrifugation at 5000 g for 5 min. Supernatants 
were discarded and washing steps were repeated twice. Soluble protein from the co-
expression was added to 10 volumes of PBS and mixed with 1 volume of glutathione-
sepharose 4B, under gentle agitation for 2 h at 4oC. The samples were centrifuged for 5 
min at 5000 g, the supernatant discarded and the gel washed 3 times with PBS.  
Protease inhibitors were added to the washed beads at an appropriate concentration, 
then the beads were suspended in SDS-PAGE sample buffer, boiled for 5 min and 
centrifuged before examination by SDS-PAGE and immunoblot.   
 
2.3.2 His Pull Down for cell free protein 
Ni-NTA His•Bind® Resin was washed twice with dilution buffer before binding in 
batch to the produced protein, rotating at 4°C for 2 h in the presence of 1X protease 
inhibitor cocktail (Roche).  The mixture was then pelleted for 2 min at 2000 g and the 
supernatant was collected. The resin was washed with 500 µl dilution buffer twice and 
supernatants were collected for every wash.  The purified protein was then eluted with 
500 µl elution buffer, incubating for 5 min on ice, before centrifugation at 2000 g for 5 
min. The samples were boiled in 2X SDS-PAGE sample buffer at 94oC for 5 min, 
centrifuged, and then examined using SDS-PAGE and immunoblot.   
 
2.3.3 Co-immunoprecipitation with GFP-TRAP system for parasite lysate 
Purified schizonts were suspended in lysis buffer ([1:10 v/v]: 10 mM Tri-HCl [pH 7.5], 
150 mM NaCl, 0.5 mM EDTA, 1% NP40, 1 mM PMSF [Sigma] and 1X protease 
inhibitor cocktail [Roche]). The mixture was placed on ice for 30 min with extensive 
mixing by pipetting every 10 min. The cell lysates were spun at 20,000 g for 10 min at 
4oC, then the supernatant was transferred to a precooled tube and the volume was 
adjusted to an appropriate volume with dilution buffer (lysis buffer without 1% NP40) 
GFP-Trap® beads (Chromotek) were washed with dilution buffer at 2700 g for 2 min at 
4oC. The supernatant was discarded and the washing step was repeated twice. The cell 
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lysate was incubated with non-coated agarose beads (bab-20, Chromotek) for 30 - 120 
min at 4oC with gentle mixing using a rotator to remove nonspecific binding proteins. 
The mixture was spun down at 2000 g for 2 min at 4oC. The supernatant was added to 
the GFP-Trap® beads and incubated with gentle mixing for 1 to 2 h at 4oC. The mixture 
was spun down at 2000 g for 2 min at 4oC. The supernatant (non-bound materials) was 
kept for western blotting analysis. The remaining supernatant was discarded and the 
pellet was washed twice with dilution buffer and washing buffer respectively. The GFP-
Trap® beads (30 µl) were re-suspended in 100 μl of 2X Laemmli sample buffer. The re-
suspended beads were heated for 10 min at 95oC to dissociate the immuno-complexes 
from the beads. The beads were collected by centrifugation at 2700 g for 2 min at 4oC 
and SDS-PAGE was performed with the supernatant (referred to as bound material). 
The presence of GFP and motor proteins was detected by western blot using specific 
antibodies (Table 2.3).  
 
2.4  The functional analysis of MyoA 
 
2.4.1 In vitro motility assay 
A flow cell was constructed from a microscope slide and 22 X 22 mm cover slip 
(Thermo Scientific). The principle of the flow cell was to allow the motility buffer to be 
changed by introducing fresh buffer at one end, and drawing it through with a filter 
paper.  10% nitrocellulose (Earnest F.Fullam) was diluted tenfold with amyl acetate 
(Sigma Aldrich) and 1 µl spread evenly onto the cover slip. Two pieces of double sided 
tape (permanent double sided tape, Scotch 3 M) were placed 5-10 mm apart upon a pre-
cleaned slide (Super Frost plus, Menzel Glaser, Thermo Scientific) to create a flow cell 
of approximately 15 µl volumes.     
The flow cell was coated with MyoA (15-30 µl) and incubated for 3 - 5 min to allow the 
MyoA  to bind to the pre-coated nitrocellulose  and  washed three times with AB- (25 
mM Imidazole, 25 mM KCl, 4 mM MgCl2, 1 mM EGTA [ pH 7.4]),   A total of 100 µl 
AB-/BSA (AB-/ 1.0 mg/ml BSA) was added and allowed to bind for 2-5 min.  This 
binds to the nitrocellulose non-specifically, blocking the surface where no protein has 
bound.  A rabbit actin labeled with Rhodamine-Phaloidin (Molecular Probes Invitrogen, 
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Life Technologies) (RhPh-actin) was diluted in AB- to a final concentration of 0.6  
µg/ml and 20 µl infused into the flow cell and left for 2-5 min to allow actin filaments 
to bind to the MyoA in the rigor state (MyoA head bound to actin filament). 100 µl AB-
/Scavenger (0.02 mg/ml catalase, 0.1 mg/ml glucose oxidase, 3.0 mg/ml glucose, 20 
mM DTT) was passed through the chamber of the flow cell to remove unbound actin.  
To check that actin was bound to the MyoA on the cover slip surface the slide was 
viewed under the Zeiss epi-fluorescent microscope (Axioskop 40, Zeiss).  Motility was 
initiated by addition of a total of 100 µl AB+/Scavenger (AB+: [AB- / 2mM ATP].  
Actin motility was recorded with a modified video camera (ICCD [Photon-P46036A, 
EEV] linked to a frame grabber [Picolo Tetra, Eurosys], developed by Gregory 
Mashanov, Physical Biochemistry, NIMR).  The user interface GMimPicolo© Software 
(Gregory Mashanov) was used to collect data.   
2.4.2 Single molecule studies 
Optical trapping using Optical tweezers (OT) was developed to measure single forces 
and the displacement that can be recorded using a feedback-enhanced laser trap assay 
(Finer et al., 1995).  The mechanical properties of individual myosin molecules were 
studied using the three bead assay developed by Spudich and co-workers. (Finer et al., 
1994).  Reactions occur in a flow cell.   
 
The flow cell preparation: To prepare the flow cell, 1 mg of 2.1 µm diameter silica 
beads (Bangs Laboratories) was suspended in 1% nitrocellulose in amylacetate (Ernest 
F. Fullam). Two microlitres of this solution was spread evenly onto a 22 mm by 40 mm 
coverslip (Menzel Glaser, Thermo Scientific). This concentration of silica beads gave a 
density of approximately 1 bead per 30 µm2. Two pieces of double sided tape 
(permanent double sided tape, Scotch 3 M) were placed 20 mm apart upon a pre-
cleaned slide (Super Frost Plus, Menzel Glaser, Thermo Scientific) to create a flow cell 
of approximately 75 µl volumes.  NeutrAvidin coated beads were prepared a day before 
the experiment.  Ten µl of carboxylate modified, biotin labelled, 1 µm polystyrene 
beads (Sigma Aldrich) were incubated with 10 µl of 0.1 mg/ml RhPh labelled BSA 
(Sigma Aldrich) and 5 mg/ml NeutrAvidin (Pierce, Thermo-Fisher Scientific) for 1.5 h, 
rotating at 4oC. A 100 µl of AB-/BSA was added to the mixture and incubated for 40 
min at room temperature. The beads were washed 10 times in 150 µl AB-/BSA by 
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centrifugation for 2 min at 7,000 rpm (Sepatech Biofuge 13).  The washing step reduces 
non-specific binding and removes free NeutrAvidin from the supernatant. Beads were 
stored in 100 µl AB- on ice for up to four days. 
N-Ethylmaleimide MyoA coated bead preparation:  One hundred µl of full length 
MyoA (25 mg/ml in MyoA preparation solution and 50% glycerol) was diluted into 1 
ml of deionised water. MyoA was pelleted by centrifugation at 15,000 rpm for 6 min 
(Sepatech Biofuge 13). The pellet was resuspended in an equal volume of 2X high salt 
buffer (1 M KCl, 40 mM potassium phosphate buffer [pH 6.5], 2 mM DTT, 4 mM 
MgCl2) and 8 µl of freshly prepared N-Ethylmaleimide (NEM) solution (12.5 mg/ml 
/100 mM NEM [Sigma Aldrich] and 2% v/v ethanol in deionised water) so that the final 
NEM concentration was 4 mM. The mixture was incubated at room temperature. After 
40 min the reaction was quenched and MyoA precipitated by the addition of 1 ml 10 
mM DTT (in deionised water). The myosin was pelleted by centrifugation at 15000 rpm 
(Sepatech Biofuge 13) for 6 min, and resuspended in an equal volume of 2X high salt 
buffer. The solution was clarified by centrifugation at 15000 rpm for 6 min (Sepatech 
Biofuge 13).  A volume of 30 µl of a 1 in ten dilution of the NEM modified myosin (in 
1X high salt buffer) was added to 5 µl of 1 µm pre washed plain latex beads (LB-11, 
Sigma Aldrich), with 10 µl RhPh labelled BSA, and made up to 100 µl using 1X high 
salt buffer. The beads and myosin were incubated for 1 h at room temperature before 
being washed 3 times in AB- (8000 rpm, 3 min, Biofuge 13, Sepatech). Beads were 
stored in 50 µl AB- on ice for up to two days.  Both NeutrAvidin coated beads and 
NEM myosin coated beads were vortexed and sonicated to disrupt aggregation 
immediately before use. 
Data Acquisition and analysis: The optical trap transducer was constructed by 
Christopher Batters (Physical Biochemistry, NIMR) and is based around an inverted 
microscope (Zeiss, Axiovert 135TV).  The setup of the laser and illumination and 
calibrating and testing of the apparatus set up and data acquisition was achieved with 
the help of Rachel Farrow (Physical Biochemistry, NIMR). A combination of bright-
field and fluorescent microscopy was used to view the experiment.  A single RhPh- 
labelled actin filament was captured between two NeutrAvidin beads within the vicinity 
of the optical trap and the third bead that was a sparsely coated NEM myosin bead was 
positioned within close proximity of the actin filament (Figure 2.1).  Interactions 
between the surface myosin and the actin filament were then recorded. The procedure to 
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initiate the interaction was followed as in the motility assay.  The reagents and buffers 
used were the same as in the motility assays. The data acquisition was performed using 
the custom software, Opittrap (Gregor Mashanov) and data were collected with a 
sampling rate of 10Hz and analysed using in-house custom software in Igor Pro (Rachel 
Farrow and Justin Molloy, Physical Biochemistry, NIMR).  The data analysis of the 
single molecule MyoA event (the attachment of MyoA to actin filament), the power 
stroke and life time analysis was performed with help from Rachel Farrow. 
 
 
2.5  In vitro parasite culture and maintenance 
2.5.1 Maintenance of Plasmodium falciparum and purification of the 
schizonts  
The P. falciparum 3D7 strain was grown in Roswell Park Memorial Institute 1640 
(RPMI) medium with supplements (25 mM  HEPES, 27 mM NaHCO3, 2 mM L-
glutamine, 25 µg/ml gentamycin, 50 µg/ml hypoxanthine and 2 mg/ml glucose and with 
or without 0.5% [w/v] AlbuMAX II  [pH 7.5])  at 2-3% haematocrit. Cultures were 
gassed with a mixture of 5% O2, 7% CO2, and 88% N2 and incubated at 37°C. To 
examine parasitaemia and cycle stage, thin blood smears were made on glass slides and 
stained with Giemsa (10% Giemsa's stain in phosphate buffer [pH 7.2-7.4]) in tap water 
for 2-3 min. Slides were then viewed using a light microscope.  At 10% parasitaemia, 
the parasite-infected red blood cells were pelleted by centrifugation and washed with the 
RPMI medium without AlbuMAXII. The pellet was layered on top of 70% Percoll 
(90% percoll, in phosphate buffered saline and diluted with RPMI) and centrifuged at 
1,000g for 11 min at room temperature. The concentrated schizont layer was harvested 
and washed with RPMI medium prior to reinvasion. For reinvasion, purified schizonts 
were added to the new culture containing fresh non infected red blood cells and 
incubated with agitation at 37oC for 2-4 h. The newly ring-infected red blood cells were 
collected by sorbitol treatment to eliminate the schizonts (Lambros and Vanderberg, 
1979). The synchronised parasites were grown until they reached 10% parasitemia and 
harvested at schizont stage. The schizont pellet was washed with RPMI without 
AlbuMAXII and kept at -80oC prior to use. 
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2.5.2 Maintenance of Plasmodium knowlesi and purification of the schizonts 
A similar technique to P. falciparum culture has been applied to P. knowlesi with 
slightly different use of medium and synchronisation reagents.  Normally, parasites 
were grown in 2% haematocrit in 75 cm2 flasks with 50 ml RPMI 1640 with 
AlbuMAXII and 10% human serum (Moon et al., 2013).  Medium was change or 
parasites were diluted every 2 days.  Human erythrocytes were tested for expression of 
the Duffy antigen before use and human serum was tested for parasite growth.  Parasites 
were synchronised using 55% Nycodenz (Axis-Shield, UK; 27.6 g [w/v], 10 ml 100 
mM Tris-HCl, [pH 7.0-7.5]) as a cushion instead of percoll. Once layered on top of the 
cushion, parasites were centrifuged at 1,000 g for 11 min at room temperature. The 
concentrated schizont layer was harvested and washed with RPMI + 10% HS medium 
prior to reinvasion. For reinvasion, purified schizonts were added to the new culture 
containing fresh non-infected red blood cells and incubated with agitation at 37oC for 2-
4 h. The newly ring-infected red blood cells were collected by Nycodenz gradient to 
eliminate the schizonts. The synchronized parasites were grown till they reached 10% 
parasitaemia and harvested at schizont stage by using Nycodenz as mentioned. 
Harvested schizont pellets were washed with RPMI without AlbuMAXII and kept at -
80oC prior to use. 
2.5.3 Freezing and thawing of parasites 
The parasites were frozen in liquid nitrogen for storage. Freezing solution (0.324 g 
NaCl, 1.512 g D-sorbitol, 14 ml glycerol in 50 ml volume) was added to the pelleted 
(1000 g for 5 min) ring-infected red blood cells with a minimum 5% parasitaemia. 
Warm freezing solution was added drop wise to the pellets (7:3 v/v). The mixture was 
transferred to cryopreservation vials and stored in liquid nitrogen.  The cryopreserved 
samples were thawed in a 37oC water bath and transferred to a 15 ml centrifuge tube. 
The original volume of thawing solution (3.5% NaCl) was added drop wise and 
centrifuged at 250 g for 5 min and the step repeated twice. The pellet was mixed with 
warm RPMI plus AlbuMAXII medium (P. falciparum) and addition of 10% HS for P. 
knowlesi. The culture was incubated at 37oC for maintenance.    
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2.6 Parasite DNA manipulation and transfection  
2.6.1 Transfection: The construction of single crossover integration constructs 
for integration of P. falciparum and P. knowlesi MyoA and MyoB GFP-tags 
Parasite vectors for single homologous genomic integration and GFP expression in P. 
falciparum were based on the pHH4-GFP transfection plasmid (Dr E. Knuepfer, 
unpublished).  This plasmid contain the human dihydrofolate reductase (hDHFR) and 
GFP cassettes, allowing WR99210 drug selection and introducing a GFP tag at the C-
terminus of the chosen protein.  In order to introduce the GFP tag at the C-terminus of 
each protein, a region of homology corresponding to MyoA (PlasmoDB ID 
PF3D7_1342600) and MyoB (PlasmoDB ID PF3D7_0503600) from the 3’ end of each 
ORF lacking the stop-codon was selected.  The region of homology was amplified by 
PCR using the primer combination of 3F1/3R2 for MyoA and 4F1/4R2 for MyoB 
(Table 2.2). The DNA from the 3’ end of each ORF lacking the stop-codon was cloned 
into the vector pHH4-GFP at the restriction site of XmaI/AvrII generating the 
constructs, pHH4-PfMyoA-GFP and pHH4-PfMyoB-GFP for Plasmodium falciparum 
MyoA and MyoB respectively.   
DNA constructs used in the P. knowlesi transfection experiment were similar to the P. 
falciparum constructs with the addition of a unique site in the middle of the homology 
region for MyoA (PlasmoDB ID PKH_121190) and MyoB (PlasmoDB ID 
PKH_102930) for linearization purposes.   NruI and AfIII were introduced as unique 
sites to generate the pHH4-PkMyoA-GFP and pHH4-PkMyoB-GFP for MyoA and 
MyoB respectively from 3’ end of each ORF lacking the stop-codon. PCR was carried 
out for different fragments for each DNA using specific primers which were designed to 
create a unique site.  For the MyoA construct, to introduce the NruI site, the first 
fragment was amplified with the primer combination of 1F1/1R1 and cloned into the 
construct using the XmaI/AvrII sites.  Finally, the second fragment was amplified with 
the primer combination of 1F2/1R2 and cloned into the construct containing the first 
fragment using XmaI/AvrII sites.   For the MyoB construct, the AfIII site was 
introduced by cloning an amplified PCR product of fragment 1 and fragment 2 into the 
vector at XmaI/AvrII sites.  For diagnostic purposes the construct was digested with 
XmaI/AvrII to obtain the full length of the region of homology, AvrII/ SacI for the GFP 
fragment, XmaI/NruI and NruI/AvrII  for the MyoA fragment 1 and fragment 2 
69 
 
respectively, and XmaI/ Af1II  and AfIII/ AvrII for fragment 1 and fragment 2 of  
MyoB respectively. 
 
2.6.2 Preparation of DNA constructs for transfection  
For circular and linear transfection, the plasmid DNA (100 μg for P. falciparum and 10-
20 μg for P. knowlesi) was purified by ethanol precipitation and mixed with TE buffer 
(10 mM Tris HCL, 1 mM EDTA, [pH 8.0]) and kept at –20oC. Briefly, 1/10 volume of 
3M sodium acetate was added to the DNA sample, followed by 2 volumes of 100% 
ethanol. DNA was left to precipitate overnight at -20°C and pelleted by centrifugation 
(20,000 g, 20 min). The pellet was washed in 70% (v/v) ethanol and spun again prior to 
air-drying and resuspended in 30 µl of TE buffer.  In addition, for P. knowlesi linear 
transfection, the construct was linearized using appropriate enzymes prior to 
transfection. 
 
2.6.3 Transfection of P. falciparum with circular plasmids 
Electroporation of parasites was carried out using the BioRad Gene Pulser 
Electroporator.  P. falciparum 3D7 parasites were synchronised to a 10% early ring  
parasitaemia (section 2.5.1). Purified plasmid DNA (100 µg) in 30 µl TE buffer was 
mixed with 385 µl cytomix solution (120 mM KCl, 0.15 mM CaCl2, 2 mM EGTA, 5 
mM MgCl, 10 mM K2HPO4/KH2PO4, 25 mM HEPES [pH 7.6]) by gently pipetting to 
dissolve the DNA (Fidock and Wellems, 1997; Wu et al., 1995). The mixture was then 
added to 150 µl of the ring-infected blood culture, and using a sterile Pasteur pipette the 
cell suspension was immediately transferred into the Gene Pulser cuvette. 
Electroporations were done one at a time at 0.310 kV/950 μF with the resistance (ohms) 
set to infinity. The electroporated samples were transferred into petri dishes containing 
10 ml culture medium with a 3% haematocrit of non-infected red blood cells. The petri 
dish was placed into a culture chamber, gassed with a mixture of 5% O2, 7% CO2, and 
88% N2 and transferred to an incubator at 37oC. The culture of transfected parasites was 
fed every day for 6 to 7 days then every other day for 2 weeks.  At the end of the second 
week, the parasite culture was fed and maintained with RPMI 1640 medium containing 
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2.5 nM WR99210 (Merck).  Once the transfected cultures had recovered, they were 
scaled up for several purposes such as cryopreservation, preparation of genomic DNA 
(gDNA), and microscopy to detect GFP expression.  This first growth and treatment 
was termed Cycle-0.  The transfected cultures were then subjected to cycling in the 
absence of drug and with WR99210 selection until GFP was expressed.  Transfected 
parasites expressing GFP were subjected to genotype and phenotype analysis and 
cloned. 
2.6.4 Transfection of P. knowlesi with linear and circular DNA 
Nycodenz-purified schizonts were used for transfection of P. knowlesi with both 
circular and linear DNA.  Electroporation of parasites was carried out using the Amaxa 
4D Electroporator (Lonza) and the P3 Primary cell 4D Nucleofector X kit L (Lonza).  
For each transfection, 20 µg of DNA (section 2.5.2) was dissolved in 10 µl TE buffer 
and added to 100 µl of supplemented P3 primary cell solution.  Approximately 5 - 10 µl 
of schizonts (~5 x 107-108) were resuspended in the DNA plus P3 Primary cell solution 
and immediately electroporated in the 4D Nucleofactor X Kit L cuvette (Lonza) using 
programme FP158.  Electroporated parasites were transferred to a 1.5 ml Eppendorf 
tube containing 500 µl pre-warmed complete RPMI 1640 medium and a 3% 
haematocrit of fresh RBC.  The transfected parasites were incubated at 37oC in a 
thermomixer with agitation for about 30-60 min and then the transfected parasites were 
transferred to a 6 well plate, each well containing 5 ml warm complete medium.  The 
plate was then placed at 37oC in a gassed chamber.  The medium was replaced with 
fresh medium containing 2.5 nM WR99210 after 24 hours and the cultivation was 
continued. The transfected parasites were subjected to genotype and phenotype analysis. 
 
2.6.5 Cloning of transgenic parasites by limiting dilution 
Limiting dilution was carried out to obtained a suspension containing three parasitised 
cells per ml by diluting 100 µl of diluted parasite culture in complete medium 
containing RBC (2% haematocrit) into each well of a U-bottom microtiter plate.  Plates 
were incubated at 37oC in a gas chamber, and then fed at 3 - 4 days intervals with 
medium containing RBCs (1% haematocrit) once a week.   Wells containing growing 
parasite clones were identified by light microscopy of Giemsa stained thin films after 
approximately ~2 weeks.  Clones were confirmed by genotype and phenotype analysis.   
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2.7 Southern Blot 
2.7.1 DNA digestion  
Approximately 5 to10 μg of DNA was digested with 30 units of the selected restriction 
enzyme and incubated at 37oC overnight. The digested DNA was separated by gel 
electrophoresis, using a 0.7% agarose gel in TBE buffer containing 0.5 µg/ml ethidium 
bromide at 40V overnight and then photographed under UV with a fluorescent ruler for 
measurements. The gel was then incubated in depurinating solution (0.25 M HCl) for 
~10 min on a shaker, washed with MilliQ water followed by denaturing buffer (0.5 M 
NaOH, 1.5 M NaCl)  for a minimum of 30 min and followed by two ~30 min washes in 
neutralising buffer (1.5 M NaCl, 0.5 M Tris-HCl, 1 mM EDTA, [pH 7.4]).  The DNA 
was then transferred from the agarose gel to Gene Screen Plus membrane (Whatman) by 
assembly of a semi-dry blot. To do this the membrane was first soaked in 10X SSC 
buffer (saline-sodium citrate: 0.3 M NaCl, 30 mM sodium citrate, [pH, 7.0]) for ~15 
min.  The agarose gel was placed upside down on saran wrap and the wet membrane 
placed on top followed by 3 layers of Whatman 3M filter paper. A layer of paper towels 
was then placed on top and the blot was weighted and left to blot overnight by capillary 
transfer (Sambrook, 1989). The blot was then disassembled, the DNA on the membrane 
was denatured by quickly rinsing in 100 ml 0.4 M NaOH for ~1 min, then neutralised 
with neutralising buffer (1.5 M NaCl, 0.5 M Tris-HCl, 1 mM EDTA, [pH 7.4]) and the 
membrane was air-dried before cross-linking under a CL-1000  Ultraviolet Cross linker 
(UVITEC Cambridge). The membrane was then left to air dry on Whatman filter paper 
and stored at -20°C until required.   
 
2.7.2 Probe generation and labelling  
Hybridisation probes were generated by PCR (section 2.1.2) or excision from a 
transfection vector and were specific for each gene of interest.  Probes were 
radioactively labelled with α-32P dATP (Perkin Elmer®) by random priming using the 
Decaprime II kit (Ambion) according to manufacturer’s instructions. Unincorporated 
labelled nucleotides were removed using a ProbeQuant™ G-50 Micro-column 
(Amersham Biosciences). The labelled probe was then denatured at 98°C for 5 min and 
used straight away for hybridisation. 
 
72 
 
2.7.3 Hybridisation 
The cross-linked membrane was pre-hybridised with 20ml hybridization solution (6X 
SSC, 5X Denhardt’s solution [1% (w/v) BSA, 1% (w/v) polyvinylpyrrolidone, 1% 
(w/v) Ficoll 400], 0.2 mg/ml salmon sperm DNA), rotating at 62°C for 1 h. The labelled 
probe was then added to the hybridisation solution and allowed to hybridise under 
rotation at 62°C overnight.  The labelled probe was poured off, and the membrane 
washed twice for 30 min with 6X SSC + 0.1% SDS at 62°C. The background radiation 
was checked and, if necessary, additional washes with 2X SSC were applied. When 
only a low background was detected the membrane was wrapped in Saran wrap, placed 
in contact with film (Kodax® BioMax™ MR)  and incubated overnight at -80oC for 
autoradiography. If necessary, the probe was stripped off the membrane by boiling in 
0.05X SSC, 0.01 M EDTA, 0.1% SDS to allow re-probing. 
 
 
2.8  Live imaging and indirect-immunofluorescence microscopy assays (IFA) 
2.8.1 Live imaging of GFP-tagged parasites  
GFP-tagged parasites were synchronized and purified as described previously and then 
diluted 1:10 with RPMI 1640 containing AlbumaxII. DNA (the nuclei) was stained with 
0.1 µg/ml Hoechst 33342 DNA reagent (Invitrogen) with incubation for 10 min at room 
temperature. Approximately 2-5 μl of the stained schizonts were dropped onto a glass 
slide and overlaid with a Vaseline-rimmed coverslip for live microscopy.  
2.8.2 Indirect immunofluorescence assay (IFA) 
For IFA, the thin films of stage-specific parasite material were made.  The slides were 
fixed with 4% paraformaldehyde (PFA) for 10 min at room temperature. The fixed 
slides were washed 3 times with PBS and permeablised with PBS containing 0.5% 
Triton X-100 for 5 min at room temperature. Then the slides were washed twice with 
PBS and blocked overnight with 4% BSA in PBS at 4oC. After blocking, the slides were  
incubated with GFP-Booster (a specific GFP-binding protein coupled to the fluorescent 
dye ATTO 488) (Chromotek) or α-GFP antibody (mouse monoclonal or affinity 
purified rabbit) for 1 hour at room temperature. The slides were washed 3 times with 
PBS prior to an incubation step with protein marker antibodies (Table 2.3).  The slides 
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were then incubated with IgG-specific second antibody coupled with Alexafluor 
594/488 (Sigma) (Table 2.3) for 60 min at room temperature and washed 3 times with 
PBS. The slides were mounted with Prolong® Gold anti-fade reagent with DAPI 
(Invitrogen) overnight. Then the slides were sealed with a coverslip and nail polish prior 
to imaging by epifluorescence microscopy on an Axio Imager M1 microscope (Zeiss). 
Images were overlaid using Axio Imager software and edited using Adobe™ 
Photoshop.  
2.8.3 Fixing live parasites for IFA 
Parasite populations were synchronised tightly (within 1 h) prior to the experiment. 
Mature schizonts (~ 44-45 h post invasion) of ~7-8% parasitemia were purified and 
maintained in complete culture medium without red blood cells.  The parasite cultures 
were monitored closely by Giemsa staining until schizont rupture was detected.  The 
cultures were then pelleted and  ~5 µl of parasites were placed into 6 microcentrifuge 
tubes containing 500 µl complete medium with 5% haematocrit, for harvesting at 6 time 
points starting from egress to 30 min post egress.  For each time point, the tube was 
taken out from a 37oC shaking incubator and smeared for Giemsa staining to provide a 
stage-specific reference.  Immediately 500 µl of fixing solution (8% PFA+ 0.02% 
glytaraldehyde in PBS) was added to the tube, and incubated for 60 min. Cells were 
permeablised with 0.1% Triton-X100, resuspended in 3% BSA, and then kept at 4oC 
until used.  The set time points were T1 (2 min), T2 (5 min), T3 (10 min), T4 (15 min), 
T5 (20 min) and T6 (30 min).  Each selected time point was further analysed with IFA, 
using the procedure as in section 2.8.2. 
 
2.9 Protein complex identification by liquid chromatography- mass spectrometry 
(LC-MS/MS) 
Proteins or immunoprecipitation products (Section 2.3.3) from P. falciparum transgenic 
parasites expressing GFP-tagged MyoA and MyoB were resolved by short run SDS-
PAGE (4mm). The protein was stained with colloidal blue stain (Invitrogen) following 
the manufacturer's instructions. The stained gel was destained (200 mM ammonium 
bicarbonate, 50% acetonitrile)  for 30 min with shaking. Then the destaining solution 
was removed and the step repeated prior to washing with ultrapure water twice at 5 min 
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intervals. All the protein bands were excised and processed.   The gel pieces were 
placed into a non-coloured 0.5 ml Eppendorf tube. The SDS and stain were further 
extracted by incubating in 500 μl of destaining solution for 30 min at room temperature 
and this step was repeated twice. The protein was then reduced by incubating in 200 μl 
reducing solution (20 mM DTT, 200 mM ammonium bicarbonate, 50% acetonitrile) for 
1 h at room temperature. The DTT was removed by washing with 500 μl destaining 
solution. The cysteines of the protein were then alkylated by incubating in 100 μl of 
freshly prepared alkylation solution (5 mM iodoacetamide, 200 mM ammonium 
bicarbonate, 50% acetonitrile) for 20 min in the dark at room temperature. The 
alkylation solution was removed and the gel washed twice with 500 μl washing solution 
(20 mM ammonium bicarbonate, 50% acetonitrile). The washed gel piece was 
incubated in 500 μl of neat acetonitrile for 15 min till it turned white, then the 
acetonitrile was removed and the gel piece was left to dry in a laminar hood for about an 
hour. The dried gel containing protein was stored at room temperature prior to the 
trypsinization step. The dried gel was incubated in 12 μl of trypsin solution (1 μg/ml of 
trypsin in 5 mM ammonium bicarbonate) at 37oC overnight; the trypsin solution was 
added so that it covered the gel piece. The released peptides were used for protein 
identification by LC-MS/MS using an LTQ Orbitrap Velos mass spectrometer (Thermo 
Scientific), which was run and the data analysed by Dr. Steven Howell, (NIMR).     
    
2.10 Antibody production 
Antibodies to recombinant MyoA (α-MyoA Rc) protein were raised in a rat by Harlan 
Ltd, UK following a standard protocol.  Anti-peptide antibodies were generated by 
Pepceuticals Ltd, UK, in either rat or rabbit following the standard protocol.  The 
resulting antibodies and their working dilutions are listed in Table 2.3. 
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Table 2.1: The primers used for expression of recombinant protein used in the in 
vitro cell free system.  The coloured letters indicate restriction sites. 
Primers ID  Restriction 
site 
Sequence (5’-3’) 
N-terminal His-tagged 
Forward 
MyoA/pEU-F 1A  SmaI TACCTTAACCCGGGATGGCTGTGACCAACG 
MTIP/pEU-F 3M  SmaI TGGCAGTCCCGGGATGAAACAAGAATGC 
GAP45/pEU-F 5G  SmaI GCAGTGTCCCGGGATGGGAAATAAATGTTC 
Reverse 
MyoA/pEU-R 2A  SpeI GCCAAGCACTAGTCTACTGAGCCACCATCTT 
MTIP/pEU-R 4M  SpeI GCGGGCCCTCACTAGTTTATTGTAATATATC 
GAP45/pEU-R 6G  SpeI GCCGAGGCCACTAGTTTAGCTCAATAAAGG 
N-terminal GST-tagged 
Forward 
G-N1/MyoAF 7A  EcoRV CGTTTATCTGATATCATGGCTGTGACCAACGAGGAGATC 
 G-N1/MTIPF 9M  EcoRV CGGCCGACGGATATCATGAAACAAGAATGCAATGTATGT 
G-N1/GAP45F 11G  EcoRV CCGGGTCGAGATATCATGGGAAATAAATGTTCAAGAAGC 
Reverse 
G-N1/MyOAR 8A  NotI AAATAGCGGCCGCTCACGGACACGCAGTTCTCCCAC 
G-N1/MTIPR 10M  NotI GCCCGGGCGGCCGCTTGTAATATATCTTCACAGAATAATTTG 
G-N1/GAP45R 12G  NotI GGGAATTGCGGCCGCTTAGCTCAATAAAGGTGTATCGG 
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Figure 2.1 A Schematic model showing the set up for single molecule myosin 
studies. (a) The positioning of the beads in the laser trap.  An actin filament (yellow 
line) was held between two beads trapped by a laser beam (red beam).  The third bead is 
coated with myosin (blue shape).  Image is adapted from the Block laboratory website 
at Stanford University; http://www.stanford.edu/group/blocklab/kinesin/kinesin.htm. 
(b) A diagram of the Acto-myosin “events” as determine by optical trapping.  Under the 
conditions used throughout this thesis (low temporal resolution) only the rigor state can 
be detected as the second phase of the power stroke (ADP isomerization or release) 
occurs within the limit of temporal resolution.  The “lifetime” of these events is, 
therefore, dependent upon ATP concentration. The components are: myosin (blue 
shape), actin filament (black line), two beads in a laser trap (green shape), and myosin 
coated bead (rectangle shape). (c) Example of the raw displacement data (red dots) and 
the corresponding standard deviation (red line). (b) and (c) are a schematic diagram 
produced by Rachel Farrow. 
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Table 2.2:  Primers used for construction of single cross over transfection plasmids 
and for the diagnostic PCR to analyse transgenic parasites.  Coloured letters show 
the restriction site, whilst the background coloured letters indicate the unique sites 
introduce into the DNA sequences.   
Primers  ID RE  Sequence (5’-3’) 
 
Primers used for flanking regions 
Forward 
PfMyoA-F  3F1 XmaI CCCGGGCAAGAATTGAACCAGAAGGAGGATTTAAAAC 
PfMyoB-F  4F1 XmaI CCCGGGGGACATCCTTTCGCCTAACATTTTGAAA 
PkMyoA-F1  1F1 XmaI CCCGGGGGTATGTTGGACATTTTCGGTTTTGAG 
 PkMyoA-F2 1F2 NruI  TCGCGAAGGGATCACTCATAGGATCTCAGTTC 
PkMyoB-F1 2F1 XmaI  CCCGGGTCGATCGTGGGAGTTTACACGAAC 
 PkMyoB-F2 2F2 AfIII  CTTAAGAAAATCAGCTCCTATTTGAAAAACACAAATATAT 
Reverse 
PfMyoA-R 3R2 AvrII  CCTAGGTTGAGCTACCATTTTTTTTCTTATATGAGCTTGTA 
PfMyoB-R 4R2 AvrII  CCTAGGTTCGTGTTCCTTAATATATTTATATTTCCTAAAATATGC 
PkMyoA-R1 1R1 Avr/
NruI  
CCTAGGGATCCCTTCGCGATTTTTCCCTTTTCTATAACTTGACCT
TCAAAC 
PkMyoA-R2 1R2 AvrII  CCTAGGCACGGTGAGTCTCTTCCTTATGTG 
PkMyoB-R1 2R1 Avr/
AflII  
CCTAGGAGCTGATTTTCTTAAGATTCTCCAAATATTTAAATGTGA
TTAAGTTTTTCCTTC 
PkMyoB-R2 2R2 AvrII  CCTAGGCTTCAGCTGTGCAATGTACTTATGTTTC 
Primers used in diagnostic PCR 
Forward 
PfMyoAs+F1 1 - GGGAAATATTAATTAAGGTAACTGTTGCTGGAGGAAC 
PfMyoBs+F1 3 - CATAACGGAAAGTTTTGTAATTAAGCATACTGTAAGTGATG 
PfMyoB 3a - CTAAGAATGAACATTATTCAGTATGTAAG 
PfMyoB 3b - CATAACGGAAAGTTTTGTAATTAAGCATACTG 
PfMyoB 3c - ATTAAGTCGATCGTAAGTGTTTATACA 
PkMyoAs+F1 5 - CGCTGGAGGAAATAAGATCGAAGGTAGATG 
PkMyoA 5a - CAAGGTTACCAACGCTGGAGGAAATAAGATCG 
PkMyoA 5b - GAGCGATGCAGAAGTGTTGCAGTTATCCCTTTG 
PkMyoBs+F1 7 - CTGGCCCCAGGAAAGAAGGACGAGGTGAGCATCGCGCAAGTG 
PkMyoB 7a - GTGCATGTGTGAAGGGGAGGCACATTTGCA 
PkMyoB 7b - CTGGCCCCAGGAAAGAAGGACGAGGTG 
Reverse 
PfMyoAs+R1 2 - CACTCATAGATGCAACATGTAAGTATACAAATAAATATGGTATGT
AG 
PfMyoBs+R1 4 - GGATGACCAGAAAGTTGTAACTTTGGCAAATTTATTC 
PkMyoAs+R1 6 - GGTCATTAAGGGGGTAAAAAGGGGGGG 
PkMyoBs+R1 8 - CTTTGATGAGGTCCAACTGGTTGGTGTTC 
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Table 2.3:  List of antibodies used in Western blot and IFA 
ID Antibody Raised 
in 
Dilution 
WB/IFA 
Source 
Polyclonal antibodies to recombinant proteins   
α-MyoA  Polyclonal MyoA Rabbit 1:5000/1:1000 Dr JC Fordham 
α-MTIP Polyclonal MTIP Rabbit 1:5000/1:1000 Dr JL Green 
α-GAP45 Polyclonal GAP45 Rabbit 1:20000/1:1000 R Rees-Channer  et al., 2006 
α-GAP45 Polyclonal GAP45 Mouse -/1:1000 R Rees-Channer  et al., 2006 
α-GAP50 Polyclonal GAP50 Rabbit 1:1000/1:200 Raised in house 
α-GFP Affinity purified GFP Rabbit 1:5000/1:500  Dr E Knuepfer 
Commercial antibodies  
GFP Booster Camelid GFP antibody  Camel -/1:200 Cromotek 
α-GFP Monoclonal mouse GFP  Mouse 1:1000/1:200 Roche 
Tub Tubulin  Mouse -/1:200 Roche 
Act Actin (AC-40) Mouse -/1:100 Roche 
Polyclonal antibodies to peptides  
α-MyoA-Rc MyoA Full length (generated from protein produced with wheat germ cell free 
system) 
Rat 1:500/1:200 This study 
Pf/k MyoA MAVTNEEIKTASKIVRRVSNVEAFDKSGSVC  
(Antibodies to this sequence should bind to both Pf and Pk MyoA)- Peptide produce 
by Pepceuticals Ltd. 
Rat 1:200/1:200 This study 
Pf/k MyoA-rabbit MAVTNEEIKTASKIVRRVSNVEAFDKSGSVC  Rabbit 1:200/1:200 This study 
Pk/f MyoB IPLSVEESLSIARSISKDIYNKIFEC  
(Antibodies to this sequence should bind to both Pf and Pk MyoA)- Peptide produce 
by Pepceuticals Ltd. 
Rabbit 1:200/1:200 This study 
Pk/f MyoB-rat IPLSVEESLSIARSISKDIYNKIFEC Rat 1:200/1:200 This study 
PkMyoB MNKASELSNYFRINSEFVNKIENE 
Peptide produce by Pepceutical Ltd 
Rat 1:200/1:200 This study 
PfMyoB MVNKINELNNYFRINSTFINKSENE Peptide produce by Pepceutical Ltd Rat 1:200/1:200 This study 
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Table 2.3 continued:  List of antibodies used in western blot and IFA  
ID Antibody Raised 
in 
Dilution 
WB/IFA 
Source 
Organelles marker antibodies  
AMA1 Apical membrane antigen-1 Rabbit -/1:3000 Arnot et al., 2008 
PTRAMP Thrombospondin-related apical membrane protein  Rabbit -/1:5000 Dr JL Green (NIMR) 
EBA175 Erythrocyte binding antigen-1 Rabbit -/1:800 MR4 
RhopH2 Rhoptry-H2 Rabbit -/1:4000 Ling et al., 2003 
RON3 Rhoptry neck-3 Mouse -/1:1000 Dr E Knuepfer (NIMR) 
RON4 Rhoptry neck-4 Mouse -/1:1000 Dr E Knuepfer (NIMR) 
RAP1 Rhoptry body-1 Mouse -/1:800 Dr E Knuepfer (NIMR) 
MSP7 Merozoite surface protein-7 Rabbit -/1:3000 Dr E Knuepfer (NIMR) 
Secondary antibodies  
α-Rat/Rabbit/Mouse 
IgG HRP 
Alexafluor® 594 Rat/ 
Rabbit/ 
Mouse 
-/1:5000 Invitrogen 
α-Rat/Rabbit/Mouse 
IgG HRP  
Alexafluor® 488 Rat/ 
Rabbit/ 
Mouse 
-/1:5000 Invitrogen 
- HRP-conjugated goat anti mouse Mouse -/1:2000 Biorad 
- HRP-conjugated goat anti rabbit Rabbit -/1:2000 Biorad 
- HRP-conjugated goat anti rat  Rat -/1:2500 Sigma 
 
 
 
80 
 
 
Chapter 3 
In vitro Protein Expression and Interaction Studies 
 
 
3.1 Introduction 
One of the challenges faced by scientists attempting to express P. falciparum 
proteins in heterologous systems, is a lack of an efficient recombinant protein synthesis 
system.  This limits not only the initial synthesis and characterisation of a protein, but 
also functional studies and downstream assessment for drug discovery, for example.  
What is required is optimised protein expression systems that can decoded A/T-rich 
malaria parasite genes, often coding for low complexity amino acid sequence, into high 
quality folded protein.   These features have been proposed as major factors limiting P. 
falciparum protein expression in heterologous cell based systems (Tsuboi et al., 2010). 
The improvements were achieved by the development of so-called bilayer translation 
methods in which a diffusion system enables the continuous supply of substrates, while 
continually removing small, low molecular mass by-products.  This is achieved via a 
phase partition between the translation mixture and the substrate mixture, mimicking 
the normal cell physiology (Sawasaki et al., 2002a).  
  
Endo et al. (2003) suggested that although classical recombinant protein 
technology is well developed it still has limitations, such as the fact that the proteins 
produced may not be correctly modified by the host cell, and generally it is time 
consuming to prepare the recombinant proteins.  On the other hand, using a cell-free 
synthesis system had several advantages over conventional recombinant expression.  
These advantages are: the proteins produced are stable at higher concentration due to 
the fact that wheatgerm contains all necessary requirements for the translation that can 
be added in a controlled way, the procedure is less time consuming (typically completed 
within 2 days), and the proteins are correctly folded (Endo and Sawasaki, 2003; 
Sawasaki et al., 2002a; Sawasaki et al., 2002b). Thus cell-free expression can prove 
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very useful in systematic studies to examine protein structure-function relationships, in 
delineating the scope of modern proteomics, in crystallisation studies, and in exploring 
protein-protein interactions (Sawasaki et al., 2002b; Sawasaki et al., 2002c).   
 
The Plasmodium molecular motor complex or glideosome, which includes 
myosin, is located between the IMC and PM of the parasite and is considered to be the 
most important driving force responsible for parasite gliding motility and cell invasion, 
such as merozoite invasion of red blood cells. This motor is powered by ATP 
hydrolysis allowing the myosin to move f-actin. In many systems it has proved 
extremely difficult to produce myosins in recombinant form to facilitate their study (Dr 
Justin Molloy, personal communication). Therefore, in the context of this study it was 
decided to examine expression of the proteins of the motor complex using the wheat 
germ in vitro expression system, with a view to studying protein-protein interactions 
and rebuilding the glideosome motor complex in vitro.  
 
In this chapter, attempts to express the glideosome motor proteins by wheat 
germ cell free system are described.  The N-terminal and C-terminal tagging with His- 
and GST- tags of MyoA, MTIP and GAP45 were undertaken in order to produce  
different tagged proteins to be used in protein-protein interaction studies.  Therefore 
His- or GST- pull down assays can be used to isolate the  protein and other associated 
proteins.   
 
 
 
3.2 Production of recombinant proteins using the wheat germ cell free system   
Re-codonized full-length genes encoding P. falciparum Myosin A (MyoA, 2454 
bp) (donated by Rachel Farrow, NIMR), Myosin Tail domain Interacting Protein 
(MTIP, 615 bp) (Judith Green, NIMR) and Glideosome Associated Protein 45 (GAP45, 
615 bp) (Ridzuan Razak, NIMR) were available in the laboratory and therefore chosen 
for these studies. The sequences were PCR amplified using pairs of primers (Chapter 2, 
Table 2.1) specifically designed for each gene to allow them to be cloned and expressed 
in either the His- or GST-tag wheat germ in vitro expression vectors (Appendix A).  All 
DNA sequences were confirmed by Sanger sequencing (Beckman Genomics) before 
82 
 
being used in the expression protocols. The recombinant plasmid DNA produced was 
used as a template for mRNA transcription.  Transcript analysis showed that all mRNAs 
encoding N-terminal His- and GST-tagged proteins were transcribed successfully. 
Following in vitro translation the soluble (S) and insoluble (P) fractions of the reaction 
were analysed using Western blotting with specific antibodies for the His- or GST-tags 
to examine the level of protein expression and each protein's solubility.   In initial 
studies looking at expression of His-MTIP (M1), His-GAP45 (G1), GST-MTIP (M5) 
and GST-GAP45 (G5), it was found that the majority of each protein was soluble 
(Figure 3.1). Unfortunately, His-MyoA (A1) was largely in the insoluble fraction. 
Although GST-MyoA (A5) was also in the insoluble fraction, some product was in the 
soluble fraction (Figure 3.1).  Therefore the GST-MyoA was purified from this soluble 
fraction using glutathione-Sepharose beads (GE Healthcare), and the eluate (E3) was 
used further as described in Section 3.3.   
 
 
 
Figure 3.1:  Generation of recombinant DNA, and protein expression in the wheat 
germ cell-free system. (a) Map of the plasmid used for expression of His-tagged 
proteins in the wheat germ cell-free system; all genes were inserted following 
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SpeI/SmaI digestion into the multiple cloning site (MCS) region.  (b) SDS-PAGE and 
western blot analysis of in vitro translation of His-tagged proteins. The gel was stained 
with Coomassie blue (SDS-PAGE gel) and the immunoblot probed with anti-hexaHis 
antibody.   Total protein translation reactions were also separated into soluble and 
insoluble (precipitate) protein fractions following centrifugation.  The reactions to 
express His-MyoA (A1), His-MTIP (M1) and His-GAP45 (G1) respectively were 
examined. His-MTIP and His-GAP45 were essentially soluble whereas most of the His-
MyoA was in the precipitate (insoluble) fraction. Fraction C is a control reaction 
without added mRNA. The mobility of molecular mass markers (kDa) is indicated on 
the left of the panel  (c) Map of the plasmid used for expression of GST-tagged proteins 
in the wheat germ cell-free-expression system; all genes were inserted following  
EcoRI/NotI digestion into the multiple cloning site (MCS) region.  (d) SDS-PAGE 
analysis of GST-MyoA (A5) expression and purification; proteins were detected by 
staining with Coomassie blue.   M-molecular mass markers; NC - negative control, 
reaction to express DHFR; T - total translation reaction; S - soluble and P - insoluble 
fractions following centrifugation;   FT - flow through of glutathione-Sepharose 
column; E1 to E3 are column elution fractions 1, 2 and 3, respectively. Bovine serum 
albumin (BSA) in the amounts specified was included on the gel to facilitate estimation 
of the yield of specific protein.  
 
3.2.1 Co-expression: MyoA co-expression with GST-tag enhances solubility 
   
  The poor solubility of the MyoA protein is consistent with previous studies that 
showed it is a difficult protein to fold, leading to aggregation and insolubility (Rachel 
Farrow, Ph.D. thesis, 2010).  Therefore the initial question was whether the MyoA 
protein produced in this study was incorrectly folded leading to its aggregation. Several 
attempts were made to optimize the level of expression and solubility of the protein 
including varying the salt (NaCl) concentration, the use of non-ionic detergents (Triton-
X100 and Nonidet P40), and addition of  reducing agent (DTT) or the divalent cation 
chelator, EDTA. However, none of these factors significantly altered MyoA solubility 
(data not shown).  In previous studies, MyoA has been shown to interact with MTIP 
through its short tail (Bergman et al., 2003; Green et al., 2006b; Thomas et al., 2010) . 
Considering MTIP’s good solubility, it was hypothesised that its addition may aid 
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MyoA folding and solubility, and following MyoA expression an excess of recombinant 
MTIP protein was added directly to the sample.  However, this had a minimal effect on 
MyoA solubility (data not shown).    
 
  In another attempt to increase MyoA solubility in both His- and GST- tagged 
forms, a series of co-expression studies were carried out.  MyoA was co-expressed with 
combinations of MTIP and GAP45 (see Chapter 2, section 2.2.4).  With His-MyoA, 
initial attempts using a ratio of 1:2 (His-MyoA: MTIP) mRNAs to provide an excess of 
MTIP showed no appreciable effect. However, by using equal volumes of MyoA and 
MTIP mRNA in the translation mixture, the solubility of His-MyoA shifted to almost 
~50% in the soluble fraction (Figure 3.2).  With respect to GST-MyoA, which when 
expressed alone was approximately 50% soluble, further co-translation with MTIP and 
GAP45 was carried out.  Co-expression of GST-MyoA with either MTIP or GAP45 
increased the proportion of soluble MyoA, although co-expression of all three proteins 
together had no notable effect on MyoA solubility (Figure 3.2.b).  Overall from these 
studies it was determined that there are no major significant differences between His- or 
GST-MyoA (Figure 3.2.c), but co-expression with MTIP or GAP45 always increased 
GST-MyoA solubility to greater than 60% (Figure 3.2.d). Unfortunately a consequence 
of co-expression (with all three proteins) was a reduction in the total amount of MyoA 
production, the result being that compared to MyoA expression alone the total amount 
of soluble MyoA protein was lower in the presence of MTIP or GAP45.   
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Figure 3.2:  Protein translation in the wheat germ cell-free system. Each translation 
mix was separated into soluble and insoluble fractions and probed for its tagged protein 
content using SDS-PAGE/Western blotting and α-MyoA, α-MTIP and α-GAP45 
antibodies. (a) N-terminal His-tagged MyoA expressed alone (A1), or together with 
MTIP (A1M1) and GAP45 (A1G1) or together with both MTIP and GAP45 (ALL). 
The western blots were probed with antibodies specific to MyoA, MTIP and GAP45.   
(b) N-terminal GST-tagged MyoA expressed alone (A5), or together with MTIP 
(A5M5) and GAP45 (A5G5), or together with both MTIP and GAP45 (ALL). The 
western blots were probed with antibodies specific to MyoA, MTIP and GAP45.   (c) 
Estimation of the amount of the expressed single proteins with His- or GST-tags in the 
soluble and insoluble fractions. The numbers indicate the percentage of the amount of  
protein in either the soluble (blue) or insoluble (red) fraction, as determined using 
western blotting and analysed using densitometry (Image J software).  (d)  
Measurement of MyoA solubility when co-expressed with either MTIP or GAP45 
individually or both together. The amount of MyoA protein was analysed by western 
blot (using anti-MyoA antibody) and densitometry and is expressed as the percentage of 
the control, with indication of the amount in the soluble and insoluble fractions.  
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3.2.2 Comparison of His vs GST tagged MyoA solubility 
 
In the previously described experiments the same tag was used on each of the 
expressed proteins, in order to give some idea of the ability of the cell-free system to 
produce soluble protein.  To facilitate studies of protein-protein interactions, a series of 
protein co-expressions was carried out with GST- or His-tagged MyoA and MTIP or 
GAP45 modified with the alternative tag. Of particular interest is the fact that MyoA 
solubility was substantially improved when GST-MyoA was co-expressed with a His-
tagged second product (Figure 3.3.b), although the overall amount of MyoA protein 
produced was reduced (as previously mentioned).  The same bias was also evident in 
reactions where all three products were co-expressed (Figure 3.3.c). 
 
These levels of protein represent general trends in their expression/solubility 
over several independent experiments, although it should be noted that the total amount 
of MyoA produced varied quite widely from experiment to experiment, as determined 
by western blotting.  This variation is likely due to inconsistencies in the quality of the 
transcription and translation preparations, given the multiple stages and the sensitivity 
of the process.  Despite this, some soluble protein was always produced, enabling us to 
further investigate protein-protein interactions within the motor complex. 
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Figure 3.3: Protein co-expression in the cell-free system and determination of 
MyoA solubility.  (a) Total protein from the wheat germ expression system resolved by 
SDS-PAGE and detected by Coomassie Blue staining following co-expression.  His-
MyoA coexpressed with GST-MTIP (A1+M5) and GST-MyoA co-expressed with His-
MTIP (A5+M1); total reaction mix (T) and soluble supernatant (S) or insoluble 
precipitate (P) fractions following centrifugation were analysed together with a negative 
88 
 
control (NC) reaction. Molecular weight markers (M) are shown, together with their 
sizes (kDa) on the left side of the gel. Known amounts (ng) of BSA standard were used 
to gauge the amount of protein produced. Proteins of the expected size were present in 
the experimental samples and are highlighted (*).  (b) Co-expression of MyoA with 
MTIP or GAP45 using different tags as detected by western blotting using α-MyoA 
antibodies (i). The bar chart indicates the percentage of MyoA in the soluble and 
insoluble fractions as determined by densitometry (Image J) (ii). (c) Expression of 
MyoA, MTIP and GAP45 all together. The percentages represent the relative 
expression of MyoA in pellet and soluble fractions  in total translation. Western blots 
using α-MyoA antibodies (i) and bar chart (i) to indicate the amounts of MyoA in the 
soluble and insoluble fractions (as determined by densitometry).  The amount of MyoA 
production was lower  when all three protein were expressed together although the total 
solubility was increased. 
 
 
3.2.3 MyoA forms a complex with MTIP but not with GAP45 
To determine whether or not MyoA produced in the cell-free system is able to 
form a complex with other glideosome motor components, we performed pull-down 
assays using each of the components in the co-expression reactions to precipitate the 
other proteins from the complex. Although an interaction between MyoA and MTIP 
was observed using GST-MTIP in GST-pull down assays, this result could not be 
replicated with other tagging combinations (Figure 3.4). In addition no interaction 
between either MyoA or MTIP with GAP45  was detected (Figure 3.4). 
 
89 
 
 
 
 
Figure 3.4 GST pull-down assays.  Combinations of His- and GST-tagged proteins 
were co-expressed and used for GST pull-down assays, in which GST-tagged proteins 
were used to pull-down associated proteins. Precipitated proteins were resolved by 
SDS-PAGE, transferred to membrane and then probed for the presence of MyoA, MTIP 
and GAP45 using specific antibodies. (A) Reactions with two components co-
expressed. (B) Reactions with all three components co-expressed.  Specific interactions 
with MyoA were observed when GST-MTIP was used, indicating an interaction 
between these two proteins (in reactions where both MyoA and MTIP and all three 
proteins were expressed). No interaction was observed between GAP45 and either of 
the other two proteins.  Western blots were probed with α-PfMyoA, α-MTIP and α-
GAP45 antibodies. TM= total protein expressed, UB (unbound) = protein not bound to 
beads, W (wash)= protein after washing step and B (Bound) = protein bound to beads.   
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3.3 Characterization of single molecules and the sliding/gliding movement of 
MyoA 
 
MyoA interacts with actin filaments to move the parasite forward during gliding 
motility or invasion into the host cell, and previous studies have focused on the crucial 
role of this type XIV myosin in parasite gliding motility.  There have been several 
attempts to express in recombinant form and study the functional properties of MyoA 
(personal communication, Justin Molloy and Rachel Farrow, NIMR) However 
expression proved to be very difficult, the produced protein was truncated and 
improperly folded, and no activity was detected. We attempted to overcome these 
limitations using the wheat germ cell-free system.  Having produced soluble MyoA in 
this study, we next investigated the functional properties of the protein, specifically its 
interaction with actin using a combination of motility- and actin binding assays, and 
also a single molecule study via optical trapping.  
 
 
3.3.1 Movement of single MyoA molecules and the step size on an actin filament, 
measured in an optical trapping assay. 
Optical traps (OT), also known as optical tweezers, are a system for 
manipulating refractive dielectric particles such as silica or latex beads, or biological 
materials such as cells (Ashkin et al., 1987). The technique uses a combination of 
proton pressure and electric field gradients generated when light of the same magnitude 
as the particle size, is directed at the particle. This effectively traps the particle and any 
displacement can be measured.  In these studies we used a three-bead assay  (Finer et 
al., 1994).  Here an actin filament is suspended between two optically trapped beads 
and positioned in close proximity to a surface bead that has been coated with myosin 
(Ruff et al., 2001). This assay is best suited to studying the non-processive motors such 
as myosin II and XIV, which detach from actin during each ATPase cycle and remain in 
the detached state for the majority of the mechanical cycle.  
   
An actin filament was suspended between two optically trapped beads and 
placed over a third, surface bound myosin coated bead.  Any binding event can be 
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detected by the displacement of the beads. Upon myosin binding to the actin filament, 
the binding event can be detected by a decrease in the running standard deviation of the 
bead displacements (see Figure 3.5.a for details).  MyoA binds to actin when ADP and 
Pi are bound in a reversible weak-binding state. On binding the ADP-Pi is released 
forming a strong actin binding complex. This effectively ‘holds’ the actin filament, 
restricting its Brownian motion, and is referred to as in a ‘myosin bound' or in a ‘rigor' 
state. Pi release occurs simultaneously with the power stroke (known as the ‘event’). 
OT does not detect the power stroke directly but allows measurement of the 
displacement of the trapped beads attached to the actin filament. Following the power 
stroke, ADP is released. As mentioned earlier (Chapter 2, section 2.4.2, Figure 2.1), this 
release is associated with a further smaller power stroke, which can be also be detected 
by optical trapping nanometry.  Following ADP release the myosin head is in a rigor 
state and tightly bound to the actin filament. Upon ATP binding the myosin cleft opens 
and myosin dissociates from the actin filament resulting in normal Brownian motion 
being restored. This is referred to as the ‘myosin unbound’ state (Figure 3.5.a-b). 
 
In these studies we used GST-tagged MyoA principally because of its greater 
solubility.  A total of 244 acto-myosin events were recorded in 2 µM ATP (a 
concentration based on the affinity of TgMyoA for 2'-/3'-O-(N'methylanthraniloyl)-
ADP (mant ADP) (Herm-Gotz et al., 2002)).  For ease of visualization the beads were 
moved backwards and forwards using a 10 Hz triangle wave applied to both beads and 
enabling us to observe approximately 20 interactions (Figure 3.5 c).  This is considered 
to be an extremely low event occurrence compared to that of some other myosin 
studies, which typically reach into thousands of events (Ishijima et al., 1998). At this 
low frequency of interaction it needed to be established whether there was any specific 
myosin-actin interaction or were the changes noted due to a random association. To 
eliminate this possibility, we repeated the experiments using different ATP 
concentrations of 300 nM and 8 µM to induce variation in the period of actin-myosin 
interaction.  At 300 nM ATP we expected to see interactions lasting on average 10 s-1 
(Nfilament =1: Nobs=79) and at 8 µM ATP lasting 76 s-1 (Nfilament=1: Nobs=165).  This 
expectation was based on the principle that at higher ATP concentrations myosin would 
undergo increased ATP hydrolysis causing disassociation from actin and reducing the 
time of interaction.  Conversely, in a low ATP environment ADP will remain bound to 
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the myosin head longer and in turn the myosin will remain bound to the actin filament 
longer (Figure 3.5.d, also see Chapter 1, Figure 1.1.7).  The results showed that the 
interactions detected in these experiments are true interactions between MyoA and actin 
filament. Even though the results were not ideal due to the low frequency of events, the 
data were sufficient to show that MyoA was binding to actin filaments.  Furthermore, 
by measurement of the lever-arm displacement induced on ATP hydrolysis (referred to 
as ‘displacement’) we observed a shift of ~3 nm (range of ~2-5 nm) (Figure 3.5.e). This 
displacement is similar to the T. gondii MyoA shift (~5 nm) and that of skeletal muscle 
myosin II (~4.8 nm) (Herm-Gotz et al., 2002; Molloy et al., 1995). Overall these data 
indicate that some of the MyoA produced in the cell-free system is active.   
 
 
 
Figure 3.5 Study of MyoA single molecules as measured by optical trapping.     (a): 
illustrated diagram of the acto-myosin ‘event’ as determine by OT.  The actin filament 
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was held between 2 beads (circles coloured green); a left hand bead and a right hand 
bead.  The third bead (square grey shape) held the MyoA molecule (coloured blue).  
The background displacement movement (noise) seen is due to Brownian motion.  
Event1, Event 2 etc. were marked decreases in the standard deviation of the 
displacement due to the myosin head binding to the actin filament. (b) Acto-myosin 
‘event’ as determine by OT with MyoA.  The movement of bead one (the right hand 
bead) is shown in blue.  The movement of the left hand bead is shown in red (and offset 
by -200 nm for display purposes).  The standard deviation for both beads is shown in 
black (black line).  The standard deviation of the left hand bead is offset by -30 nm. The 
sudden decrease in standard deviation (dash lines) indicates that MyoA bound to the 
actin filament.  Movement below the dotted red/ blue line indicates an ‘event’ (bound 
MyoA)  whereas above the dotted red/blue line no ‘events’ were recorded and the 
MyoA remained ‘unbound’.  (c) To make the effects easier to visualise, the beads were 
moved backwards and forwards using a 10Hz triangle wave.  (d) MyoA displacement 
histogram collected for acto-myosin events and fitted Gaussian distribution.  On the x-
axis is the average of the beads held in the  optical trap during binding.  The y-axis is 
the number of observations at that value (Nobs).  The displacement of MyoA was 
detected as 3 nm.  If  MyoA only bound actin and did not do anything, the expected 
histogram would have a maximum at zero. (e) MyoA lifetime displacement distribution 
histogram.  The x-axis is the duration in seconds of the binding events; the y-axis, is the 
number of observations at that value when the event occurred.  The data at 300 nM are 
in red and the 8 µM data are in blue.  This duration of event was fit to a single 
exponential as the myosin-actin binding is a ‘stochastic’ process. 
 
3.3.2 Characterisation of the MyoA-actin interaction  
 
Knowing that single MyoA molecules were capable of actin binding and 
movement, next we carried out motility assays to observe actin filament gliding and to 
determine translocation velocity. The motility assay displays the sliding/gliding of actin 
filament caused by myosin bound to a solid substrate (the coverslip). Actin labelled 
with Rhodamine-Phaloidin (RhPh) forms filaments that are observed via fluorescence 
microscopy and their movement can be tracked, enabling calculation of myosin 
speed/velocity.  
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GST-MyoA was used for the in vitro motility assay and rabbit skeletal heavy 
mero myosin (HMM) was used as a control.  In a control experiment, rabbit F-actin  
bound strongly to HMM (~40 µg/ml) and upon addition of ATP, moved at a velocity of 
2.9 µm/s.  However, with GST-MyoA (~48 µg/ml) although there was an indication 
that the MyoA was binding to actin, on addition of 2 µM ATP the actin filaments were 
washed off of the surface.  Although no gliding was seen, the loss of the actin from the 
surface provides some indication that MyoA was functional, as in the presence of ATP 
the myosin head will release actin.  Unfortunately, it is unclear why they do not rebind 
following ATP hydrolysis as this is the normal behaviour enabling actin translocation.  
In an attempt to increase binding the MyoA concentration was increased, however, even 
at  ~92 µg/ml, there was no indication of gliding movement (Figure 3.6). 
 
A series of optimisations was performed in an attempted to improve the 
conditions for gliding movement. For example, we reasoned that using a combination of 
MyoA/MTIP might help MyoA translocate actin, allowing gliding movement to be 
observed and recorded. MyoA lacks the long tail that normally binds to cargo but 
possesses a neck, which binds to MTIP (Green et al., 2006b) and MLC1 in Toxoplasma, 
bringing MyoA to its site of action. Other changes included immobilisation with MTIP 
antibody and adding methylcellulose to the scavenger buffer, AB+, to restrict the 
diffusion of actin filaments away from the surface of the cover slip when the effective 
MyoA concentration used was too low for smooth motility.  Although MyoA showed 
properties characteristic of actin-binding as mention above (MyoA bound to actin 
filaments in the absent of ATP), unfortunately we failed to observed any gliding 
movement under the new conditions.  We further investigated the actin-myosin 
interaction by performing the most straight forward assay, which takes advantage of the 
ability of actin to co-sediment MyoA on ultracentrifugation (Dobrowolski et al., 
1997b).  This method is based on  a simple observation which is that if MyoA binds to 
actin in the absence of ATP, then by ultracentrifugation MyoA-actin will co-sediment 
in the pellet fraction. Conversely in the presence of ATP, MyoA will be in the soluble 
fraction, while actin will be pelleted.  Following analysis of these fractions by Western 
blots probed with specific antibody to actin and MyoA, none of these expectations were 
fulfilled (data not shown), and therefore this experiment also failed to show MyoA-
actin binding. 
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Since MyoA was soluble and functional as showed by OT, but failed to promote 
actin filament gliding in the motility assay, and the inconclusive result of MyoA-actin 
binding in the actin sedimentation assay, we decided to look at the interaction of actin 
with MyoA by transmission Electron Microscopy (EM).  This experiment was carried 
out with help from Ms Lesley Calder (Physical Biochemistry, NIMR).  EM should 
enable us to see the MyoA bound to or decorating the actin filament.  The result 
obtained indicated that MyoA was abundant in the sample preparation but unfortunately 
most of it seemed to be aggregated or precipitated. Therefore, the expected decoration 
of the actin filament was rarely seen (Figure 3.6).  Finally, the unfolded structure of 
MyoA was confirmed by Far UV circular dichroism (CD) analysis (data not shown).  
Taking into consideration all of the results obtained, we decided not to investigate 
further this MyoA produced in the cell free system.   
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Figure 3.6 Actin-Myosin interactions. (I) (a and b) Control experiments using  RhPh 
labelled rabbit actin (RhPh-actin) and rabbit heavy-meromyosin (HMM) in the presence 
or absence of ATP. Upon addition of 2 µM ATP, HMM translocated actin filaments 
with an observed gliding velocity of 2.8 µm s-1.  (c and d) RhPh-actin and MyoA in the 
presence or absence of ATP.  Upon addition of ATP, actin filaments were washed away 
as the MyoA head released the actin filament, with no evidence of re-binding or gliding 
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motility. (e and f) A combination of GST-MyoA and His- MTIP with and without ATP.  
As with the MyoA alone, the addition of ATP allowed the actin filaments to be washed 
away indicating that the presence of MTIP caused no additional improvement to 
activity. (II) Transmission EM  of expressed MyoA and actin filaments. (a) MyoA 
alone; protein was abundant but highly aggregated. (b) Actin alone; a control showing 
long filaments of rabbit skeletal actin. (c) MyoA mixed with rabbit-actin filaments; only 
a small proportion of the MyoA was observed bound to actin filaments with the 
majority of the protein aggregated.  (d-f) Expanded images from that shown in (c) 
showing some MyoA molecules (arrows) decorating actin filaments.   
 
3.3 Discussion 
 
The aim of this study was to produce soluble MyoA protein that could be used 
to reconstitute the invasion motor complex in a test tube. An additional aim was to 
study protein-protein interactions and the functional properties of MyoA in association 
with glideosome complex proteins, and the interaction with actin.   
 
In order to rebuild the glideosome complex in vitro, we required a soluble and 
functional MyoA protein together with the associated glideosome complex proteins, 
MTIP and GAP45.  These two proteins had been established to be in association with 
MyoA as a part of the invasion machinery during parasite invasion (Baum et al., 2006b; 
Bergman et al., 2003; Gaskins et al., 2004; Herm-Gotz et al., 2002). MyoA has  proved 
to be difficult to express in a folded form using heterologous recombinant systems 
(personal communication with Rachel Farrow and Justin Molloy, NIMR).  However, no 
attempted had been made to express MyoA in the wheat germ cell free extract, and 
therefore this system was our choice to produce soluble MyoA protein.  Using this 
system we produced MyoA, MTIP and GAP45 individually.  We also produced MyoA 
co-expressed with MTIP or GAP45, or all three proteins expressed together.   
Previously MTIP and GAP45 had been expressed successfully in another heterologous 
system, however it was important to produce all the protein in the same system as they 
needed to be synthesized together for the purpose of establishing an in vitro protein-
protein interaction study using pull down assays.  
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The results showed that MyoA and MTIP would associate when expressed 
together in vitro, but no interaction was detected between MyoA and GAP45 and 
between MTIP and GAP45.  The interaction of between MyoA and MTIP has been well 
studied previously (Bergman et al., 2003; Green et al., 2006b; Thomas et al., 2010) , but 
not in this format.  Tagging at the N-terminus of MyoA was used so as not to affect the 
binding to MTIP, since the MyoA-MTIP interaction occurs at the extreme C-terminal 
end of MyoA.  Direct interaction, either between MyoA and GAP45 or MTIP and 
GAP45, has never been reported (Bosch et al., 2006; Bosch et al., 2007b; Green et al., 
2006b; Thomas et al., 2010).   Frenal et al (2010) showed that the N-terminal region of  
T. gondii MLC1 (the orthologue of MTIP) was important for interaction with GAP45 
and the GAP45 C-terminal domain was essential to recruite MLC1 and indirectly 
MyoA to  the IMC. 
 
The study was extended to investigate the functional properties of the MyoA 
produced and its interaction with actin using OT and gliding motility assays.   A single 
molecule study using OT showed that the MyoA was functional due to the detection of 
interactions occurring with actin during this assay.  Although the binding to actin or the 
detection of a working stroke (displacement) was not extensive due to the very few 
binding events (244 events examined during this study), a working stroke of ~3 nm was 
measured. The number of events was ten times lower compared to what was found in 
studies on other myosins such as myosin II (Ishijima et al., 1998).  However, the results 
are  comparable to what was reported with TgMyoA (598 events, with a measured 
working stroke of ~5.3 nm),  for PfMyoA from a parasite lysate (measured working 
stroke, 4.7 nm;  Rachel Farrow, NIMR, unpublished data) and with myosin II (working 
stroke ~5-6 nm; (Veigel et al., 1999)).  It is possible that the presence of MTIP on the 
MyoA from the parasite lysate increases the binding with the actin filament, helped by 
the unusual extended conformation of MTIP which can completely wrap around the IQ 
motif. In addition the lever arm may be extended into the myosin head adding a further 
2 nm to the lever arm length (if PfMyoA goes through  a 60/70o lever arm swing as in 
myosin II, then the lever arm will be greater than 5 nm which could easily explain the 
4.7 nm power stroke, Rachel Farrow personal communication and (Farrow, 2007)).  
 
Generally Apicomplexan MyoA has a very short or almost no tail domain 
(Chaparro-Olaya et al., 2005; Hodge and Cope, 2000), but still they can propel the 
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parasite at speeds of 0.05 to 0.1 µm s-1 and move actin filaments at an average velocity 
of 3.5 µm s-1 (Herm-Gotz et al., 2002), 3.51 µm s-1 (Green et al., 2006b) and 3.0 µm s-1 
(Schmitz et al., 2005) in an in vitro motility assay using parasite lysate.  Here, we 
expected to see the gliding movement of F-actin at this velocity by MyoA produced 
from the in vitro expression system.   There was no question about the concentration of 
MyoA added to the flow cell, or the density of attachment to the motility surface 
because MyoA was produced in sufficient abundance. However we failed to detect 
movement, most likely because most of the MyoA was aggregated and unstructured as 
shown in the EM micrograph, and later confirmed by CD.   
 
We had also intended to explore the regulation of MyoA by phosphorylation 
with kinases such as CDPK1, PKA and PKG and the possibility to extend the study into 
investigating the effect of MyoA phosphorylation during motility assay or optical 
trapping as well as analysis of the sites of modification by mass spectrometry.  CDPK1 
and PKA is believed to phosphorylate MyoA (Lasonder et al., 2012) and CDPK1 had 
been shown to phosphorylate MTIP and GAP45 (Gilk et al., 2009; Green et al., 2006b; 
Rees-Channer et al., 2006; Ridzuan et al., 2012).  Unfortunately, due to the failure to 
demonstrate that the MyoA produced in the in vitro system was able to support actin 
motility, planned future experiments including studies of MyoA regulation in vitro were 
abandoned.  
As a conclusion, we felt that this aspect of the project could not go any further at 
this time.  It proved impossible to reconstitute the motor complex in vitro because the 
experiments could not be performed with unstructured protein. In the future it is 
possible that fresh approaches might allow this, but for now new directions were 
required and the focus this project shifted to using transgenic parasites to address all the 
questions which we lay out in our aims.   
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Chapter 4 
Characterisation of Myosin A and Myosin B in asexual 
blood stages of Plasmodium 
 
 
4.1 Introduction 
It has been previously established that MyoA is involved in the glideosome 
motor complex in both Toxoplasma and Plasmodium.  In previous studies both 
TgMyoA and PfMyoA have been shown to be localised to a space between the plasma 
membrane and the IMC, where the glideosome motor complex is thought to lie.  MyoA 
is expressed during late schizogony, almost at the same time as the other glideosome 
proteins, GAP45, MTIP/ MLC1 and GAP50, thus MyoA is found at the right time and 
place, which is during parasite segmentation and the assembly of the glideosome 
complex, consistent with the parasites gearing themselves up for invasion of the host 
cell (Baum et al., 2008a; Gilk et al., 2009; Herm-Gotz et al., 2002; Hettmann et al., 
2000; Johnson et al., 2007; Pinder et al., 2000).  Furthermore, genetic knock down of 
MyoA in Toxoplasma tachyzoites (Meissner et al., 2002) and Plasmodium ookinetes 
(Siden-Kiamos et al., 2011) was shown to abrogate gliding motility, impairing both 
egress and host cell invasion, whereas no effect on intracellular replication or secretion 
of micronemal proteins was observed, consistent with a role in the glideosome complex 
(Meissner et al., 2002; Siden-Kiamos et al., 2011; Soldati and Meissner, 2004).  The 
failure to express functional MyoA in vitro, using the cell free system (Chapter 3), 
prevented further in vitro characterisation of the MyoA motor complex.  However, the 
role of MyoA in merozoite red blood cell invasion is still unclear and the motor 
complex may also play a role beyond invasion, for example in cytokinesis in the 
segmenting schizont, so further examination of its function in vivo was warranted.  
Little is known about the function of the other type XIV myosins.  MyoB, for instance, 
is the smallest myosin in this particular myosin class. PfMyoB has been described as 
expressed in late schizonts and merozoites and therefore may also be involved in 
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invasion (Chaparro-Olaya et al., 2005).  However, the precise location of MyoB and its 
function are still unknown.  
A key technology for exploring protein trafficking and localisation is the use of 
reporter molecules such as GFP.  This method has given valuable information on 
protein localisation in Plasmodium.  The technique relies on genetic manipulation to 
create a transgenic parasite encoding the GFP sequence introduced within or at the N- 
or C-terminus of the ORF. Transgenic parasites are generated by transfection – the 
introduction of foreign DNA into the parasite in order, for example, to alter normal 
gene expression. Transfection of Plasmodium blood stage parasites has been developed 
relatively recently and requires the translocation of DNA through four membranes 
before finally reaching the nucleus, making transfection of Plasmodium a difficult and 
complicated technique (Carvalho and Menard, 2005). For integration of the DNA into 
the genome, a single or double cross-over recombination event can occur; this relies on 
a vector carrying a homologous sequence to facilitate targeting to locus by homologous 
recombination as well as a positive selection cassette conferring drug resistance 
(Waterkeyn et al., 1999). Fortunately, the methodology has been improved significantly 
since the first reported transfection of zygotes and gametocytes, which was done in the 
absence of a drug selection cassette in the avian malaria parasite, Plasmodium 
gallinaceum (Goonewardene et al., 1993).  Wu and colleagues managed to transfect 
ring stage parasites which lead to the transformation of P. falciparum by homologous 
integration into the genome (Wu et al., 1996; Wu et al., 1995).   Using this approach, 
DNA is able to be maintained transiently as an episome or integrated into the parasite’s 
haploid genome (Crabb et al., 1997; Wu et al., 1996).   
Transfection has also been highly successful in other malaria parasite species, 
for example rodent malaria parasites, particularly in P. berghei (van Dijk et al., 1995), 
but also in other rodent malaria such as P. yoelii (Ono et al., 2007) and P. chabaudi 
(Reece and Thompson, 2008; Spence et al., 2011). P. knowlesi transfection can be 
performed successfully in in vitro culture either with monkey blood (Kocken et al., 
2002) or using P. knowlesi A1-H.1, a parasite clone recently adapted to culture in 
human blood (Moon et al., 2013). Genetic manipulation of P. knowlesi is an important 
new tool to study malaria parasites as this species is phylogenetically close to P. vivax, 
which lacks an in vitro culture system, and is itself a human malaria pathogen,  causing 
a large number of cases of infection in South-East Asia (Cox-Singh et al., 2008).  P. 
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knowlesi also has the experimental advantage of being a bigger parasite, which is more 
amenable to genetic manipulation than P. falciparum, and therefore the parasite's 
asexual blood stages are more tractable to study (Moon et al., 2013). The recent 
development of improved transfection methods such as the use of the Amaxa 
electroporation system (Janse et al., 2006) and new selectable markers (de Koning-
Ward et al., 2000; Wel et al., 2004), has increased transfection efficiency and facilitated 
the possibility of double and triple transfectants. Together with whole genome transcript 
profiling and proteomic analysis, the production of transgenic parasites (for example 
gene knockouts, allelic replacements and transgene expression) will be a very valuable 
functional analysis tool.   
 In this chapter, attempts to GFP-tag both MyoA and MyoB and the 
characterisation of the resultant transgenic lines are described. This was carried out in 
order to localise the fusion-protein within the parasite as well as to identify potential 
interacting proteins and improve our understanding of the roles of MyoA and MyoB in 
host cell invasion by Plasmodium. The GFP-tag allows direct visualisation of the 
endogenous protein in live parasites using epifluorescence microscopy and avoids the 
need for protein-specific antibody generation.  Using these transgenic parasites, the 
expression of MyoA and MyoB throughout the asexual blood stage cycle of P. 
falciparum was analysed. First, the fusion proteins were localised within the parasite by 
live imaging and IFAs relative to known organelle marker proteins; second, 
immunoprecipitation and mass spectrometry studies were undertaken to explore 
potential associations with other proteins or protein complexes; and third to establish 
the role and localisation of MyoA and MyoB during parasite invasion into the host cell, 
in comparison with the established marker of the moving junction, RON4.  Further 
characterisation of MyoA and MyoB was performed by GFP-tagging of both proteins in 
P. knowlesi in order to enhance their microscopic visualisation as the merozoites are 
bigger in size than those of P. falciparum, and to confirm the similarity across the 
genus.  For the same purposes, we also generated MyoA- and MyoB-specific antibodies 
to be used in co-localisation studies and to be used in other techniques such as Western 
blotting and immunoprecipitation.   
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4.2 Production and Genotyping of GFP-tagged MyoA (PfMyoA) and MyoB 
(PfMyoB) P. falciparum parasite lines 
The GFP-tagging of the endogenous MyoA and MyoB genes of  P. falciparum 
was achieved by integration of DNA constructs, via single crossover homologous 
recombination, into the parasite's genome. In order to introduce the GFP tag at the C-
terminus of each protein, a region of homology corresponding to 1057bp (MyoA) and 
1069bp (MyoB) from the 3’ end of each ORF and lacking the stop-codon was selected.  
The region of homology was amplified from genomic DNA by PCR using primer 
combination 3F1/3R2 for MyoA and 4F1/4R2 for MyoB (Chapter 2, Table 2.2). These 
regions of homology were cloned between the XmaI/AvrII sites of the pHH4-GFP 
plasmid (Knuepfer et al., unpublished) and the correct sequence confirmed by Sanger 
sequencing (Beckman Genomics), generating the constructs pHH4-PfMyoA-GFP and 
pHH4-PfMyoB-GFP, respectively. In each case the cloning resulted in the targeting 
fragment being placed upstream of the GFP ORF followed by the Pbdhfr 3’UTR. The 
strategy for integration is summarised in Figure 4.1 for MyoA and Figure 4.2 for 
MyoB.  The pHH4-GFP transfection vector map which includes the human DHFR 
resistance cassette as a selectable marker is depicted in Appendix B- pHH4-GFP vector.   
Genomic integration of DNA constructs is generally achieved in P. falciparum 
through transfection of episomal constructs, followed by cycles of drug selection to 
select for the rare integration events. In each cycle drug pressure is withdrawn for a 
period of time to allow plasmid loss, and then resistant parasites are reselected by 
reapplication of drug pressure. Removal of drug pressure results in loss of episome over 
time due to uneven segregation of plasmid in daughter cells (Waterkeyn et al., 1999), 
whereas integrant parasites grow steadily during this time.  Normally several cycles of 
drug pressure are required taking at least ~ 3 months. This compares to P. knowlesi and 
P. berghei to which the integrant can be obtained in ~3 weeks.  The lengthy period of 
time is due to the procedure used to select for integration (de Koning-Ward et al., 2000; 
Tonkin et al., 2004), which in turn is required due to the extremely low efficiency of 
both transfection and genomic integration in P. falciparum.  
After transfection with 100 µg plasmid DNA for each construct into ring stage 
parasites, 2.5 nM WR99210 was added and the parasites cultured continuously under 
drug selection for approximately 3 weeks. The parasites that grew after this time were 
104 
 
designated cycle 0, and whilst resistant to WR99210, as expected, this was 
predominantly due episomal maintenance of the targeting construct. The transfected 
cultures were then grown for 3 weeks without drug selection, to allow loss of the 
episomal construct (due to uneven segregation of the episome) followed by a further 
week of growth under WR99210 selection again. The resultant parasite populations 
were designated cycle 1 and this was repeated a further time; parasites were obtained 
from cycle 2 for both MyoA and MyoB.  Cultures were checked after each cycle for 
integration of the construct by both diagnostic PCRs and monitoring for GFP 
expression.   The MyoA and MyoB fragments cloned into the transfection vectors lack 
a promoter, thus the GFP tagged version can only be expressed once the plasmid has 
integrated and expression can be driven by the endogenous promoter. This means that 
expression of GFP can be taken as a strong indication of correct integration of the 
plasmids.   
 
4.2.1 PfMyoA-GFP parasites: cloning and genotyping 
GFP-expression was detectable in the PfMyoA-GFP transfected parasites as 
early as in cycle 1, and in the PfMyoB-GFP transfected parasites in cycle 2.  Correct 
integration in the un-cloned lines was confirmed by PCRs (data not shown). 
Preliminary live fluorescent imaging of PfMyoA-GFP showed strong GFP fluorescence 
associated with the periphery of developing merozoites, providing further evidence for 
the correct integration of the tagging construct. Western blots of PfMyoA-GFP parasite 
lysates, probed with an anti-GFP antibody also confirmed the MyoA fusion protein was 
at the expected ~120kDa size (Figure 4.3).   The PfMyoA-GFP parasites were then 
cloned by limiting dilution and 6 clones (C1-C6) screened for integration by PCR.  One 
single band was detected for each cloned parasite when using the 1/GFP primers for 
detection of parasite integrants, whereas, when using primers 1/2 to detect wild type 
sequence, none of the cloned parasites produced a band.  These data indicate that all the 
clones produced contain the construct integrated into the parasite genome. The integrant 
clones were further validated by Southern blotting, where the expected band for 
integration was detected in four cloned lines tested. The same band was also visible in 
cycle 0 (A0), suggesting that integrated parasites formed a high proportion of the 
parasites even at this early stage.   A band diagnostic of wild type was present only in 
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the 3D7 parasites; therefore the PfMyoA-GFP sequence was integrated correctly by 
homologous recombination into the genomic locus (Figure 4.1).  
 
 
Figure 4.1: Generation of parasites expressing PfMyoA-GFP.  (a) Schematic 
representation of the GFP tagging of MyoA by single cross-over homologous 
recombination into the MyoA locus, with primers for PCR (arrows with primer 
3F1/3R2) and Southern blot probe and restriction sites labelled.   (b) The uncloned 
PfMyoA-GFP parasites as viewed by live fluorescence microscopy. Merge of GFP and 
DAPI channels shows that GFP signal is distributed to the parasite periphery in 
schizonts. (c) Diagnostic PCR on genomic DNA showing integration of PfMyoA-GFP 
(Primers 1/GFP) and wild type (Primers 1/2).Six PfMyoA-GFP clones (C1to C6) were 
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examined. (d)  Southern blot analysis of cloned PfMyoA-GFP parasites.  Probes to the 
5’ homologous flanking region gave the expected two integration bands at 11136 bp 
and 3799 bp.  A0: PfMyoA-GFP parasites at cycle 0 and 3D7 is the wild type control 
(7347 bp). 
 
4.2.2 PfMyoB-GFP parasites: cloning and genotyping 
Genotyping of PfMyoB-GFP parasite was carried out in the same way as for 
PfMyoA-GFP.  Diagnostic PCR was performed initially on the un-cloned PfMyoB-GFP 
parasites, and then later with cloned parasite lines using primers for integration 
(3/GFP).  The PfMyoB-GFP parasites were cloned by limiting dilution and 3 clones 
(C1-C3) screened for integration. Integration was detected by diagnostic PCR, 
indicating correct integration of the PfMyoB-GFP construct into the MyoB locus on 
chromosome 5.  The integration PCR consistently produced a doublet band, despite the 
use of several alternative forward primers in the PCR (Table 2.2).  We also used primer 
1/GFP, a primer set designed for PfMyoA, in order to eliminate the possibility that the 
PfMyoB-GFP construct had additionally integrated into the MyoA locus, and the result 
was confirmed by Southern blot Southern blot analysis revealed that two bands for 
integration were detected in all clones as predicted (7994 and 5439 bp).  Interestingly, 
an additional band at the same size as the episomal transgene band was also present in 
two clones of PfMyoB-GFP (clone C1 and C3).  As our strategy targets the locus using 
single crossover homologous recombination, it is possible for multiple copies of the 
plasmid to integrate into the target locus.  In the current result, the additional band of 
episomal size might indicated either the maintenance of an episomal construct in 
addition to the integrated copy or it might be due to multiple copies integrated into the 
targeted locus.  Fortunately, an episomal transgene will not interfere with the one 
integrated into the genome and can be removed by reapplication of drug pressure 
cycling until loss.  In wild type 3D7, only a band corresponding to the endogenous gene 
sequence was detected and in cycle 0 (B0), two bands were detected which correspond 
to this wild type and an episomal copy, therefore PfMyoB-GFP was detected as an 
integrant in the correct locus (Figure 4.2). Expression of GFP was detectable in the 
PfMyoB-GFP transfected parasites during cycle 2, (although Southern blot indicated 
that integration was detectable as early as in cycle 1).   
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Preliminary live fluorescence imaging of PfMyoB-GFP showed GFP 
fluorescence in the developing merozoite.  However, this technique revealed a very 
different localisation compared to that of PfMyoA-GFP (Figure 4.2).  Even though the 
GFP fluorescence signal was seen, it was less strong than that of PfMyoA-GFP and 
faded very quickly. In this preliminary observation, the PfMyoB-GFP signal seemed to 
locate to a single discrete dot possibly at the apical end of merozoites in mature 
schizonts.  Although the localisation of PfMyoA-GFP was very easily observed and 
monitored, work with PfMyoB-GFP was a challenging task: the fluorescence signal 
bleached rapidly in only a few seconds.  Finally after several attempts, we managed to 
capture live images of PfMyoB-GFP parasitesby using only transmitted light to focus 
the microscope and setup the cell to minimize exposure to UV light before the images 
were collected. Western blots of PfMyoB-GFP parasite lysate, probed with an anti-GFP 
antibody confirmed that the MyoB fusion protein was at the expected ~120 kDa size 
(Figure 4.3).   
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Figure 4.2: Generation of parasites expressing PfMyoB-GFP.  (a) Schematic 
representation of the GFP tagging of MyoB by single cross over homologous 
recombination into the MyoB locus with primers for PCR (arrows: 4F1/4R2) and 
Southern blot probe and restriction sites labelled. An additional schematic (a. ii) shows 
the result of possible integration of multiple plasmid copies into the same locus. (b)  
The uncloned PfMyoB-GFP parasites as viewed by live fluorescence microscopy. The 
merge of GFP and DAPI channels shows that GFP signal is localised to the parasite 
apex in schizonts. (c) Diagnostic PCR on genomic DNA showing integration of 
PfMyoB-GFP (Primers: 3/GFP) and wild type (Primers: 3/4). Three  PfMyoB-GFP  
clones (C1 to C3) were examined. (d)  Southern blot analysis of cloned PfMyoB-GFP 
parasites.  Probes to the 5’ homologous flanking region gave the expected two 
integration bands at 7994 bp and 5439 bp.  PfMyoB-GFP Cycle 0 (B0) shows the 
presence of wild type (9102 bp) and episomal (4331 bp) bands; 3D7 parasites only 
show the wild type band. 
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Figure 4.3: Western blot of uncloned transgenic parasites. Bands corresponding to 
PfMyoA-GFP (MyoA) and PfMyoB-GFP (MyoB) were clearly detected in the 
corresponding parasite lysate, whereas no band detected in the wild type (3D7).  
Schizont lysates were probed with α-GFP.   
 
4.3 PfMyoA-GFP is part of the established glideosome motor complex whereas 
PfMyoB is not 
To determine whether PfMyoA-GFP and PfMyoB-GFP participate in the 
glideosome motor complex, we can use anti-GFP antibodies to immunoprecipitate the 
motor complex components from the transgenic parasite lines.  Mature schizont-stage 
parasites were enriched and solubilised using an NP-40 containing buffer.  Soluble 
lysates were immunoprecipitated with α-GFP antibodies coupled to agarose beads.  The 
GFP antibodies should only bind the GFP-tagged protein, and wild type 3D7 parasites, 
prepared in the same way, can be used as negative control.  The GFP-TRAP 
(Chromotek) system utilises camelid monoclonal anti-GFP “nanobodies”. Camelid 
antibodies do not contain a light chain and the heavy chain variable region is sufficient 
for highly specific antigen recognition. Nanobodies are composed of only these short 
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variable regions and so are highly stable and only 13 kDa in size. Since cross reactivity 
is a common problem with many antibodies, this GFP-TRAP is very suitable for the 
purposes of this experiment.   
 
 
4.3.1 MyoA-GFP is precipitated with the protein of glideosome motor complex 
When a Western blot of the precipitated samples was probed with a GFP-
specific mouse mAb, bands corresponded to PfMyoA-GFP and PfMyoB-GFP (both 
~120 kDa) were detected.  There was band detected in lysates from wild type 3D7 
parasites. The relative intensity of the bands in the two parasite samples indicated that 
PfMyoA-GFP is much more abundant than PfMyoB-GFP, as an equal amount of total 
parasite protein was loaded in each case.  This is unsurprising when considering the live 
imaging data described above.  The PfMyoA-GFP immunoprecipitate also contained 
both PfGAP45 and PfGAP50.  Rabbit α-GAP45 detected a doublet band at ~37 and 39 
kDa, while rabbit α-GAP50 detected a ~42 kDa band corresponding to GAP50.   
The precipitated lysate also contained MTIP, as a rabbit α-MTIP antibody 
detected a band at ~27 kDa.  These data demonstrated that PfMyoA-GFP is in the 
glideosome motor complex together with endogenous MTIP, GAP45 and GAP50 
(Figure 4.4a).  On the other hand, when the same antibodies were used to probe the 
PfMyoB-GFP precipitated lysate no MTIP, GAP45 or GAP50 was detected. None of 
the glideosome complex proteins was precipitated together with PfMyoB-GFP (Figure 
4.4a) demonstrating that MyoB does not form a complex with the same proteins as 
MyoA.  This co-immunoprecipitation was carried out in the absence of Ca2+, and 
therefore any Ca2+-dependent proteins potentially associated with the glideosome motor 
complex, such as calmodulin, would not be co-precipitated with the GFP-tagged 
protein.  There are also other proteins that are known to bind with the glideosome 
complex in either Plasmodium or Toxoplasma such as GAP40, GAP70 and GAPMs,   
however we currently lack antibodies to these proteins.     
To confirm the co-localisation of PfMyoA-GFP with the glideosome motor 
complex, we performed IFA on the transgenic PfMyoA-GFP parasite.  It is critical for 
the proposed function for PfMyoA-GFP to be located at the parasite’s periphery, 
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between the PM and IMC.  To determine whether this is indeed the case, we used our 
specific antisera to each glideosome sub unit (MTIP, GAP45 and GAP50) and mouse 
monoclonal α-GFP (for MyoA) for an IFA analysis of late schizonts and merozoites of 
the clonal PfMyoA-GFP line.  The PfMyoA-GFP signal was concentrated around the 
periphery of each merozoite, both within schizonts as well as free merozoites.  As 
expected, all subunits of the putative glideosome complex were also confined to the 
periphery of the parasite pellicle, overlapping with PfMyoA-GFP.  Co-staining with 
antiserum against RON3, which labels the rhoptries at the very anterior end of the 
parasite, suggested that the glideosome protein complex is co-localised with the IMC, 
as the components are present around a major proportion of the parasite periphery, 
consistent with their proposed role as members of an active motor complex that drives 
parasite invasion (Figure 4.4b). 
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Figure 4.4:  PfMyoA-GFP forms a tetrameric complex in the glideosome motor 
complex. (a) The left hand side shows the whole parasite lysate (Lysate) for PMyoA-
GFP (A), PfMyoB-GFP (B) and 3D7 parasites before imuunoprecipitation with GFP-
TRAP (Chromotek). GFP-IP, on the right hand side, shows the precipitated proteins 
probed with   rabbit α-GFP, α-MTIP, α-GAP45 and α-GAP50.  Wild type 3D7 parasite 
lysates were used as a control.  Single bands corresponding to MyoA-GFP, MyoB-GFP, 
MTIP and GAP50 were detected, whereas a doubled band was detected for GAP45.  
PfMyoA-GFP interacts with MTIP, GAP45 and GAP50, whereas PfMyoB-GFP is not 
in association with the glideosome complex proteins.  Proteins were detergent 
solubilised from enriched mature schizont stages of clonal PfMyoA-GFP and PfMyoB-
GFP parasites.    (b)  Co-localisation of PfMyoA-GFP with MTIP, GAP45 and GAP50 
confirming the association of PfMyoA-GFP with the glideosome motor complex by 
location at the parasite periphery.  Co-localisation with RON3 that is located in the 
rhoptry neck is used as a marker for the apical end of the parasite. DAPI stained 
nucleus. Scale bar is 2µM. 
 
4.3.2 PfMyoB-GFP localises to the extreme apical tip of merozoites. 
Based on the preliminary data, PfMyoB-GFP appeared to be localised to the 
apical end of the merozoite (Figure 4.2.b) and, from the IP experiments, it had no 
association with the glideosome motor complex (Figure 4.4a).  In order to determine a 
more exact location of PfMyoB-GFP, co-localisation IFA was performed using a range 
of antibodies against known apical organelle markers such as the micronemal markers 
AMA1 and EBA175, the rhoptry neck marker RON3 and RON4 and the rhoptry bulb 
markers RAP1 and RhopH2.   Co-localisation was also carried out for the merozoite 
surface marker PfMSP7. We also further co-localised PfMyoB-GFP with a cytoplasmic 
component of the invasion machinery, α-actin (AC-40: Sigma), and with α-tubulin 
(Sigma) antibodies to identify the location of this cytoskeletal component.  The α-
AMA1, α-EBA175 and α-MSP7 were raised in rabbit, whereas α-RON4, α-RON3 and 
α-RAP1 were raised in mouse. The best fluorescent anti-GFP signal was obtained from 
an affinity purified rabbit polyclonal α-GFP (rabbit-GFP: Dr Ellen Knuepfer, NIMR) 
which gave a very stable and strong fluorescent signal (at 1:500 up to 1:5000 dilution) 
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compared to both mouse monoclonal α-GFP (mouse-GFP: Roche), and camel 
monoclonal α-GFP-booster-atto4880 (Chromotek).  Despite the lower sensitivity of the 
mouse mAb compared to the rabbit antibody, this mAb was used in co-localisations 
with antibodies raised in rabbits.  
In mature schizonts and merozoites, PfMyoB-GFP produced a compact ‘dotty’ 
pattern of GFP fluorescence located at the very apical end of the parasite, near to the 
localisation of the apical markers AMA1, EBA175, RON4, RON3 and RAP1.  
However, whilst in some cases the fluorescent signal partially overlapped with these 
markers, MyoB appears to be in a distinct location within the cell. Examination of the 
localisation in detail revealed that the protein appeared to be anterior to the 
micronemes, organelles visible as a speckled pattern at the anterior one third of the 
parasite. The protein was also anterior of RAP1, in the rhoptry bulb and even to the 
RON4 and RON3 signal at the very anterior end of the rhoptry neck. The signal for that 
latter appeared as a single or double dot close together (Figure 4.5). We also co-
localised PfMyoB-GFP with the other apical markers RhopH2 and PTRAMP, as well as 
the surface membrane marker MSP7, and the glideosome proteins MTIP, GAP45 and 
GAP50 but due to poor imaging and little additional information gathered, the data are 
not shown. For more precise localisation of MyoB, immuno-electron microscopy (IEM) 
would be required.  Gold labelling of α-GFP antibodies to detect PfMyoB-GFP was 
carried out, but likely due to the poor performance of the antibody in IEM, this 
experiment was unsuccessful (data not shown).  The other good apical markers to use 
would be antisera to the Rh proteins  which locate at the rhoptry head (Cowman et al., 
2012) and the late marker of the apical polar ring, RNG1 (Tran et al., 2010).  However, 
unfortunately the appropriate antibodies are unavailable in our lab and therefore this 
additional experiment could not be performed.  
We also complemented this co-localisation by performing IFA against proteins 
such as actin and tubulin which might provide some information regarding the 
association of PfMyoB-GFP. Normally, actin and tubulin are located in the anterior 
two-thirds of the parasite, beneath the parasite membrane complex, with tubulin 
forming the subpellicular microtubules known in merozoites as f-MAST (Fowler et al., 
2001). Actin has also previously been shown to be concentrated at the apical tip of 
merozoites (Angrisano et al., 2012; Baum et al., 2008b; Field et al., 1993).  Given its 
pattern of expression and anterior localisation we co-localised PfMyoB-GFP with α-
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actin and α-tubulin antibodies.  The anti- actin mAb AC-40 (A3853; Sigma) we used 
recognises an epitope located at the C-terminal end of actin, which is also conserved in 
all actin isoforms. This IFA showed that PfMyoB-GFP resides at the apical pole of 
merozoites in front of the rhoptries and co-localised with actin detected with α-actin 
antibodies, which revealed that both proteins might be located in the same region 
(Figure 4.5).   This localisation also appeared to be coincident with the apical polar ring 
and microtubule organising centre from which microtubules originate, which might 
indicate an association of PfMyoB-GFP with the polar ring. Anti-α-tubulin mAb clone 
DM 1A (T9026: Sigma) was used to detect the parasite α-tubulin. Tubulin is expected 
to be a major component of the two or three microtubules and was localised at the apex 
and running in parallel along the merozoite periphery spreading towards the posterior of 
the merozoite.  The localisation of microtubules was confirmed in previous studies by 
immunofluorescence (Fowler et al., 2001; Read et al., 1993) and EM (Bannister and 
Mitchell, 1995).  As can be seen, the localisation of PfMyoB-GFP partially overlaps 
with tubulin at the apical part of the merozoite, further supporting the putative 
association with the apical polar ring.  
116 
 
 
117 
 
 
Figure 4.5: PfMyoB-GFP localised at the apical pole of the parasite.  Co-
localisation of PfMyoB-GFP in schizonts and merozoites as determined by IFA with 
various merozoite organelle components, using rabbit antisera to AMA1 and EBA175 
(the micronemes); mouse antisera to RON4, RON3,and RAP1 (the rhoptries); and 
commercial mouse antisera to actin and α-tubulin (a component of sub-pellicular 
microtubules). The distribution of PfMyoB-GFP was clearly at the apical end of the 
merozoite.  Samples were counterstained with DAPI. Scale bar is 2µM. 
 
4.4 PfMyoA-GFP is localised at the periphery and PfMyoB-GFP is confined to the 
apical apex as seen by live parasite development.   
We have demonstrated that the GFP-tagged MyoA and MyoB are successfully 
expressed in P. falciparum.  In order to examine expression of the tagged proteins over 
the parasite’s development in the red blood cell we carried out a live time course 
microscopy study over the latter half of the parasite’s development in these cells. 
Although the peripheral localisation of MyoA was reported by Pinder et al., (1998, 
2000) and others, presumably the GFP-tagged MyoA must locate to the correct site, 
which is at the IMC, in order to function correctly.  Tightly synchronised GFP-tagged 
parasite lines were harvested at two to three hour intervals from 24 h to 46 h post 
invasion, corresponding to a period from late trophozoites up to merozoite release and 
early ring formation (~30 min after egress).  This also corresponds to the period when 
most of the MyoA associated proteins were expressed, for example onset of MTIP and 
GAP45 synthesis starts at ~24-30 h (Baum et al., 2006b; Ridzuan et al., 2012) which is 
consistent with the initial formation of IMC and assembly of the glideosome complex.  
In the earlier stages, from ~24 to 38 h post invasion, MyoA-GFP produced a diffuse 
green fluorescence pattern throughout the cytosol, and at this time the typical peripheral 
localisation was not yet visible.  At later stages, from 40-46 h, the GFP fluorescence 
signal was highly visible especially when the parasites started to segment at 
approximately ~40 h post invasion and displayed a distinctive peripheral localisation in 
later schizont and merozoites (~42-46 h post invasion) (Figure 4.6).  The association 
and the assembly of MyoA into the motor complex were further investigated by co-
localisation of PfMyoA-GFP with MTIP, GAP45 and GAP50 using IFA in the time 
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course experiment and the same results were obtained, confirming these data (data not 
shown because no additional information was gathered). The peripheral localisation 
was also observed in P. berghei ookinetes expressing GFP-tagged MyoA (Rita Tewari, 
unpublished data) supporting the earlier findings reported in other publications of 
MyoA localisation detected by IFA and EM using anti-MyoA antibody (Baum et al., 
2006b; Pinder et al., 2000; Pinder et al., 1998),  
The experimental protocol designed for the PfMyoB-GFP live microscopy 
imaging time course experiment followed that used for PfMyoA-GFP.  The initial 
results were a bit unclear and disappointing, especially at the earlier time points because 
of the faint GFP signal for this line, along with problems of overlap with the Hoechst 
nuclear staining.  The strong DNA staining caused some crossover into the green (GFP) 
channel giving a false GFP fluorescence signal that overlapped with Hoechst staining.  
However, although at earlier stages a diffuse green fluorescence was detected, the 
distinctive discrete dot at the apical end as determine in the preliminary studies was 
clearly not seen until around ~40-48 h post invasion (data not shown) giving a rough 
idea of the timing of the MyoB expression.  To determine the expression and 
localisation of MyoB during parasite development, we instead took images of parasites 
at various stages of development, based on visible morphology and the number of 
nuclei, in mixed stage cultures. We compared the number of nuclei in individual cells 
from these images to the number of nuclei from the real live time course images and 
examined the GFP fluorescence, revealing a pattern of GFP expression as we would 
have predicted which is at the apical end of the parasite and with maximum expression 
at 40 h (Figure 4.7).  At the earlier time points from 21- 38 h post invasion, there was 
no clear green fluorescence signal detected, although a very faint ‘dot’ pattern was 
observed at ~36 and ~38 h.   The GFP signal with a clear apical end localisation became 
visible at around ~40 h and more prominent as the parasite development continued to 
mature schizonts (42-44 h) and merozoites (46 h).  This localisation and timing of the 
MyoB expression were further confirmed by performing further IFAs (data not shown).  
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Figure 4.6: Live microscopy analysis of GFP-tagged MyoA (PfMyoA-GFP) 
parasite development time course.  A synchronised PfMyoA-GFP parasite population 
was separated into several cultures.  Cultures were harvested starting at 24 h post 
invasion, and every two or three hours until 46 h post invasion. The harvested parasites 
were visualised and analysed by fluorescencet microscopy.  The nucleus was labelled 
with Hoechst stain prior to microscopic analysis at 1000X magnification.  In the early 
schizont stages, the GFP signal was very faint giving a diffuse green fluorescence.  In 
the segmented parasite (40 h post invasion), the GFP signal was observed around the 
parasite’s periphery, typical of a localisation at the IMC.  The peripheral pattern 
continued until the parasite was fully segmented and divided into merozoites. Images of 
Giemsa-stained parasites were produced to aid comparison of the stages during parasite 
development.  Scale bar is 2µm. 
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Figure 4.7: Live microscopy analysis of GFP-tagged MyoB (PfMyoB-GFP) 
parasites.  A mixed population of the transfected parasite was harvested, visualised and 
analysed by fluorescence microscopy.  The nucleus was labelled with Hoechst stain 
prior to microscopic analysis at 1000X magnification.  The images were assembled by 
comparing the number of nuclei to represent the stages of parasite development.  In the 
trophozoite and early schizont stages, GFP signal was undetectable.  In the segmented 
parasite (40 h post invasion and later), the GFP signal was observed at the parasite’s 
apical end.  The apical end pattern was retained in the fully segmented schizont and free 
merozoites.  Scale bar is 2µm. 
 
 
4.5 The assembly of PfMyoA-GFP into the glideosome motor complex  
Endogenous MyoA bound to MTIP/MLC1, GAP45 and GAP50 forms part of 
the glideosome complex that is associated with the IMC (Baum et al., 2006b; Bergman 
et al., 2003; Frenal et al., 2010; Yeoman et al., 2011).  Having shown that the 
expression of PfMyoA-GFP was at the periphery, we further investigated the 
association of MyoA with the other glideosome motor complex components.  We used 
parasite lysates collected during the time course analysis and performed co-
immunoprecipitation with GFP-TRAP (Chromotek) (see section 4.3).  These 
experiments complement the studies on the time of MyoA expression that were difficult 
to interpret due to the weak GFP signal detected during the earlier time points of 
parasite development in the live microscopy analysis. The parasite lysates used were 
collected during the time course experiment from 21 h to 46 h post invasion (section 
4.6).  We used our specific antisera to each glideosome component (MTIP, GAP45 and 
GAP50) and mouse α-GFP mAb (for MyoA) for this immunoblot analysis of the time 
course, probing parasite lysates (Lysate) and immunoprecipitated proteins from the 
clonal PfMyoA-GFP line (GFP-IP).  We also used the same batch of antibodies as in 
the immunoblot (section 4.3.1) and IFA (section 4.3.2) analyses to minimise any 
discrepancies that might occur.   An equivalent amount of PfMyoA-GFP protein lysate 
from each time point was probed with the antibodies.  The results showed that MyoA-
GFP was expressed at the trophozoite stages starting from ~24 h (Figure 4.7)   
(confirming the diffuse green fluorescence detected in the live microscopy imaging: 
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Figure 4.6). Early expression also occurred for GAP50 at ~21 h, whereas MTIP was 
first detected later at ~33 h (Figure 4.8: Parasite lysate panel).  Although GAP45 was 
first detected here at around ~36 h (Figure 4.8: Parasite lysate) it has previously been 
detected as early as ~30 h post infection by Ridzuan et.al., (2012) using live imaging 
and IFA of the transgenic GFP-tagged GAP45 parasite. This discrepancy could be due 
to several factors such as the amount of protein being expressed at the ~30 h time point 
in this study was low and the sensitivity of detection was less than that which can be 
achieved by direct tagging of GAP45 with GFP as performed by Ridzuan et al., (2012), 
although the exact cause is not clear. 
The PfMyoA-GFP immunoprecipitate from the lysate (GFP-IP panel) also 
contained the glideosome complex proteins as mention above.  However the 
comparison between these results and those from examining the timing of protein 
expression in parasite lysates indicated that although, the expression of of PfMyoA-
GFP and GAP50 started during the earlier stages compared to MTIP and GAP45, they 
only come together in the formation of the complex at around ~38 h together with 
MTIP and GAP45 (Figure 4.8: GFP IP).  It appears that even though PfMyoA-GFP was 
expressed earlier, it was only assembled together with MTIP and GAP45 into the motor 
complex and anchored to the IMC via GAP50 at a later time.  Yeoman et al., (2011) 
showed the earlier transcription and expression of GAP50 in T. gondii that may reflect a 
role in another cellular process outside of host cell invasion and the early synthesis 
could be required for its proper processing and insertion into the IMC.  Therefore, the 
role of PfGAP50 might be similar to that of TgGAP50. 
Even though in these particular studies we do not know exactly which proteins 
interact first in the complex formation, previous studies have shows that GAP45 will 
interact with the MyoA-MTIP complex first, which is then followed by binding of 
GAP50 to the pre-assembled complex of MyoA-MTIP-GAP45 (Bergman et al., 2003; 
Gaskins et al., 2004; Herm-Gotz et al., 2002; Johnson et al., 2007; Rees-Channer et al., 
2006; Yeoman et al., 2011).  Although, PfMyoB-GFP does not associate with known 
motor proteins, similar time course samples were taken. When candidate binding 
partners for MyoB have been identified, and antibody reagents generated, these samples 
will be used in the same way as for the analysis of MyoA interactions.    
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Figure 4.8: PfMyoA-GFP is incorporated into the glideosome motor complex. The 
immunoblot samples were collected during the time course experiment from 11 time 
point, from 21 h to 46 h post invasion. Parasite cultures collected at each time point 
were saponin lysed and kept on dry ice to avoid protein degradation and then proteins 
were detergent solubilised.  On the left hand side are the total parasite lysates (Parasite 
lysate), whereas on the right hand side are the samples immunoprecipitated with GFP-
TRAP (GFP-IP) and probed with mouse α-GFP, rabbit α-MTIP, α-GAP45 and α-
GAP50.  Single bands corresponded to MyoA, MTIP and GAP50 were detected, 
whereas a doublet band was detected for GAP45.    MyoA and GAP50 were expressed 
at the earlier stages compared to MTIP and GAP45.  The assembly of the motor 
complex occurred from ~38 h post invasion onwards. 
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4.6 Mass spectrometry analysis of proteins associated with PfMyoA-GFP and 
PfMyoB-GFP  
We further characterised the possible interaction of PfMyoA-GFP and PfMyoB-
GFP with unknown proteins in the parasite, through IP using GFP-TRAP (Chromotek).   
We intended to confirm PfMyoA-GFP as part of the glideosome motor complex as well 
as identify any new and interesting proteins associated with either PfMyoA-GFP or 
PfMyoB-GFP using mass spectrometry (MS) analysis.  The identification of known and 
unknown proteins associated with P. falciparum MyoA and MyoB was performed by 
liquid chromatography mass spectrometry (LC-MS), implementing the electrospray 
ionisation methodology. Generally, MS is a powerful tool for measuring the mass of 
proteins using either intact or proteolytically digested molecules.  Protonated proteins 
are fragmented and detected by the mass spectrometer corresponding to their 
mass/charge ratio (m/z).  The mass spectrum is characterised by a series of peaks 
caused by multiple charges on the protein molecules, which then can be de-convoluted 
by an algorithm into a single peak of protein mass with an accuracy typically within 1 
Da in every 10 kDa (Mann and Wilm, 1995).  MS has been used for proteome analysis 
in P. falciparum of a range of selected life cycle stages, which has provided a wealth of 
information for malaria research (Lasonder et al., 2002). 
The IP of GFP-tagged MyoA and MyoB was performed as described in Chapter 
2 (section 2.3.3) prior to LC-MS/MS analysis.  The immunoprecipitated proteins were 
separated by SDS-PAGE and stained with Sypro-Ruby (Invitrogen) for determination 
of precipitation efficiency.   Wild type 3D7 parasites were used as a control and were 
treated in the same way as the samples from the GFP tagged parasite lines. A distinct 
~120 kDa protein band corresponding to MyoA-GFP was seen in the 
immunoprecipitate from the PfMyoA-GFP line (lane A) (Figure 4.9).  Other protein 
bands suggested the presence of MTIP, GAP45, GAP50 and GAP40 although the 
clarity was poor due to the presence of a background of other proteins.  Due to low 
intensity, a distinct band corresponding to MyoB could not be distinguished from other 
potentially nonspecific bands as shown in lane B and lane 3D7 (Figure 4.9).   
For the purpose of LC-MS/MS analysis, the anti-GFP precipitated proteins were 
subjected to SDS-PAGE for a short electrophoresis period (run length: 4 mm) and then 
the whole gel piece was excised and prepared for trypsin digestion prior to protein 
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identification by LC-MS/MS (Chapter 2, section 2.9).  Results from the deconvoluted 
LC-MS/MS spectra were converted into molecular weights by the ExPASy ProtParam 
tool, and showed MyoA and MyoB were present as major proteins at the expected 
molecular weight of ~120 kDa in each case.  The other proteins present in these 
samples were tabulated after comparison with spectra hits in the control.  Any protein 
detected in the GFP tagged samples but also present in the wild type control sample was 
excluded from this analysis table.   
 
 
 
Figure 4.9: Immunoprecipitation of PfMyoA-GFP and PfMyoB-GFP and 
associated proteins for LC-MS/MS analysis. On the left hand side (Lysate) are 
lysates before immunoprecipitation with GFP-TRAP from wild type (3D7), PfMyoA-
GFP (A) and PfMyoB-GFP (B) parasites.  On the right hand side (GFP-IP) are 
immunoprecipitated proteins from each of the lysates. Each sample were resolved by 
SDS-PAGE and stained with Sypro-ruby (Invitrogen) staining.    Only the band 
corresponding to PfMyoA (A can be distinguished from the other protein bands.  The 
respective bands of GAP40, GAP50, GAP45 and MTIP should be within the areas 
indicated. 
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4.6.1 Confirmation of MyoA association with the glideosome motor complex 
From a total of 221 proteins identified by LC-MS/MS in the MyoA-GFP 
sample, only 21 proteins were selected and tabulated, whereas 200 proteins were 
excluded.  This selection of proteins was based on comparison with the proteins 
detected in the control sample from the WT parasite line, and each protein had to be 
represented by two or more peptides.    Only proteins which did not appear in the WT 
sample were selected (Table 4.1).   This excluded some important proteins such as 
actin, tubulin, apical organelle and merozoite surface proteins and others were present 
in both MyoA and WT datasets.   LC-MS/MS of the MyoA-GFP complex identified 
MyoA along with the known glideosome proteins MTIP, GAP45 and GAP50 (Table 
4.1).  Moreover, MyoA was identified with the highest coverage (72.49%) and with the 
number of peptides identified correspondingly high (66 peptides), which confirmed the 
MyoA protein.  As expected, the known glideosome proteins were also detected in this 
MS dataset.  The coverage of each protein was also high, with 31.37% (7 peptides), 
29.80% (9 peptides) and 19.61% (4 peptides) for MTIP, GAP50 and GAP45, 
respectively.  These results validated the previous IP (Figure 4.3.a and section 4.5), 
which confirmed MyoA as belonging to the glideosome complex.    
Interestingly, the 51.8 kDa GAP40 was also precipitated with MyoA.  The 
orthologue of this protein in T. gondii, TgGAP40, was first described by Frenal et al., 
(2010) and identified as an additional member of the glideosome motor complex by co-
IP and MS analysis of MLC1-Ty-expressing parasites (Frenal et al., 2010) and affinity 
purification of  GAP50 (Fauquenoy et al., 2011).  By reference to the Plasmodium 
genome database (PlasmoDB: http://plasmodb.org), PfGAP40 transcriptional profiling 
(Bozdech et al., 2003) showed that it is highly expressed in schizonts and so also likely 
forms part of the glideosome motor complex in P. falciparum as has been shown for 
TgGAP40.  Therefore, in this study we have provided evidence of  the glideosome 
complex in P. falciparum consisting of MyoA-MTIP-GAP45-GAP50-GAP40. GAPM 
proteins (GAPM2 and GAPM3) were also identified in the complex by LC-MS/MS. 
These proteins have also been suggested to be involved with the glideosome motor 
complex (Bullen et al., 2009).  GAPMs in both T. gondii and P. falciparum localise to 
the IMC where they form highly SDS resistant oligomeric complexes which are 
conserved throughout Apicomplexa.  GAPMs co-purify with the cytoskeletal alveolin 
proteins and are also thought to interact with the actin-myosin motor itself.  These 
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might be strong candidates for providing an IMC-anchoring role, either directly or 
indirectly tethering the motor to the cytoskeleton (Bullen et al., 2009).    It would also 
be interesting to further characterise the root hair defective 3 GTP-binding protein 
(RHD3).  RHD3 (110 kDa) is a protein involved in the transport of secreted and Golgi 
marker proteins between the ER and Golgi apparatus (Zheng et al., 2004) .  In addition 
to these proteins, there were a number of other previously unknown proteins, some at 
low level, which were detected in the PfMyoA-GFP immunoprecipitated product with 
low coverage and low peptide representation.  These proteins include, for example  the 
Cu2+ -transporting ATPase, putative (CUP), a tetratricopeptide repeat family protein, 
and nucleoside transporter 2 (NT2).  LC-MS/MS analysis identified four hypothetical 
proteins which are PF3D7_0822900, PF3D7_1409400, PF3D7_0912400, and 
PF3D7_1017500.   PlasmoDB contains little extra interesting information about these 
hypothetical proteins at the moment, upon which to carry out further investigation 
(Table 4.1). To validate further the novel MyoA interacting proteins identified here one 
possibility would be to undertake a reciprocal IP approach through the use of either 
antibodies or tagged version of the target proteins. This work is currently on-going 
within the lab.     
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Table 4.1 Members of the glideosome motor complex determined by mass spectrometry analysis of immunoprecipitated PfMyoA-GFP 
protein. Each protein identified by MS is listed with their PlasmoDB accession number (column 1); a description of the protein identified 
(column 2) and the molecular weight (column 3).  Column 4 gives the percentage probability MS score and number of peptides hits (column 5).  
Column 6 (C5: Area), and 7 (D5: Area) represent the duplicates of the MS datasets obtained.  The highlighted proteins are those that have been 
previously shown to be in the motor complex (blue) and those that are judged potentially associated with the glideosome complex (grey). 
Accession Description MW [kDa] ΣCoverage 
Σ# 
Peptides 
C5: 
Area 
D5: 
Area 
PF3D7_1342600  myosin A (MyoA)  92.2 72.49 66 7.237E8 7.553E8 
PF3D7_0423500  glideosome associated protein with multiple membrane spans 2 
(GAPM2)  
42.6 12.37 2 3.339E7 3.242E7 
PF3D7_0515700  glideosome-associated protein 40, putative (GAP40)  51.8 7.46 4 2.769E7 3.194E7 
PF3D7_1246400  myosin light chain 1,myosin A tail domain interacting protein (MTIP)  23.5 31.37 7 9.911E6 2.653E7 
PF3D7_0822900  conserved Plasmodium protein, unknown function  138.2 16.24 15 1.765E7 1.581E7 
PF3D7_1033200  early transcribed membrane protein 10.2 (ETRAMP10.2)  38.9 22.82 6 4.274E6 7.205E6 
PF3D7_0918000  glideosome-associated protein 50,secreted acid phosphatase (GAP50)  44.6 29.80 9 6.927E6 7.140E6 
PF3D7_1409400  conserved Plasmodium membrane protein, unknown function  30.5 10.69 5 1.556E7 7.136E6 
PF3D7_1416100  root hair defective 3 GTP-binding protein (RHD3) homolog, putative  110.5 12.17 10 3.568E6 5.461E6 
PF3D7_0824400  nucleoside transporter 2 (NT2)  67.6 3.76 2 4.518E6 4.523E6 
PF3D7_0912400  conserved Plasmodium protein, unknown function  52.7 5.83 2 2.666E6 4.327E6 
PF3D7_1032500  DER1-like protein, putative (Der1-2)  31.0 10.27 3 3.856E6 3.963E6 
PF3D7_1444300  apicoplast 1-acyl-sn-glycerol-3-phosphate acyltransferase, putative  33.7 12.67 2 3.154E6 3.458E6 
PF3D7_1406800  glideosome associated protein with multiple membrane spans 3 
(GAPM3)  
32.9 6.69 2 0.000E0 3.256E6 
PF3D7_1017500  conserved Plasmodium protein, unknown function  15.7 24.63 2 0.000E0 3.157E6 
PF3D7_0204700  hexose transporter (HT)  56.4 5.36 2 1.175E6 2.587E6 
PF3D7_1457000  signal peptide peptidase (SPP)  47.5 8.01 3 3.204E6 2.444E6 
PF3D7_1222700  glideosome-associated protein 45 (GAP45)  23.6 19.61 4 3.547E6 2.406E6 
PF3D7_0500800  mature parasite-infected erythrocyte surface antigen,erythrocyte 
membrane protein 2 (MESA)  
168.2 6.90 6 2.843E6 1.694E6 
PF3D7_0904900  Cu2 -transporting ATPase, putative (CUP)  298.6 1.13 2 3.369E6 1.166E6 
PF3D7_1420200  tetratricopeptide repeat family protein, putative  147.9 1.93 2 8.916E5 6.173E5 
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4.6.2 MyoB is part of a novel protein complex in the parasite 
LC-MS/MS analysis of the immunoprecipitated GFP-tagged MyoB identified 
229 proteins. By comparison to the WT dataset, proteins present in both MyoB-GFP 
and WT samples were excluded. Only 27 proteins were selected.  Table 4.2 shows the 
resulting data and includes only proteins identified by two or more peptides.  The 
numbers of peptides representing MyoB was high (40 peptides) confirming the 
presence of MyoB-GFP protein.  None of the confirmed proteins from the glideosome 
complex (MyoA, MTIP, GAP45, and GAP50) nor the potential proteins for glideosome 
complex (GAP40 and GAPMs) was identified in this MyoB dataset.  This result of the 
analysis of PfMyoB-GFP by LC-MS/MS confirmed the earlier result presented in 
sections 4.3 and Table.4.1 which revealed no association between PfMyoB-GFP and 
known glideosome motor complex proteins.  
The most interesting protein present in the LC-MS/MS analysis is designated as 
‘a conserved Plasmodium protein of unknown function’ (PF3D7_1118700; 78.7 kDa; 
11.66% coverage and 6 peptides) (Table 4.2) which later we designate PfMTIP-B. 
Some of the proteins identified in the MoB-GFP complex are involved in protein 
trafficking and endocytosis, such as protein transport protein (SEC31: 3.74% coverage; 
4 peptides); Pf332 (0.36% coverage; 2 peptides); clathrin heavy chain, putative (2.35% 
coverage; 4 peptides); and Dynamin-like protein (DYN2: 3.24% coverage; 2 peptides).  
Although this number of peptides hits is within the threshold range, the result is 
considered less convincing due to low coverage (less than 5%).  This might be due to 
the low abundance of MyoB and associated proteins giving a lower signal to noise ratio.  
These vesicular trafficking proteins may be worth investigating further: Plasmodium 
SEC31 protein is a homologue of COPII in mammalian cells which is involved in 
trafficking clathrin coated vesicles (CCV) from the ER to the Golgi, (Adisa et al., 2001; 
Taraschi et al., 2001), whereas  DYN2  is involved in membrane scission (Charneau et 
al., 2007). Protein involved in other functions also identified by this LC-MS/MS 
approach include polyubiquitin (PfpUB) (61.68% coverage; 4 peptides) which is 
present in all cellular compartments of the parasite and is involved in non-lysosomal, 
ATP-dependent degradation of misfolded, short-lived proteins (such as transcription 
factors) and cell cycle regulatory proteins (Horrocks and Newbold, 2000).  
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There are proteins in the MyoB-GFP dataset that were also detected in the 
MyoA-GFP dataset (Table 4.1), such as mature parasite-infected erythrocyte surface 
antigen/erythrocyte membrane protein 2 (MESA/EMP2), which may be binding non-
specifically and other proteins which may be present because of their generally high 
abundance such as Hsp40/90 organising protein (HOPs), acyl-CoA-synthase (AC11) 
and translocon component (PTEX88) (Table 4.2 non-highlighted proteins).  
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Table 4.2   Members of the PfMyoB complex as determined by MS analysis of immunoprecipitated PfMyoB-GFP proteins.  Each protein 
identified by MS is listed with their PlasmoDB accession number (column 1); a description of the protein identified (column 2) and the 
molecular weight (column 3).  Column 4 gives the percentage probability MS score and the number of peptides hits is in column 5.  Columns 6 
(C5: Area), 7 (D5: Area) and 8 (E5: Area) represent the triplicates of the MS datasets obtained.  MyoB and its potential light chain are 
highlighted in blue, and proteins potentially associated with vesicular trafficking and endocytosis are highlighted in grey. 
 
 
 
 
 
 
 
133 
 
Accession Description MW [kDa] ΣCoverage 
Σ# 
Peptides C5: Area 
D5: 
Area 
E5: 
Area 
PF3D7_0503600  myosin B (MyoB)  93.1 49.56 40 3.948E7 3.545E7 4.150E7 
PF3D7_1211700  minchromosome maintenance (MCM) complex subunit, putative 
(MCM5)  
85.8 11.87 7 5.720E5 6.153E5 1.240E6 
PF3D7_1118700  conserved Plasmodium protein, unknown function  78.7 11.66 6 7.533E5 7.408E5 6.616E5 
PF3D7_0619500  acyl-CoA synthetase (ACS12)  163.8 3.88 5 3.721E5 2.640E5 4.180E5 
PF3D7_1211800  polyubiquitin (PfpUB)  42.8 61.68 4 1.054E7 4.692E6 0.000E0 
PF3D7_1219100  clathrin heavy chain, putative  232.8 2.35 4 2.752E5 0.000E0 2.242E5 
PF3D7_0214100  protein transport protein sec31 (SEC31)  166.6 3.74 4 2.587E5 0.000E0 7.721E5 
PF3D7_1238800  acyl-CoA synthetase, PfACS11 (ACS11)  92.0 4.42 3 9.231E5 5.842E5 6.957E5 
PF3D7_1208900  conserved Plasmodium protein, unknown function  166.8 2.50 3 1.527E5 2.884E5 0.000E0 
PF3D7_1213800  bifunctional aminoacyl-tRNA synthetase, putative  86.6 5.50 3 1.607E5 2.289E5 2.753E5 
PF3D7_0305200  conserved Plasmodium protein, unknown function  135.7 9.92 3 3.350E5 3.018E5 2.755E5 
PF3D7_1434300  Hsp70/Hsp90 organizing protein (HOP)  66.0 4.08 2 2.894E5 2.634E5 2.689E5 
PF3D7_0309500  asparagine synthetase, putative  69.8 3.93 2 1.211E6 0.000E0 7.280E5 
PF3D7_0812100  conserved Plasmodium protein, unknown function  314.3 1.17 2 0.000E0 9.594E4 5.986E5 
PF3D7_0500800  mature parasite-infected erythrocyte surface antigen,erythrocyte 
membrane protein 2 (MESA)  
168.2 2.58 2 1.829E5 1.620E5 0.000E0 
PF3D7_1105600  translocon component PTEX88 (PTEX88)  90.7 3.60 2 0.000E0 3.459E5 3.202E5 
PF3D7_1420700  surface protein, Pf113 (Pf113)  112.5 2.37 2 0.000E0 8.654E5 1.037E6 
PF3D7_0918900  gamma-glutamylcysteine synthetase (gammaGCS)  124.4 2.54 2 0.000E0 2.409E5 3.233E5 
PF3D7_1447900  multidrug resistance protein 2 (heavy metal transport family) 
(MDR2)  
118.9 2.54 2 1.361E5 4.973E5 2.682E5 
PF3D7_0204100  conserved Plasmodium protein, unknown function  271.3 1.35 2 0.000E0 1.635E5 1.881E5 
PF3D7_0917600  pre-mRNA-splicing factor ATP-dependent RNA helicase PRP43, 
putative (PRP43)  
94.1 2.93 2 1.395E5 0.000E0 2.727E5 
PF3D7_1457300  conserved Plasmodium protein, unknown function  75.9 3.91 2 3.939E5 2.580E5 1.959E6 
PF3D7_1027300  peroxiredoxin (nPrx)  43.9 7.38 2 4.796E5 4.065E6 5.993E5 
PF3D7_1037500  dynamin-like protein (DYN2)  81.5 3.24 2 2.151E5 2.493E5 2.479E5 
PF3D7_1149000  antigen 332, DBL-like protein (Pf332)  688.9 0.36 2 0.000E0 8.858E5 1.908E5 
PF3D7_1136400  conserved Plasmodium protein, unknown function  107.0 2.71 2 4.650E5 4.140E5 3.921E5 
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4.7 PF3D7_1118700 protein is a myosin B light chain related to MTIP (MTIP-B) 
Immunoprecipitation and LC-MS/MS analysis of PfMyoB-GFP and associated 
proteins revealed seven proteins of unknown function, i.e. with PlasmoDB ID  of 
PF3D7_1118700, PF3D7_1208900, PF3D7_0305200, PF3D7_0812100, 
PF3D7_0204100, PF3D7_1457300 and PF3D7_1136400,     proteins for which no 
function could be deduced by homology to known proteins in public databases and 
suggesting that they might be Plasmodium-specific molecules.  Among these unknown 
proteins, the protein coded by PF3D7_1118700 was further investigated in silico due to 
the fact that it contained an EF-hand domain identified by the InterPro programme. 
Referring to PlasmoDB (http://plasmodb.org/plasmo/), this protein was predicted to 
have a myosin light chain domain.  Bioinformatics searches showed that this protein 
contained at least one EF-Hand domain (Accession: SSF47473; Coordinates from 
residues 513 to 646 ) which was used to BLAST search the Calcium Domain Database 
(CDD). The result confirmed that the protein belonged to the EF-Hand Superfamily and 
that this protein contained Ca2+-binding protein motifs (FRQ1: COG5126).  These 
calcium binding domains are a common feature of Myosin Light Chains. For 
comparison, MTIP (PF3D7_1246400) was found to contain 2 EF-hands (PlasmoDB: 
Accession: SSF47473; coordinate 84-202) as identified by the EF-hand Superfamily 
database and Accession: PS50222; coordinate 139-174 as identified by the Profile 
database (Bosch et al., 2006).   
A clustal alignment of the full length of MTIP (204 residues) and the C-terminal 
232 residues (from 652 residues) of PF3D7_1118700 (henceforth called PfMTIP-B) 
revealed that they have 56% similarity and 31% identity within this region (Figure 
4.9a). We discard the first 420 aa of MTIP-B because it has much longer N-terminus 
than MTIP giving a distinct size of 78.8 kDa for PfMTIP-B relative to the 23.5 kDa of 
MTIP (Table 4.1 and 4.2).   The transcriptional profiling of PfMTIP-B showed that it is 
highly expressed in late asexual blood stages as is also the case for MTIP (Figure 4.9.b).  
Furthermore, this protein is also found in P. berghei (PBANKA_092940), P. chabaudi 
chabaudi (PCHAS_091490), P. knowlesi (PKH_091610) and P. yoelii yoelii 
(PYYM_0930800) (PlasmoDB) which shows it has homologues across Plasmodium 
species (Appendix C). This protein was absent in the MyoA-GFP pull down indicating 
that MTIP-B does not associate with MyoA.  From studies conducted previously, MTIP 
(MLC1 in Toxoplasma) had been identified as the light chain for MyoA and the the 
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association occurred through the degenerate IQ motif at the extreme C-terminal end of 
MyoA (Bergman et al., 2003; Green et al., 2006b; Herm-Gotz et al., 2002). (Appendix 
D). Considering the association of PfMyoA and MTIP through binding of the MyoA-
tail by the C-terminal domain of MTIP, a 12 residue peptide (EPQRKPLSIEESFENSE) 
was identified (Green et al., 2006b); this domain is also present in the PfMyoB 
sequence (QKIEIPLSIEESLSICR), thus PfMTIP-B might be associated with PfMyoB 
and a further investigation needs to be carried out in order to confirm this MTIP-B as a 
MyoB light chain.  
The first step that we need to carry out is to establish the residues of MyoB 
binding to MTIP-B followed by studies on the expression profile of MTIP-B in 
developing parasite by generating a GFP- or HA-tagged MTIP-B transgenic parasite.  
The localisation of MTIP-B can be determined using IFA or IEM with specific 
antibodies against MTIP-B, or live imaging microscopy.  The function of the protein 
may be investigated by mutagenesis studies or the generation of a knockout parasite.  
The important features of the structure of MTIP-B and MyoB-MTIP-B complexes need 
to be established. As a start, the interactions of MyoB and MTIP-B can be examined 
using methods developed to study the MyoA – MTIP complex (Douse et al., 2012; 
Green et al., 2006b; Thomas et al., 2010). 
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Figure 4.10:  Identification of PfMTIP-B.  (a) Clustal alignment of the MTIP 
sequence with the C-terminal 232 amino acids of MTIP-B.  This alignment clearly 
shows the similarity between PfMTIP and PfMTIP-B.  The residues in red and blue 
indicate the EF hand domains. *, identity; :, strong similarity; .(b) The expression 
profile of PfMTIP and (c) The expression profile of PF3D7_1118700 (PfMTIP-B) as 
reported in the Plasmodium database.  The expression level of both PfMTIP and 
PfMTIP-B (peaks at later stages) during the erythrocyte cycle.  The blue, red and 
orange colours represent expression profiles of the HB3, 3D7 and DD2 strains.  The x-
axis shows hours post invasion of the parasite and the y-axis represent the signal 
obtained for the protein expression.  
 
4.8 Microscopic visualisation of PfMyoA-GFP and PfMyoB-GFP during 
erythrocyte invasion. 
 
Merozoite invasion of the host erythrocyte is a necessary stage in Plasmodium 
infection and essential for malaria parasite survival. The first EM visualisation of 
invasion was in the 1970s  by Aikawa (Aikawa et al., 1978; Aikawa et al., 1981; 
Bannister et al., 1975) and more recently using high resolution epifluorescence imaging 
technologies (Riglar et al., 2011; Zuccala et al., 2012).  Although the moving junction 
(MJ) has been recognised morphologically for many decades, the proteins that 
contribute to this interface were only recently identified.  The rhoptry neck proteins 
(RONs) along with micronemal protein AMA1 form a complex which was found to be 
localised to the MJ forming a ring at the site of invasion.  Several RON proteins are 
inserted into the host cell plasma membrane and function as the parasite’s own receptor 
transferred into the host cell, which also provides a point of anchorage for the invasion 
process.  According to Boyle and colleagues merozoites invade the host cell within 10 
min at 37oC (Boyle et al., 2010).  With a reliable and quick method of fixation of P. 
falciparum merozoites during the invasion process the localisation of merozoite 
proteins relative to the moving junction can be visualised during this whole process. 
RON4 has been established as a key protein in the moving junction.  Therefore we 
decided to use antibodies to RON4 to facilitate the visualisation and determination of 
the stage of invasion. PfMyoA-GFP and PfMyoB-GFP were visualised during invasion 
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relative to RON4, which can be traced by IFA from a single point at the apex of the 
merozoite during attachment through to junction closure upon completion of the entry 
and formation of the PV. The localisation of PfMyoA-GFP and PfMyoB-GFP during 
erythrocyte invasion is shown in Figure 4.11 and Figure 4.12 respectively. 
As described in section 2.9 (Chapter 2) tightly synchronised PfMyoA-GFP or 
PfMyoB-GFP late stage schizonts were mixed with uninfected erythrocytes and shaken 
at 37oC for 30 min. Samples were taken at 2, 5, 8, 10, 20 and 30 min and fixed and 
permeabilised in solution. RON4 was detected with mouse α-RON4 mAb (24C6) 
followed by goat anti mouse secondary antibody coupled with Alexa 594.  To 
investigate the PfMyoA-GFP and PfMyoB-GFP localisation, affinity purified rabbit α-
GFP antibodies were applied followed by goat-anti rabbit Alexafluor 488-labeled 
antibodies. DNA was stained with 0.1µg/ml DAPI. In free merozoites RON4 showed a 
single dot at the apical tip of the cell. PfMyoA-GFP localised at the periphery of free 
merozoites (Fig 4.11 top row) and PfMyoB-GFP (Fig 4.12 top row) at the anterior end 
of the merozoites apical to RON4. In live host cell invasion, the initial attachment is 
reversible, here this event has been frozen and was identified by RON4’s localisation, 
changing from a single point at the merozoite apex to a slightly elongated band when 
the actual moving junction has been formed.  Also the erythrocyte shows a slight 
indentation at the point of attachment and protuberances of the erythrocyte’s membrane 
mark the formation of a moving junction.  Protuberances are detected associated with 
echinocytosis, which was triggered by the internalisation and sealing events when a 
merozoite enters into the erythrocyte. The protuberances may result from the increased 
erythrocyte membrane deformability that is probably due to changes of rigidity and 
flexibility in the underlying cytoskeleton and resulting from stimulation of signalling 
receptors (β-adrenergic) which increase the cyclic AMP level (Gilson and Crabb, 2009).  
PfMyoA-GFP remained circumferential throughout the invasion process, whereas 
PfMyoB-GFP at initial attachment showed a partial co-localisation with RON4 (Fig 
4.12, second row). As the merozoite moves into the developing PV, RON4 forms a 
circumferential zone of labelling around the attachment point of the parasite to the cell, 
which appears as  a ring in three dimensions or two points of fluorescence in a two-
dimensional cross section and depicts the movement of the tight junction (Riglar et al., 
2011).   
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In this experiment, the stage of RON4 ring formation as mention above was not 
clearly displayed, however RON4 appeared as an elongated band marking the 
progression of the junction.  As can be clearly seen from Fig 4.11 PfMyoA-GFP still 
showed peripheral merozoite staining. The staining did not seem to follow the moving 
junction but rather be circumferential throughout. PfMyoB-GFP also did not follow the 
moving junction but rather stayed in the apical position of the merozoite with the 
moving junction, as visualised by RON4, moving over the merozoite. In Figure 4.12 
(row 3) RON4 shows a partial co-localisation with PfMyoB-GFP and in row 4 RON4 is 
located anterior to PfMyoB-GFP suggesting the secretion of RON4 from the rhoptry 
neck into the host cell. Finally the parasite has finished invading the erythrocyte and 
RON4 is localised in the remnant junction, which has closed the developing PV and 
plasma membrane at the posterior of the parasite. After completion of invasion 
PfMyoA-GFP lies on the inside of the sealing PV (RON4 demarking the host cell side 
of the PVM), whereas PfMyoB-GFP stayed at the original apical localisation at the 
opposite end to PfRON4 and before RON4 spreads in patches around the expanding PV 
membrane (PVM), suggesting loss of structural integrity of the junction at this stage. 
During early ring stages PfMyoA-GFP seems to localise inside the PVM 
however it is gradually lost until it is expressed prominently again during parasite 
segmentation, which suggests a role for it in the invasion motor complex as discussed in 
section 4.4 and 4.5.  On the other hand, PfMyoB-GFP still appeared as a single dot 
localised inside the PVM.  We knew from the time course studies that PfMyoB-GFP 
was expressed later in the intracellular life cycle starting around ~40 hours post 
invasion during parasite segmentation and localised at the apical end anterior to the 
RONs (section 4.3 and Figure 4.5). We assume that after invasion has been completed 
that PfMyoB-GFP will gradually be lost.  If this is the case we may hypothesize that 
PfMyoB-GFP is crucial for invasion although the actual role remains unknown. More 
investigations need to be performed to answer this question, for example by generating 
gene knockout parasites. 
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Figure 4.11:  Stepwise visualisation of PfMyoA-GFP parasites during merozoite 
invasion of the host cell.   The PfMyoA-GFP parasite was fixed during various stages 
of invasion. MyoA-GFP was localised using rabbit anti GFP antibodies (1:200), RON4 
was detected using mouse monoclonal antibody 24C6 (1:400), and the nucleus stained 
with DAPI.  The invasion steps were divided into free merozoites, initial attachment, 
followed by attachment and invasion as well as the final steps depicted as final sealing 
of the parasite within the host cell and establishment in the PV for development (ring).   
PfMyoA-GFP (green), RON4 (red) and nucleus (blue) are shown as well as a cartoon of 
the invasion. Scale bar is 2µM. 
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Figure 4.12:  Stepwise visualisation of PfMyoB-GFP during merozoite invasion of 
the host cell. The PfMyoB-GFP parasite was fixed during various stages of invasion. 
MyoB-GFP was localised using rabbit anti GFP antibodies (1:200), RON4 was detected 
using mouse monoclonal antibody 24C6 (1:400) and the nucleus stained with DAPI.  
The invasion steps were divided into free merozoites, initial attachment, followed by 
early and late stages of invasion (neck in versus final invasion) as well as the finishing 
steps of invasion with the release of the remnant junction and the formation of ring 
stage. PfMyoA-GFP (green), RON4 (red) and nucleus (blue) are shown as well as a 
cartoon of the invasion. Scale bar is 2µM.  
 
4.9 Characterisation of MyoA and MyoB in Plasmodium knowlesi 
Despite the successful GFP-tagging of MyoA and MyoB in P. falciparum, the 
localisation, especially for MyoB, proved to be very challenging to establish due to the 
size of the parasite.   By comparison, P. knowlesi merozoites are about twice the length 
of P. falciparum (1.5 versus 3.7 µm) and are viable for a longer period after egress 
(Aikawa et al., 1978; Aikawa et al., 1981).  Therefore P. knowlesi may enable more 
detailed observation of protein localisation.  In this section we performed transfections 
with linear and circular DNA to generate P. knowlesi MyoA and MyoB transgene 
parasite lines.  Single cross over transfection using circular DNA is widely used in P. 
falciparum, whilst linear DNA is the preferred substrate for homologous recombination 
in P. knowlesi.   Whilst linear DNA may integrate more readily, it cannot be replicated 
in the parasite and so is rapidly degraded. As transfection efficiency is lower in P. 
falciparum there is very small chance that it is integrated straight away.  The advantage 
of using linear DNA is that the time required for selecting integrants is about 2 weeks 
versus the 3-4 months required for transfection with circular DNA. This is because the 
transgenic population that initially grows contains a high proportion of parasites with 
integrated DNA and few carrying the plasmid as an episome.  In P. knowlesi, MyoA-
GFP DNA and MyoB-GFP DNA were transfected using both linear and circular 
constructs.  Both were tried as this work was carried out at an early stage in the 
development of the P. knowlesi in vitro transfection system in 100% human blood 
(Moon et al., 2013), and we were not sure of the efficiency of transfection.   
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The GFP-tagging of the endogenous MyoA and MyoB genes of  P. knowlesi  
was achieved by integration of a tagging construct via single cross over homologous 
recombination into the parasite genome. In order to introduce the GFP tag at the C-
terminus of each protein, a region of homology corresponding to 1097 bp (MyoA) and 
1064 bp (MyoB) from the 3’ end of each ORF lacking the stop-codon was selected.  
The region of homology was amplified by PCR using primer combination 1F1/1R2 for 
MyoA and 2F1/2R2 for MyoB (Chapter 2, Table 2.2). These regions of homology were 
cloned between the XmaI/AvrII sites of pHH4-GFP (Knuepfer et al., unpublished) and 
the correct sequence confirmed by Sanger sequencing (Beckman Genomics), generating 
the constructs pHH4-PkMyoA-GFP and pHH4-PkMyoB-GFP respectively. In each 
case the cloning resulted in the targeting fragment being placed upstream of the GFP 
ORF followed by the Pbdhfr 3’UTR. The strategy for integration followed the work in 
P. falciparum and is summarised in Figure 4.13 for MyoA and Figure 4.14 for MyoB.   
Prior to linear transfection, plasmid DNA was linearized with NruI and AflII for 
MyoA and MyoB respectively.  After transfection of 20 µg plasmid DNA (linear and 
circular plasmid) for each construct into schizont stage parasites, 2.5 nM WR99210 was 
added and the parasites cultured continuously under drug selection for approximately 2 
to 3 weeks.  The parasite that grew after these times were depicted as cycle 0, and 
whilst resistant to WR99210, as expected; this resistance was predominantly due 
episomal maintenance of the targeting construct. The transfected cultures were then 
grown for 3 weeks without drug selection, to allow loss of the episomal construct (due 
to uneven segregation of the episome) followed by a further week of growth under 
WR99210 selection again. The resultant parasite populations were designated cycle 1 
and this was repeated further until transgenic parasites were obtained.  Cultures were 
checked after each cycle for integration of the construct by both diagnostic PCRs and 
monitoring for GFP expression.  The plasmids transfected into the parasites lack a 
promoter to drive expression of the tagged genes, thus the GFP tagged version can only 
be expressed once the plasmid has integrated and expression can be driven by the 
endogenous promoter. This means that expression of GFP can be taken as a strong 
indication of correct integration of the plasmid.   
Expression of MyoA-GFP was detected in parasites following transfection with 
a linear construct (henceforth called PkLinA-GFP) and for MyoB-GFP following 
transfection with a circular construct (henceforth called PkCirB-GFP).    Preliminary 
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live fluorescent imaging of PkLinA-GFP and PkCirB-GFP showed a pattern of GFP 
signal similar to that as detected in P. falciparum.   A strong GFP fluorescence signal 
associated with the periphery of developing merozoites was detected in PkLinA-GFP 
(Figure 4.13), and a PkCirB-GFP signal with an apical end localization was also 
detected (Figure 4.14). These results were further confirmed by IFA using GFP 
antibody. Although transfection with these constructs eventually produced P. knowlesi 
transgenic parasite lines for MyoA and MyoB, cloning of these transgenic parasite lines 
was unsuccessful due to the relatively low proportion of integrated parasites.   To 
improve the efficiency of the transgene’s expression, we plan in the future to transfect 
using newly produced vectors specifically designed for P. knowlesi (produced by 
Robert Moon, NIMR). This work is in progress. These vectors replace P. falciparum 
promoter regions with P. knowlesi sequence, resulting in better expression of the 
selectable marker, and much higher integration efficiency. 
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Figure 4.13: Generation of PkLinA-GFP parasites.  (a) Plasmid DNA used for 
circular and linear transfection.  This illustrated diagram depicts the unique site (NruI) 
for linearization purposed.   Schematic representation of the gene replacement strategy 
by single cross over MyoA homologous recombinant and integration into the P. 
knowlesi genome with primers for PCR (arrows), and containing the pyrimethamine-
resistant DHFR selectable marker and a complete integration strategy.  The 1097bp 
homology region of PkMyoA gene is also present.  (b) The un-cloned PkLinA-GFPIFA 
probed with GFP antibody (1:300) and analysed at 1000X magnification. PkLinA-GFP 
is evenly distributed at the parasite periphery as shown in P. falciparum.  .Nucleus 
stained with DAPI. Scale bar is 2µM. 
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Figure 4.14: Generation of PkCirB-GFP parasites.  (a) The vector is linearized at the 
unique Af1II site generated in the homology region.  Schematic representation of the 
gene replacement strategy by single cross over MyoB homologous recombination and 
integration strategy into P. knowlesi with primers for PCR (arrows) and containing the 
pyrimethamine-resistant DHFR selectable marker and a complete integration strategy.  
The 1064bp homology region of PkMyoA gene is also present. (b) and (c) The un-
cloned PkCirB-GFP transgene parasite as viewed by live fluorescence microscopy. 
PkCirB-GFP is eventually located at the parasite anterior at the apical end as 
demonstrated for PfMyoB-GFP. Nucleus stained with DAPI.  Scale bar is 2µM 
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4.10 Generation of anti -MyoA and anti-MyoB antibodies 
In addition to the generation of transgenic parasites expressing proteins of 
interest, specific antibodies to these proteins will also be important tools, for example 
for  use with western blots, IFAs and immunoprecipitation.  Although in this scenario it 
is not crucial due to the use of commercial α-GFP antibodies for transgene expression 
detection, it is an advantage to have those specific antibodies to complement this 
strategy or to serve as controls for these tagged lines.   
Four peptide sequences were chosen to generate MyoA and MyoB antibodies.  
The MyoA peptide was selected based on a region conserved between P. falciparum 
and P. knowlesi to increase the chance antibodies would cross-react between the two 
species (Figure 4.15.i), and this was used to raise antibodies in rats.  MyoB antibody 
was raised in rabbits using MyoB sequences selected to be conserved between both P. 
falciparum and P. knowlesi (Figure 4.15.ii).  Based on previous experience of 
producing antibody in rabbit, there was the possibility that the antibody produced would 
not be very specific, and therefore antibodies for another 2 peptide sequences 
specifically targeting either MyoB in P. falciparum (anti-PfMyoB) or P. knowlesi (anti-
PkMyoB) were raised in rats (Figure 4.15.iii).  Synthesis of all peptides and production 
of the antibody was carried out by Pepceutical Ltd following a standard protocol.  In 
addition, an antibody to full length MyoA (MyoA-FL) was also generated against the 
recombinant protein produced in the cell free system.  The immunization was carried 
out in rats by Harlan Biosciences following the 34 day standard protocol.  Animals to 
be used were pre-screened by western blot prior to inoculation to avoid previously 
existing cross reacting antibodies.   Terminal bleeds were used in immunoblot to detect 
MyoA and MyoB.  Immunoblot analysis showed that the MyoA-FL antibody reacted 
strongly with a P. falciparum parasite lysate in western blot (Figure 4.16.a), whereas 
Pf/k-MyoA and Pk/f-MyoB antibodies strongly detected a single band corresponding to 
native MyoA (~93 kDa) in both P. knowlesi and P. falciparum western blot (Figure 
4.16.b and c) with a stronger band detected for MyoA compared to MyoB as expected 
due to the abundance of the proteins. 
We used MyoA-FL, Pf/k-MyoA, Pk/f-MyoB, anti-PfMyoB and anti-PkMyoB 
antibodies to establish whether or not the signal co-localised with the GFP signal in 
PkLinA-GFP and PfMyoA-GFP parasites by IFA.  Although, MyoA-FL and Pk/f-
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MyoB antibodies strongly recognized a band corresponding to MyoA and 
MyoA/MyoB, respectively on a western blot, unfortunately no fluorescence signal was 
detected in either GFP-tagged parasite lines (data not shown).  Co-localization of 
PkLinA-GFP with Pf/k-MyoA antibody gave a strong peripheral fluorescent signal that 
indicated a strong recognition of MyoA by Pf/k-MyoA antibody (Figure 4.16.d).  Co-
localisation of PkLinA-GFP and PfMyoA-GFP with anti-PkMyoB antibody showed 
that MyoB was recognized by these antibodies (Figure 4.16.e and f).  Although the 
localization of MyoB at the apical end  of the parasite had been shown in section 4.2 
and 4.3, this is the first time we observed the MyoB pattern as recognized by antibodies.  
In P. falciparum, MyoB antibody gave a single discrete dot at the apical end as 
predicted (Figure 4.16.f).  On the other hand, in P. knowlesi, MyoB gave a slightly 
different pattern: in microscopy imaging of the P. knowlesi transgenic parasite, MyoB 
appeared as a doubled dot.  This may be due to possible cross reaction with unspecified 
antigen (we used crude serum), alternatively it might be a consequence of the bigger 
size of P. knowlesi compared to P. falciparum, allowing us to resolve the labeled 
structure in greater detail.  This is a very interesting finding and further investigation is 
needed.   Due to some technical difficulties and time limitations, the IFA for PkCirB-
GFP parasites with all the generated antibodies was not performed, thus we can’t 
confirm by reciprocal analysis the antibody activities.  We hope to resolve the technical 
problems and further clarify the protein’s location by performing IEM.  
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Figure 4.15:  Sequence selection for generation of synthetics peptides to elicit 
MyoA and MyoB antibodies.   (I) P. falciparum sequence (pink residues) used for 
MyoA antibody production that can be used in both P. falciparum and P. knowlesi. (II) 
P. knowlesi sequence (pink residues) used for production of MyoB antibody that can be 
used in both P. falciparum and P. knowlesi. (III) Species specific sequences used to 
produce P. knowlesi MyoB and P. falciparum MyoB (pink residues).  In general, the 
red and blue residues are for sequence comparison between P. knowlesi MyoA and 
MyoB, and P. falciparum MyoA and MyoB respectively  
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Figure 4.16: Production of MyoA and MyoB antibodies tested by western blot and 
IFAs. (a) to (c) Western blot of the full length MyoA (MyoA-FL), Pf/k-MyoA and 
Pk/f-MyoB antibodies (1:200) against P. falciparum and P. knowlesi wild type parasite 
lysate.  Single band (~93 kDa) indicated the recognition of MyoA or MyoB by these 
antibodies.  RBC (1); 3D7 schizont NP-40 lysate (2a); 3D7 crude schizont lysate (2) 
and P. knowlesi schizont lysate (3).  (d) and (e) Co localisation of PkLinA-GFP with 
GFP antibody and Pf/k-MyoA or with anti-PfMyoB antibodies. Pf/k-MyoA antibody 
gave a strong fluorescence signal at the periphery of the parasite indicating the 
recognition of MyoA.  (f) Co localisation of PfMyoA-GFP with GFP antibody and anti 
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PfMyoB antibodies.  Anti-PfMyoB antibody also gave a strong fluorescence signal at 
the apical end of the merozoite in both PkLinA–GFP and PfMyoA-GFP indicating the 
recognition of MyoB.  GFP-antibody shown in green (Alexa 488), the Pf/k-MyoA and 
anti-PfMyoB antibody in red (Alexa 594), nucleus stained blue. 1000x  magnification. 
Scale bar is 2 µm. 
 
 
4.11 Discussion 
Myosins are molecular motor proteins that are capable of either translocating 
actin filaments using ATP hydrolysis to provide energy, and driving cellular movement 
in eukaryotes or of translocating vesicles or cargo on fixed actin filaments.  In this 
chapter, Plasmodium Myosin A and B are characterised in vivo.  
 
Myosins A and B are the smallest members of the myosin superfamily (Foth et 
al., 2006), both displaying a similar molecular weight (~93kDa each), and like their 
homologue in T. gondii, they each are characterised by a short or almost nonexistent tail 
which cannot be defined easily.  Compared to the other myosins, MyoA appears to 
possess a very divergent neck with one degenerate IQ motif.  The degenerate IQ motif, 
present at the extreme C-terminus of MyoA, associates with the calmodulin-like 
protein, TgMLC1 or PfMTIP (Bergman et al., 2003; Herm-Gotz et al., 2002).  In T. 
gondii it has been proposed that the N-terminal extension of MLC1 substitutes for the 
tail of MyoA.   MyoA along with at least four additional proteins makes up the invasion 
motor complex, which consists of MyoA-MLC1/MTIP-GAP45-GAP50 (Baum et al., 
2006b; Frenal et al., 2010; Green et al., 2006b; Heaslip et al., 2010; Herm-Gotz et al., 
2002; Jones et al., 2006; Soldati and Meissner, 2004).   General conservation of the 
glideosome components has been demonstrated between at least six Apicomplexa 
genera, indicating that this complex plays an important role in host cell invasion and 
motility (Bergman et al., 2003; Gaskins et al., 2004). An important role for MyoA and 
the motor complex in host cell invasion is supported by the successful genetic knock 
down of MyoA in T. gondii and P. berghei ookinetes  (Siden-Kiamos et al., 2011) 
which led to a severe impairment of cell entry (Meissner et al., 2002), although this 
result has been contradicted by recent studies which show by the generation of a MyoA 
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knockout that this protein is not absolutely necessary for cell invasion (Andenmatten et 
al., 2013). Although MyoA has been biochemically characterised by various studies in 
both Plasmodium and Toxoplasma, little is known about MyoB. This study was 
intended to characterise PfMyoB further in particular to investigate where it is located 
and which proteins it forms a complex with. 
 
 
4.11.1 The use of transgenic parasites to investigate the timing and localisation of 
MyoA and MyoB expression  
 
The localisation of MyoA and MyoB has been clearly demonstrated in this 
study. PfMyoA-GFP shows a strong and stable peripheral localisation suggestive of the 
pellicle. Meanwhile, the signal from PfMyoB-GFP indicates a different localisation, at 
the apex of the merozoite. Using P. knowlesi, newly adapted to continuous culture in 
human blood (Moon et al., 2013), the GFP sequence was inserted into the endogenous 
locus of PkMyoA and PkMyoB.   Interestingly, PkMyoA-GFP showed a peripheral 
merozoite staining similar to that of PfMyoA-GFP, whereas PkMyoB-GFP gave a 
signal at the extreme apex of the merozoite. Using GFP has allowed the direct 
localisation of MyoA and MyoB to be achieved in a living cell in real time by live 
fluorescence microscopy.  A similar pattern of localisation of MyoA and MyoB at the 
periphery and apical tip respectively has been shown recently in ookinetes of P. berghei 
(personal communication, Rita Tewari, University of Nottingham).   The addition of 
GFP to the protein’s C terminus has overcome the need to fix and label proteins with 
specific antibodies to the protein of interest, eliminating possible fixation problems and 
artefacts. Nevertheless, antigen-specific antibodies were used to identify MyoA and 
MyoB in both transgenic parasite species, which has aided the characterisation and 
localisation of MyoA and MyoB in the parasite.  Due to time constraints, the 
characterisation of MyoA and MyoB from only one species of the parasite - P. 
falciparum – was pursued. Any further characterisation of P. knowlesi MyoA and 
MyoB will be carried out in the future but is beyond the scope of this thesis.   
 
Upon successfully generating PfMyoA-GFP parasites, the expression and 
localisation pattern previously described was confirmed (Pinder et al., 1998). MyoA 
colocalises with the glideosome motor complex at the IMC.  The peripheral location of 
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MyoA has previously been shown in P. falciparum by immuno-EM imaging (Pinder et 
al., 2000) and by immunofluorescence using specific antibodies to MyoA in T. gondii 
(Hettmann et al., 2000; Opitz and Soldati, 2002) and P. yoelii sporozoites 
(Matuschewski et al., 2001). Although the peripheral localisation of PfMyoA is 
established, this study demonstrates for the first time the development of PfMyoA-GFP 
throughout the intra-erythrocytic cycle by live cell imaging and Western blot as well as 
immunoprecipitation of PfMyoA-GFP from time course protein samples.   Using tightly 
synchronised parasites and live cell imaging, we found that PfMyoA-GFP was highly 
expressed at the parasite periphery during segmentation (~40 h post invasion), marked 
by a high intensity of fluorescence around the parasite pellicle.  PfMyoA-GFP also 
colocalised with PfMTIP, PfGAP45 and PfGAP50 throughout the segmentation 
process, as determined by IFA over the time course. This co-localisation complements 
previous work which located  the other motor complex components to the periphery of 
several Apicomplexan zoites by live microscopy and IFA: GAP45 (Frenal et al., 2010; 
Gaskins et al., 2004; Ridzuan et al., 2012), GAP40 (Frenal et al., 2010), GAP50 
(Gaskins et al., 2004; Yeoman et al., 2011), and MTIP (Bergman et al., 2003; Green et 
al., 2006b).  Therefore in this study we support and confirm the earlier findings of 
MyoA’s involvement in the motor complex.   In addition, Rizduan et al., (2012) showed  
that the episomally expressed GFP tagged GAP45 start as dots or rings that elongate 
and spread rearward as the IMC forms starting at 30 h, but MyoA did not show the 
same development pattern suggesting that, MyoA only binds to fully formed IMC.  As 
mention earlier in section 4.5,  the expression of GAP45 was not detected at 30 h as 
found in a previous study (Ridzuan et al., 2012); it was only found at around 36-38 h by 
GFP-IP, suggesting that it only comes into association with MyoA at a later stage (38 h) 
when the IMC is fully developed.  
 
As well as providing confirmation of the location and expression of MyoA, this 
study presented a novel insight into PfMyoB-GFP expression and localisation.  
PfMyoB-GFP displays a distinct expression profile: very late during schizont 
development and at the extreme apex of the cell.  Although MyoA and MyoB are from 
the same class of myosins (XIV), and have a similar molecular weight (~93 kDa) and 
amino acid sequence (>50% similarity), they appear very different under the 
microscope. As described above, PfMyoA-GFP is located at the parasite periphery, 
whereas PfMyoB-GFP is located at the apex of merozoites.  The timing of PfMyoB-
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GFP expression indicates that the protein is relatively abundant at the time of parasite 
segmentation, around ~40 h or later post invasion.  It might be expressed earlier than 
that, probably from around~36 h post invasion, but in low abundance.  Live time course 
experiments showed that at the earlier times, the expression of PfMyoB-GFP is very 
faint and diffuse. This can not be ignored,  because as also shown for PfMyoA-GFP 
expression, although only faint diffuse fluorescence was detected during earlier time 
points (from 21 h post invasion) in the time course analysis, the expression was 
confirmed by western blot, indicating that the protein was clearly expressed.  Therefore, 
PfMyoB-GFP may also be expressed as early as the faint diffuse fluorescence was 
detected in the time course analysis, which is ~36 h post invasion.  This result needs to 
be confirmed by western blotting of the time course protein samples, but unfortunately, 
this experiment will be beyond the scope of the thesis.   This issue was also discussed 
briefly by Chaparro  and colleagues (Chaparro-Olaya et al., 2005), where the authors 
used RT-PCR to analyse cDNA from different stages of parasite development, and 
suggested a role for MyoB in invasion due to the fact that MyoB was transcribed in late 
schizonts and merozoites. In order to determine the exact location of PfMyoB-GFP 
within the parasite, colocalisation studies were carried out with apical markers, such as 
micronemal proteins (AMA1 and EBA175), rhoptry proteins (RON3, RON4 and 
RAP1) and antibodies to actin and microtubules (α-tubulin).  Consistent with the earlier 
hypothesis that MyoB is involved in invasion; this study showed the localisation of 
PfMyoB-GFP to be at the very apical tip of the merozoite, in front of other apical 
organelle markers. There was some overlap with the actin marker (AC-40).  However 
due to the small size of the cell (1 µm) and a resolution limit of 0.2 µm for light 
microscopy we cannot be certain about this.  
 
Due to PfMyoB’s distinct location separate from these known apical markers, 
further investigation was required. At the extreme apical tip of the merozoite lies a 
microtubule organising centre (MTOC) unique to Apicomplexa and named the apical 
polar ring (Morrissette and Sibley, 2002; Russell and Burns, 1984).  The polar ring is 
made up of three tubulin ring-like structures, the third of which (anterior to posterior) is 
believed to be the site of subpellicular microtubule organisation, which maintains the 
cell’s shape and polarity (Bannister et al., 2000a). Due to the extreme apical location of 
PfMyoB-GFP, it is possible that this protein interacts with or forms part of the polar 
ring.  IFAs were performed using actin and tubulin antibodies to investigate this 
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hypothesis.  PfMyoB-GFP co-localised partially with actin, meanwhile co-staining with 
tubulin antibodies showed a localisation in between two connecting microtubules.  
Since the minus ends of sub-pellicular microtubules reside inside the polar ring and are 
laterally attached to MTOC through a shallow depression, there is a linkage between 
both polar ring and microtubules (Morrissette and Sibley, 2002; Russell and Burns, 
1984). According to the apparent location of MyoB at the opposite end to the nucleus, 
in front of the  apical markers, partially overlapping with actin  and  overlapped with 
the two tubulin ring,  perhaps it is a component related to the sub-pellicular 
microtubules.   In Toxoplasma, the apical polar ring can be identified using antibodies 
to a recently discovered component of the apical polar ring - RNG1(Tran et al., 2010). 
This protein appears to be unique to coccidian Apicomplexa as it is absent from 
Plasmodium spp. and therefore could not be used for co-localisation studies. However 
Plasmodium may share an orthologous proline-rich protein which is yet to be 
characterised. The location of RNG1 seems to be comparable to PfMyoB-GFP 
localisation. Potential interactions between MyoB and the apical ring complex remain 
to be studied.   
 
 
4.11.2 MyoA and MyoB share common ancestry but are retained in different 
complexes. 
 
Due to the small size of merozoites, localisation by fluorescence microscopy is 
not a definitive method of identifying a protein’s subcellular location. If MyoA and B 
were shown to interact with a protein of known location and role within the cell then 
more reliable conclusions could be drawn regarding these proteins’ function. The 
method of choice to complement the microscopy results in this study was 
immunoprecipitation (IP), followed by mass spectrometry or western blotting.  IP using 
α-GFP specific antibodies demonstrated that PfMyoA-GFP assembled into the 
glideosome motor complex as it co-precipitated other motor components - PfMTIP, 
PfGAP45 and PfGAP50.  Previous work on the complex has shown that PfGAP50 is 
synthesized before other components of the complex, and its role is likely to reflect the 
formation of the IMC and the host cell invasion by merozoites (Yeoman et al., 2011).  
The results showing the association of MyoA with the glideosome motor complex 
complements earlier studies in both Toxoplasma and Plasmodium. Since the first 
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characterisation of MyoA in Toxoplasma (Heintzelman and Schwartzman, 1997) and 
Plasmodium (Pinder et al., 1998),  the role of MyoA in the acto-myosin motor has been 
widely discussed (Herm-Gotz et al., 2002; Meissner et al., 2002). A dibasic motif in the 
MyoA tail was shown to be  essential to determine membrane localization (Hettmann et 
al., 2000), due to it’s role in binding to myosin light chain (TgMLC1) (Herm-Gotz et 
al., 2002), and anchoring to the IMC by TgGAP45 via TgGAP50  (Gaskins et al., 2004; 
Johnson et al., 2007) in the invasion motor complex.   
 
In Plasmodium, PfMyoA, PfMTIP, PfGAP45 and PfGAP50 (orthologous 
proteins of TgMyoA, TgMLC1, TgGAP45 and TgGAP50, respectively) were 
demonstrated to participate in gliding motility and host cell invasion (Baum et al., 
2006a).  MyoA interacts with MTIP (Bergman et al., 2003; Bosch et al., 2007a; Bosch 
et al., 2006; Green et al., 2006a; Thomas et al., 2010) and is anchored to GAP50 (Bosch 
et al., 2012; Yeoman et al., 2011) in the IMC via GAP45 (Gilk et al., 2009; Rees-
Channer et al., 2006; Ridzuan et al., 2012; Thomas et al., 2012).  Therefore the 
expression of PfMyoA-GFP at the periphery occurs at the right location and the right 
time to be part of the motor complex.  
 
LC-MS/MS analysis of PfMyoA-GFP immunoprecipitated proteins revealed 
novel motor complex-associated proteins such as several members of the PfGAPM 
protein family, GAPM2 and GAPM3. These proteins are multi-pass membrane proteins 
and may provide additional anchoring of the motor complex to the IMC, and have also 
been identified in T. gondii. Using HA-tagged GAPM3 co-localised with GAP45 
identified by IFA, GAPM3 localised at the IMC and co-localised with GAP45 but not 
with MSP119 (Bullen et al., 2009).  This study showed for the first time in Plasmodium 
an interaction between GAP40 and the motor complex. GAP40 (Accession ID: 
PF3D7_0515700) with a molecular weight of 51.8kDa is highly expressed during late 
schizogony (PlasmoDB:  http://plasmodb.org/plasmo/). This association had only 
previously been described in T. gondii (Frenal et al., 2010).  According to Frenal et al., 
GAP40 which contains nine transmembrane spanning domains might play an important 
role in anchoring the motor complex to the IMC and partnering with GAP50.   
 
Interestingly, this study provides direct evidence that PfMyoB-GFP does not 
have any relationship with the previously described glideosome motor complex. IP 
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experiments were performed using GFP specific antibodies on lysates of PfMyoB-GFP-
schizonts and no interaction with MTIP, GAP45 or GAP50 was detected (Figure 4.3(i)).  
LC-MS/MS analysis clarified the western blot finding and identified several potential 
interaction partners for PfMyoB-GFP that are not identified in a complex with 
PfMyoA-GFP. Interestingly, PfMyoB-GFP associated with what is believed to be 
PfMTIP-B. It is not clear whether the interaction of PfMyoB and MTIP-B is the basis 
for a separate invasion motor which has not previously been identified. This requires 
further investigation but is beyond the scope of this thesis. PfMyoB-GFP seems to also 
interact with dynamin 2 (DNY2) and clathrin, as identified by MS analysis.  Dynamin 
and clathrin are known to be involved in vesicular protein trafficking, endocytosis and 
cytokinesis (Breinich et al., 2009; De Camilli et al., 1995; Rao et al., 2012; Taraschi et 
al., 2001; van Dooren et al., 2009).   
 
The classical eukaryotic secretory pathway involves budding and fusion of small 
vesicles between the intracellular organelles.  In Plasmodium, this classical vesicle 
mediated secretory pathway is present within the cytoplasm and is involved in protein 
trafficking to the parasite PM (Foley and Tilley, 1998).   DYN2 and clathrin are two 
proteins precipitated from the GFP-tagged MyoB lysate during the GFP-TRAP analysis 
and identified by MS analysis (Table 4.2). DYN2 is involved in membrane scission and 
actin reorganisation (Menon and Schafer, 2013),   plays a role in cytokinesis and  may 
contribute to multiple forms of endocytosis. DYN2 is required for scission of 
endocytotic vesicles by acting as a mechanoenzyme or molecular switch, and the 
mechanism of action is best understood in the context of its interaction with clathrin in 
clathrin-mediated endocytosis (CME) (Royle, 2006, 2012).  A further literature search 
of both proteins revealed that together with F-actin they play important roles in clathrin 
coated vesicle (CCV) formation and vesicle endocytosis (Breinich et al., 2009; 
Ferguson and De Camilli, 2012; Li et al., 2004; Merrifield, 2004; Praefcke and 
McMahon, 2004; Royle, 2006, 2012; van Dooren et al., 2009; Zhou et al., 2009).   CCV 
are generated at a single Golgi apparatus and subsequently are delivered to the IMC 
(Bannister et al., 2000b). 
Phylogenetic analysis of the Apicomplexa dynamin family shows PfDYN2 
belongs to  dynamin related proteins, DrpB together with TgDrpB (Toxoplasma) and 
PvDYN2 (P. vivax)  (van Dooren et al., 2009).  PfDYN2 was implicated in vesicular 
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trafficking and/or organelle fission.  PfDYN2 was found to bind to GTP and hydrolyse 
it into GDP, and also self-associated in low-salt conditions.  The expression of PfDYN2 
is restricted to late stages of parasite development in the asexual blood stages as 
determined by western blot and it’s localised by IFA in punctuate structures within the 
parasite cytoplasm, suggesting its role is to participate in protein trafficking (Charneau 
et al., 2007).  Data obtained from other studies of DrpB showed more evidence of DrpB 
proteins involved in replication to generate vesicles for the regulated secretory pathway 
that forms the unique secretory organelles such as micronemes, dense granules and 
rhoptries, and for protein sorting for targeting to the food vacuole in Plasmodium and 
the apicoplast (a unique chloroplast-like organelle) for other Apicomplexa (Breinich et 
al., 2009).  In this study, clathrin and dynamin were in association with MyoB either 
directly or indirectly to form a complex.  Exactly where or when MyoB comes into 
contact with these proteins or is assembled into the possible complex is not known.   
Putting together the results of the PfMyoB-GFP time course experiment (the 
protein is expressed highly during segmentation), the co-localisation with actin (a 
partial localisation) and tubulin (at the microtubule connection), and the  association 
with proteins involved in trafficking, it could be hypothesised that MyoB has a role in 
vesicular transport or an involvement in cytokinesis,   where during this final act of cell 
division, the cytoplasm is pinched off  as shown by the role of Myosin II in the 
assembly of the actin contractile ring for cell division (DeBiasio et al., 1996; Pelham 
and Chang, 2002).  However, further investigation is needed.    The results of the IP 
experiments using MyoA- and MyoB-GFP tagged lines suggest that these two proteins 
have completely distinct roles.  
 
 
4.11.3 Investigation of PfMyoA-GFP and PfMyoB-GFP localization during 
erythrocyte invasion 
 
Invasion occurs in distinct stages: initial attachment; apical reorientation; MJ 
formation and the movement of the MJ from apical to posterior end of the parasite 
before host cell membrane sealing and PV formation.  Although erythrocyte invasion 
has been the focus of many laboratories for a number of decades, there are several basic 
questions that remain unanswered such as: what are the molecules involved in initial 
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attachment and how do they facilitate reorientation; what are the actual molecules 
involved at the MJ; what causes erythrocyte deformation; what molecules are involved 
in PV formation; is the vacuolar membrane of parasite or erythrocyte origin; what 
proteins are involved in gliding motility?  Some of the proteins involved in invasion 
have been successfully identified but there are many more proteins yet to be 
characterised.  Some of the proteins involved directly in the invasion processes have 
been thoroughly investigated such as the apical rhoptry neck proteins RON2, 4 and 5, 
micronemal proteins such as AMA1 and EBA-175, several surface proteins, and the 
glideosome complex. With new technologies emerging, proteins involved in invasion 
can be labelled and followed over time by microscopy, including 3D imaging and EM.   
Our ability to image cellular events during P. falciparum invasion provides a 
unique window into the processes of erythrocyte invasion by these deadly parasites. In 
this study, fluorescence imaging was used to track GFP-tagged MyoA and MyoB 
throughout the invasion process. RON4 was used as a cellular invasion marker as the 
timing of release as well its location at the moving junction has been established (Riglar 
et al., 2011; Zuccala et al., 2012).   Co-localisation IFAs on merozoites arrested within 
the invasion process were conducted by using α- GFP and α-RON4 antibodies. 
PfMyoA-GFP and PfMyoB-GFP did not follow the movement of RON4 but remained 
at the same location within the merozoite during and after invasion as they did prior to 
release at the end of schizogony.  The role of MyoB here remains unclear.  One 
hypothesis is that MyoB is involved in the release of the contents of the apical 
organelles but remains attached to a structure within the parasite. Alternatively, it might 
have a role early in ring stage development. The actual role of MyoB is still open for 
discussion and is under investigation. In order to gather more information the 
methodology could be improved, for example by the isolation of viable merozoites, as 
suggested by (Boyle et al., 2010) to ensure that  each step of invasion can be visualised 
easily.  
Generation of a knockout parasite line seem to be crucial for defining the role of 
MyoA in the glideosome motor complex and of MyoB. Although, Meissner et al., 
(2002) reported that a TgMyoA conditional gene knockout only decreased the host cell 
invasion it did not prevent the invasion, confirming the important role of MyoA. In 
more recent work Meissner and co-workers used the  DiCre system to generate 
knockouts of  MyoA, a micronemal protein (MIC2) and Actin (Act1 ) of T. gondii in 
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order to disrupt the function of the glideosome motor complex. MyoA deletion or  the 
absence of MIC2 did not inhibit invasion although some growth defect was observed, 
whilst the knockout of Act1 showed that actin is essential for parasite survival 
(Andenmatten et al., 2013). Therefore, the generation of PfMyoA and PfMyoB 
knockouts using the DiCre system may provide information regarding the functions of 
both MyoA and MyoB in P. falciparum.  The application of this conditional knockout 
approach is a powerful way to generate a rapid and efficient system to examine the 
phenotype for stage- specific disruption of particular genes.  Expanding the 
investigation to P. knowlesi may provide additional advantages such as improvement of 
image clarity due to a larger cell size. Visualisation by IEM would confirm the location 
of MyoB during invasion. Although IEM was attempted, imaging was unsuccessful due 
to an incompatibility of the antibody with the fixation process.   
The localisation and interaction between MyoA and the glideosome motor 
complex has been studied by other groups either in T. gondii or Plasmodium, producing 
similar conclusions about both localisation and association of MyoA with the invasion 
complex.  In addition, our studies have also demonstrated the presence of additional 
proteins in the Plasmodium glideosome complex, including GAP40 and the GAPMs 
family.  However, the studies on the actual association should be carried further in the 
future.  Most notably, these studies have provided the first information on PfMyoA-
GFP protein expression in live parasites (using live imaging of GFP) and most 
importantly,  the visualisation of MyoA during parasite progression into the host cell 
during invasion.  Although, MyoB was briefly discussed especially during classification 
of the myosin superfamily, MyoB possesses a different localisation and a different 
protein complex from MyoA.  This is the first study of  PfMyoB-GFP protein 
expression and its localisation in parasite development and during parasite invasion of 
host cells and the possible MyoB protein complexes. 
If MyoB plays a role in gliding motility and invasion as MyoA does, then 
several questions arise.   First, we do not know the mechanism of how a MyoB motor is 
controlled, although the regulation might involve a mechanism similar to that for 
MyoA.  MyoA is regulated by phosphorylation at the consensus TEDS phosphorylation 
site, which is serine residue 19 in MyoA, whereas for MyoB, the phosphorylation site(s) 
are likely to be serine 16 and/or threonine 17.    Microtubules have been shown to have 
signalling roles (Bejon et al., 1997) and a role in translocating AMA1 (within 
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mcronemes) during merozoites development (Bannister et al., 2003).  Although, 
myosins use actin as their track for translocation, the association of MyoB with 
microtubules is open for discussion.  One possibility is that if MyoB is involved in 
initiation of invasion by squeezing or stiffening the cisternal membrane to release the 
secretory organelles, microtubules might support this, and assist with the scission of the 
opening by PfDNY2.  Thirdly, does MyoB play an important role in invasion such as 
becoming transiently involved withthe same complex as MyoA to determine the 
direction of movement, as well as anchoring cytoskeletal structures and defining the 
polar ring structure.   
These data indicate that MyoB may have a very interesting role in parasite 
biology. Future work should therefore include the generation of a MyoB knockout, 
detailed localization studies using IEM, protein interaction studies with PfMTIP-B, and 
analysis of functional activities with actin and the association with tubulin. Further 
analysis of the proteins in P. knowlesi may provide significant advantages.  All together 
this will gave a better understanding of the role of the MyoB protein.  
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Chapter 5 
Research Summary  
 
5.1 The reconstitution of the glideosome motor complex in vitro using protein 
produced in the wheat germ cell free translation system  
• Attempts to reconstitute the glideosome complex were relatively unsuccessful 
due to a largely unstructured MyoA protein produced by the cell free system.  
Although, a proportion of the MyoA was structured to some extent and active, 
as determined by the optical trapping methods with single molecules, there 
wasn’t sufficient in the protein preparations for their successful use in motility 
or actin-binding based assays. This study was, therefore, unable to produce the 
high quality and quantity of soluble MyoA required.  Although there was some 
suggestion of interaction between MyoA and MTIP, these experiments failed to 
give conclusive evidence of the protein-protein interactions required to 
reconstruct the motor complex in vitro, or to demonstrate the association of 
MyoA with actin filaments to establish gliding motility (Chapter 3). Initially, it 
was intended that MyoB should also be produced in the cell free in vitro 
expression system for characterisation and functional studies, but the decision 
was taken to suspend these plans.  Therefore, no future work was planned for 
this study. 
 
5.2  MyoA has a peripheral localization, forms part of the glideosome motor 
complex and is involved in erythrocyte invasion 
• Characterisation of MyoA by producing a GFP-tagged MyoA in both P. 
falciparum and P. knowlesi. With the current technology, the best way to 
monitor MyoA expression and localisation is by following the GFP-tagged 
MyoA throughout parasite development, by tagging the endogenous MyoA 
gene.  The successful addition of GFP to the C-terminus of both proteins 
revealed that MyoA was present around the periphery of invasive merozoites 
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and expressed in abundance during parasite segmentation, in schizonts and 
merozoites (Chapter 4; Figure 4.1, 4.6 and 4.13) which is consistent with the 
findings of Pinder et al (1998), where the authors confirm the peripheral 
localisation with IEM (Pinder et al., 1998). 
 
• The assembly of MyoA to the glideosome motor complex.  This study found 
that MyoA co-localises with MTIP, GAP45 and GAP50 by IFA (Chapter 4; 
Figure 4.4).  This result was further validated by co-immunoprecipitation of 
GFP-tagged MyoA with the glideosome complex proteins where MyoA was 
precipitated together with these proteins.  The structure of the motor complex 
was further confirmed by MS analysis of the precipitated GFP-tagged MyoA 
and associated proteins. The MS results showed that all the proteins previously 
identified as associated with the glideosome complex including MyoA were 
present as expected, with the addition of GAP40 (previously identified in 
Toxoplasma by Frenal et al., 2010) and GAPMs (Chapter 4; Table 4.1).  
GAPMs were previously isolated in P. falciparum and Toxoplasma where they 
were proposed as candidates for an IMC anchoring role (Bullen et al., 2009).  
Prior to this study as shown in Figure 1.12, the P. falciparum glideosome motor 
complex was thought to consist of MyoA (Pinder et al., 1998), MTIP (Bergman 
et al., 2003; Green et al., 2006b), GAP45,  GAP50 (Baum et al., 2006b) and 
GAPM (Bullen et al., 2009).  In this present study, PfGAP40, GAPM2 and 
GAPM3 were detected by MS analysis of the MyoA IP and have been added to 
the diagram depicted in Figure 5.1a. 
 
• The redistribution of GFP-tagged MyoA during parasite invasion.  It was 
important to follow the stages of MyoA’s progress during invasion until parasite 
internalisation, in order to clarify its role.  This is the first study to investigate 
the progression of MyoA during the invasion process. Using RON4 as a marker 
to follow the stages of invasion, MyoA could be seen to progress into the host 
cell as expected, however the sub-cellular location of MyoA was distinct to that 
of RON4. MyoA remained associated with the parasite during PV formation, 
whereas RON4 diffuses into the PVM (Chapter 4; Figure 4.11).   
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5.3 MyoB is localised to the apical tip of merozoites, is not part of the glideosome 
motor complex and may have a role in erythrocyte invasion 
• Characterisation of GFP-tagged MyoB in P. falciparum and P. knowlesi.   
The gene encoding C-terminal GFP-tagged MyoB was successfully 
integrated into the parasite genome.  Whilst MyoA localised to the parasite 
periphery, MyoB localised at the apical end of the merozoite and the 
expression was optimum during parasite segmentation through out parasite 
development to merozoites (Chapter 4; Figure 4.2, 4.7 and 4.14), a result 
which is also complemented by the studies carried out by Chapparo-olaya et. 
al., (2003) where the authors used IFA of schizont stages probed with 
Pfmyo-B antibody.  In addition, the present study has also showed MyoB 
localised at the apical tip of the merozoite ahead of the RON and microneme 
specific antibodies as determined by IFA co-localisation studies.  
Futhermore, using the same approach, co-localisation with tubulin and actin 
showed MyoB was partially overlapped with actin and might be overlapped 
with tubulin at the MTOC (Chapter 4; Figure 4.5).  MyoB seems to be in the 
wrong place to be directly involved in gliding motility, but it could be 
involved in the initiation of invasion due to its association with microtubules 
or by controlling release of the contents of the apical organelles. 
Microtubules have been shown to have signalling roles (Bejon et al., 1997) 
and are important in translocating AMA1 (within micronemes) during 
merozoite development (Bannister et al., 2003).   
• This study was also carried out in order to determine wether MyoB was part 
of the glideosome motor complex and what is the potential MyoB 
contribution to the invasion process.  Attempts to co-localise MyoB with 
proteins from the glideosome complex (MTIP, GAP45 and GAP50) showed 
none of these proteins co-precipitated with GFP-tagged MyoB, indicating 
MyoB does not associated with the known glideosome complex proteins. 
This result was validated by western blot and MS analysis (Chapter 4; 
Figure 4.4a).  However, MyoB forms part of a novel complex, potentially 
including the vesicular transport-related proteins such as PfDYN2, clathrin, 
SEC31 and Pf332.  In addition a potential MyoB light chain, PfMTIP-B was 
also identified (Chapter 4; Table 4.2) (Figure 5.1b).   
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• Further investigation to determine the role of MyoB during erythrocyte 
invasion was carried out as in MyoA,. using RON4 as a MJ marker.  Results 
showed MyoB did not followed the characteristic RON4 pattern during 
invasion; instead MyoB stayed exactly where it was  associated with the 
parasite’s apex throughout the progression of the merozoite into the 
erythrocyte.  One interesting characteristic is that during MJ formation, 
RON4 initially localised behind MyoB moved forward ahead of MyoB to go 
to the front of the merozoite for the TJ formation (Chapter 4; Figure 4.12). 
 
5.4 Future Studies 
The present study has discussed two myosin of type XIV in Apicomplexa  The first 
protein is MyoA which is known to be involved in the gliding motility of the merozoite 
to invade erythrocytes.   The second protein is MyoB which might be potentially 
involved in the invasion process.   
1) The study has shown that the endogenous GFP-tagged MyoA is able to interact 
with the other glideosome motor complex protein components and the 
merozoites invaded erythrocytes suggesting it is functional. Therefore, further 
phenotype identification is needed to fully understand its functionalities.   
2) In addition, it is also important to study the function of the newly identified 
glideosome component, the PfGAP40 protein. The posttranslational 
modification of GAP40 and its IMC localisation also need to be established in 
order to confirm its association and the assembly of the glideosome complex.   
3) Generation of parasite lines with inducible knockouts of endogenous MyoA and 
GAP40 needs to be carried out in the future.  The conditional knockout can be 
performed using the DiCre system which was recently developed.  Together 
with IEM analysis of MyoA and GAP40, such experiments will elucidate further 
the glideosome motor complex components which have been shown to consist 
of GAP45-MTIP-MyoA-GAP50-GAP40 T.gondii.   
On the other hand, the endogenous GFP-tagged MyoB is not interacting with any 
protein from the glideosome complex although the apical localisation suggests that it 
may be involved in the invasion processes. It is important to study MyoB in more detail 
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in order to understand its possible role in the parasite.  There are several experiments 
that should be carried out for this purposes which are: 
1) Immuno-EM- In this study the localisation of MyoB was only determine by live 
microscopy imaging and co-localisation IFAs for which the resolution was 
limited. Therefore, it needs to be confirmed by IEM analysis.  A new 
endogenous HA-tagged MyoB to replace the GFP-tagged version is required in 
order to characterise the actual localisation, due to failure of IEM using the 
available GFP antibody. 
2) Establishment of the MyoB novel complex.  There are several protein identified 
during this study which have possible interactions with MyoB.  The interaction 
of MyoB with the vesicular transport proteins such as clathrin, DNY2, Sec31 
and the MyoB light chain which is MTIP-B, as well as tubulin and actin should 
be further investigated.  As MTIP-B was shown to have interaction with MyoB, 
a close investigation should be carried out for example of the binding affinity to 
MyoB.  The association of MyoB-MTIP-B can be examined using the 
experimental approach which was carried out previously for MyoA-MTIP.  In 
addition, generation of GFP-tagged MTIP-B, Clathrin, DNY2 and Sec31 will 
further clarify the associations of this novel complex.   
3) Western blot and IFAs using newly produced MyoA and MyoB antibodies can 
be used in protein interaction studies. 
4) An alternative approach to identify MyoB functionalities can be carried out by 
generating a knockout parasite line for MyoB and its potential complex 
components.  This experiment will give clear ideas on how MyoB and its 
binding partners work.   
5) The live invasion studies should be repeated by using higher resolution 
microscopy such as the 3D-SIM, time-lapse microscopy or EM/ IEM imaging.  
Although the exact function is not yet known, this experiment should give 
evidence of MyoB function during the invasion process. 
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5.5 Concluding remarks  
Invasion of the erythrocyte involves multiple cellular steps:  from merozoite 
egress and red cell rupture, followed by initial merozoite attachment, reorientation and 
tight junction formation, invasion powered by the acto-myosin motor in parallel with 
shedding of the surface coat, PV formation and post invasion events marked by vacuole 
sealing (Cowman et al., 2012).   In this study, the results provide evidence for the 
association of MyoA with the glideosome complex. On the other hand, MyoB appears 
to play a different role from MyoA although it may also contribute to the invasion 
process.  The data presented here indicate an independent role for both myosins during 
the invasion process.  This is backed up by the fact that depletion of MyoA impaired 
host cell invasion (Meissner et al., 2002) and is not essential for invasion (Andenmatten 
et al., 2013), and MyoB appears at the right location and the right time to be implicated 
in erythrocyte invasion by a different pathway.   This is the first detailed study, to our 
knowledge, to investigate the location and timing of expression of MyoA and MyoB 
throughout the parasite’s asexual life cycle of development and erythrocyte invasion. 
Figure 5.1 shows an illustrated diagram of the additional proteins added to the current 
model of the acto-myosin motor (Figure 1.12) as provided by this study.   
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Figure 5.1: A current view of the acto-myosin motor complex and the location of 
MyoA and MyoB, based on the results of this study.  GAP40, GAPM2 and GAPM3 
have possible interactions with the MyoA glideosome complex as identified by MS in 
this study.  The merozoite illustration shows MyoA localised at the periphery of the 
merozoite (green line) and MyoB and its MTIP-B localised at the apical prominence 
(green) ahead of rhoptries and micronemes. Also shown are MTIP (yellow circles), 
GAPMs (orange); GAP45 (pink shape with blue and yellow Ct and Nt, respectively), 
transmembrane GAP50 (purple) and GAP40 (deep purple), and F-actin (black and grey 
circles).  Nt: N-terminal; Ct: C-terminal; mt: microtubule. 
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Appendix A: Wheat germ His- and GST-tagging vectors used in the wheat germ cell 
free expression system. pEU-E01-His-TEV-MCS-N1 used for His-tagged protein.  
pEU-E01-GST-TEV-MCS-N1 used for GST-tagged protein 
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Appendix B: Vector map of (a) the PHH4-PfMyoA-GFP and (b) the PHH4-PfMyoB-
GFP plasmids.  The diagram shows the vector map of the construct used in single 
crossover homologous recombination.  All unique sites and important features are 
indicated. 
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Appendix C:  Clustal alignment of P. falciparum MTIP-B amino acid sequence with 
the protein sequence in other Plasmodium parasites.  PCYB - P. cynomolgi B strain 
hypothetical protein; PKH - P. knowlesi H strain; PBANKA - P. berghei ANKA strain; 
PCHAS - P. chabaudi chabaudi AS strain; PfMTIP-B - P. falciparum, 3D7 strain. *, 
identity; :, strong similarity. 
 
 
 
PCYB_092480        ---------------------------------------------------MDNFPPPSL 9 
PKH_091610         MEILKGSVNKIVNTQRSPLSYDDDGKPFSSLFRKNRVSFYDDLRTEAVLLLWKNSHHPKY 60 
PBANKA_092940      -------MIQNLYVPQNNKIKNYNERKTTSLFRNNSVSFYNDVNTEAICLLDRATQP--- 50 
PCHAS_091490       -------MIQNLYTPKNNKIKNVNERKNTSLFRNNSVSFYNDVNTEAISLLDRATQQ--- 50 
PfMTIB-B           -MKVLKTSKNNFVHPNKSNQYNCNDQPYDSLFRKNCVSFYEDFDTEAIFLLDKGSRP--- 56 
                                                                                
 
PCYB_092480        SSYVTNFRINRECVLFSQGKQIRHTRKK-------------------------QEFEKIN 44 
PKH_091610         FAYVTNFRINRECVLFSQGKQIRHIRKKQVLLIMRKGFPQLVLVNMFSLLRLREEFEKIN 120 
PBANKA_092940      ---INYKIIKNDCILFKDGNKIQHTKKE-------------------------KEFDKIT 82 
PCHAS_091490       ---IDYNMIKNDCILYKDGNKNQHTKKE-------------------------KEFEKIT 82 
PfMTIB-B           ---IYHKLKDKEWGSSNNQKDTEKKKKK-------------------------EEFEKID 88 
                      :     ..:    .: :. .: :*:                         :**:**  
 
PCYB_092480        DIINNIDYLDTLKEKVHDRNVEKIVEPLGICAPREGIPKGSDGEYGELTYKDKFEALKNK 104 
PKH_091610         DILNSIDYLDTLKEKVHDRNVEKIIEPLGICAPREGIPKGSGEEYGELTYKDKFEVMKNK 180 
PBANKA_092940      QIVNASNYLNSLKSKIHTTDIEQITKPLGIYFSNE-KSNSLRTKDNDLVYKNKYESLKKE 141 
PCHAS_091490       KIVNDADYLNSLKSKIHTTDIEKITQPLGIYSSKE-KSNSHRAKYNDIIYKNKYKSLKKE 141 
PfMTIB-B           EIISNAEHLNNLRNKLYSFEYQNILEPLGIYISQQEDKEENIKREMGNFYKDEYEILKKK 148 
                   .*:.  ::*:.*:.*::  : ::* :****  ..:   :    .     **:::: :*:: 
 
PCYB_092480        YDHLKKNLDTRIHLELIKAGVFYNQDDIKNVLYMVRKYQGDLKTKKSIINVQNGIIQNVM 164 
PKH_091610         YNDLKKNMDTRIHLELIKAGVFYNQDDIQNVLHMVRKYQGDLKTKKSIINVQNGIIQNVV 240 
PBANKA_092940      YDNLKERMDIKIDLELIKAGAFYNKEDIHDILRLIKKYQSRIKEKKDIIDTQNNVIENIM 201 
PCHAS_091490       YDDLKERIDIKIDLELIKSGAFYNKEDIHDILHLIKKYQSKIKEKKDIIDTQNNVIENIM 201 
PfMTIB-B           YIHLKENMDTILDVERIKAGLFYTKEDLQKIFEIIRKHQSKINNKNDIIKFQSSMLEKAI 208 
                   * .**:.:*  :.:* **:* **.::*::.:: :::*:*. :: *:.**. *..:::: : 
 
PCYB_092480        ERNKLSRNKLLVDKKKNEELMKMCRTYYEQNKSAQTRLRKLKHAFLQYKIALESIVSCCE 224 
PKH_091610         ERNKLSRNKLRLDKEKNEGLMKMCRTYYEQNKNTQMRLRKLKHAFLEYKIALESIVSCCE 300 
PBANKA_092940      EQTKLNRNKFIVEKKKNEDMAKICHSYYRQSKKTQMKMKMLKYSFLEYKMALENIVSCCE 261 
PCHAS_091490       EQTKLNRNKFIVEKKKNEDMAKICNSYYHQSKKTQMKMKMLKYSFLEYKMALENIVSCCE 261 
PfMTIB-B           EHNKKNKLTIIKDKRKNEKLLEICKSYYEQNEKAQKKLRHLKYSFLEYKIALENIVSCCE 268 
                   *:.* .: .:  :*.*** : ::*.:**.*.:.:* ::: **::**:**:***.****** 
 
PCYB_092480        KIGGDKIILMDAVKSARAQTDLSIATDILNTKKIQELEMNICYCEHQINSLKDDLDVMLG 284 
PKH_091610         KIGGDKIILMDVVKSARAQTDLSIATDILNTKKIQELEMNICYCEHQINSLKDDLDTMLA 360 
PBANKA_092940      QIGGDKIILMDAIKSAKTQTDLSIATEILNIKKIKDLEMSICYCEHHINYLNEELNLKLQ 321 
PCHAS_091490       QIGGDKIILMDAIKSAKTQTDLSIATEMLNIKKIKELEMSICYCEHHINYLNEELNLKLQ 321 
PfMTIB-B           KIGGDKIILMDGIKSARAQADMSIANDIKNKIKIEELEMNISYCEQQINYLKDDLDFKME 328 
                   :********** :***::*:*:***.:: *  **::***.*.***::** *:::*:  :  
 
PCYB_092480        KLQNEKKEKREVMNQTLRYKEHLEKNNAMLIEALENFRRVMTSVDEHLSREG--NRSDFK 342 
PKH_091610         KLQDEKKEKREVMNQALQYKEHLAKNNDMLIEALENFRRVMISVDEHLSRES--DRSDFK 418 
PBANKA_092940      ELKNETKEKKEAQNEIYSYKKELTKNNNMIIKILENYHQMMATMEKIIYEND--IANKYK 379 
PCHAS_091490       ELKNAAKEKKETQNEIYSYKKELAKNNNMIIKILEDYHQTMATMEKIIYENDNANANKHK 381 
PfMTIB-B           ELRNTTLYTEEVKNEASYFKQELSKNNDLLLEVMEHFHQMINNVDEFIYKNK--DKNELI 386 
                   :*::    ..*. *:   :*:.* *** :::: :*.::: : .::: : .:     ..   
 
PCYB_092480        ETFDKSKKKYNDFVRKAAEKNKDLQKMGDKLLLTSALSGHELKRHQEYLNRQINEMKKNQ 402 
PKH_091610         KTFDNSKKKYNDFVRKAAVKNKELQKMGDKLILMNALSGQELKKHQEYLNRQINQIRKNQ 478 
PBANKA_092940      PDFIKDKKKYNDMVKLLLESNKELKNINDKLFLSNNVFKGKLKNHQEFLTKHMNEDN--- 436 
PCHAS_091490       TDFIKDKKKYNDLVKKVLESNNELKNNNDKLFLHDNVLKGKLKAHQELLTKHMN------ 435 
PfMTIB-B           TYMNKKKKKYGDITKKISEKNKELNLKVKNFVPYNFSMGTELKKHEEYLKIQMDEMKKK- 445 
                     : :.****.*:.:    .*::*:   .::.  .     :** *:* *. :::       
 
PCYB_092480        GGVEEEEEQKGHKNGGKVGEAEKSSHEEEQDKKQPLEGESSQGAKEITNDTERKQA-EQK 461 
PKH_091610         GGIEEEE-QKGNKNNGKVGEVEKGNQEEEQDQKQTLEGKSCQGVKDIPNDIEGKQG-KEK 536 
PBANKA_092940      -------KNKHKDDANKISNLTDQTNETKNIDKS--ETEIIAKENNSTNETVLKN----- 482 
PCHAS_091490       -------EHKPKEAVNKAPSLADQKNETENADKP--ETGVMGNENNSTNEVEPKD----- 481 
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PfMTIB-B           ---EEEEKRKRREEEEEEQKKRKEEEEEEQKKRKEEEEKIEKKKKEEEEEKRKKEEQELL 502 
                           .* ..   :  .  .  .* :: .:   *       ::  ::   *:      
 
PCYB_092480        GEQPTHVDESLEGRKINQVMELLQKKEIDKLTFEDCVDVIYKVNLPLTQSKLNELKAMGE 521 
PKH_091610         EEQTKRVDESLEGRIINQVMELLQKKENNKLTFEDCVDVIYKVNLPLTQSKLNELKAMGE 596 
PBANKA_092940      -----NIDINVELDKIEKIQEFIKNKNIDKLKFEDCVDIMYKSNIVLTRNKMEELKQMGL 537 
PCHAS_091490       -----NQDIPVDLEKIEKIQEFIKNKNVDKLKFEDCLDIMYKSNVVLTRSKMEELKQMDP 536 
PfMTIB-B           EEKDIKNNETFEEKKIRLVKELMKEVNEETLSLEKCVDIIYKANLPLTQNKLNKLKNMGD 562 
                        . :  .:   *. : *:::: : :.*.:*.*:*::** *: **:.*:::** *.  
 
PCYB_092480        VHKDDLVAFIKTFIVQEEEALQNMITFFEIWDVQKTGYMHKELILLILKQFGDSLTEDEM 581 
PKH_091610         VDKEDLIAFIKTFIMDEDEALQNMITFFEIWDVQKTGYMHKELILLILKQFGDKLTEDEM 656 
PBANKA_092940      ITANEFVTFIKPFIINEEEALKNMITFFEIWDVKKTGYMHKDLFMPILKYFGDHLSDQEI 597 
PCHAS_091490       ITTDEFVTFIKPFIINEEEALKNMITFFEIWDVKKTGYMHKDLFMPILKYFGDHLSDQEM 596 
PfMTIB-B           IKKDELVTFVKTLMLNEQEAFENMKTFFEIWDIMKTGYMHKNLIISILKQFGDNLTEEES 622 
                   :  :::::*:*.::::*:**::** *******: *******:*:: *** *** *:::*  
 
PCYB_092480        EYLR-------ESKK------KR--------- 591 
PKH_091610         EYLRGEVNAFKESNISYVDLLKRWIQGTGE-- 686 
PBANKA_092940      DYLQKELNLSNEPKISYADILKKWIYGKDQQI 629 
PCHAS_091490       DYLQKELSLSNEPNISYVDILKKWIYGKDQQT 628 
PfMTIB-B           NYIQKELNQMSESNISYVKLLKKWIYGTEE-- 652 
                   :*::       *.:       *:          
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Appendix D:  Clustal alignment of amino acid sequences of  full length  P. falciparum 
MyoA and MyoB.  *, identity; :, strong similarity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PfMyoB          ---MVNKINELNNYFR--INSTFINKSENESENFYVWTYKSPNVDLYPDLVFFKCQVLN- 54 
PfMyoA          MAVTNEEIKTASKIVRRVSNVEAFDKSGSVFKGYQIWTDISPTIENDPNIMFVKCVVQQG 60 
 ::*:  .: .*   *   ::** .  :.: :**  **.::  *:::*.** * : 
PfMyoB          INGDNYEVKEISP-ETNSVYTVKKEHLFNCNNMVN-INSHRLNDMVHQNSAEVLNTLALR 112 
PfMyoA          SKKEKLTVVQIDPPGTGTPYDIDPTHAWNCNSQVDPMSFGDIGLLNHTNIPCVLDFLKHR 120 
 : ::  * :*.*  *.: * :.  * :***. *: :.   :. : * * . **: *  * 
PfMyoB          YEKNYIYTIAEPMLISVNPYQVIDTDMNEYKNKSTD-----LLPPHVYTYAKDAMLDFIN 167 
PfMyoA          YLKNQIYTTAVPLIVAINPYKDLGNTTNEWIRRYRDTADHTKLPPHVFTCAREALSNLHG 180 
 * ** *** * *:::::***: :..  **: .:  *      *****:* *::*: :: . 
PfMyoB          TKNSQSIIISGESGSGKTEASKLVIKFYLSGVRE--DNDISKTLWDSNFILEAFGNAKTV 225 
PfMyoA          VNKSQTIIVSGESGAGKTEATKQIMRYFASSKSGNMDLRIQTAIMAANPVLEAFGNAKTI 240 
 .::**:**:*****:*****:* ::::: *.     *  *..::  :* :*********: 
PfMyoB          KNNNSSRYGKYIKIQLDENQNIVSSSIEIFLLEKIRVVSQEPDERCYHIFYEILKGMNDE 285 
PfMyoA          RNNNSSRFGRFMQLVISHEGGIRYGSVVAFLLEKSRIITQDDNERSYHIFYQFLKGANST 300 
 :******:*::::: :..: .*  .*:  ***** *:::*: :**.*****::*** *. 
PfMyoB          MKKKYKIKSEEDYKYISNKSINIPEIDDAKDFENLMISFDKMKMSD-LKDDLFLTLSGLL 344 
PfMyoA          MKSKFGLKGVTEYKLLNPNSTEVSGVDDVKDFEEVIESLKNMELSESDIEVIFSIVAGIL 360 
 **.*: :*.  :** :. :* ::. :**.****::: *:.:*::*:   : :*  ::*:* 
PfMyoB          LLGNIQFNGIEKGGKSNCSELDDENLEVVNEASELLGIDYESLKNSLVITEKSIANQKIE 404 
PfMyoA          TLGNVRLIEKQEAGLSDAAAIMDEDMGVFNKACELMYLDPELIKREILIKVTVAGGTKIE 420 
 ***:::   ::.* *:.: : **:: *.*:*.**: :* * :*..::*. .  .. *** 
PfMyoB          IPLSIEESLSICRSISKDIYNKIFEYITKRINNFLNNNKELENFIGILDIFGFEIFVKNS 464 
PfMyoA          GRWNKNDAEVLKSSLCKAMYEKLFLWIIRHLNSRIEPEGGFKTFMGMLDIFGFEVFKNNS 480 
 . :::  :  *:.* :*:*:* :* :::*. :: :  ::.*:*:*******:* :** 
PfMyoB          LEQLLINIANEEIHNIYLFVVYEKESNLYKKEGIIIESVKYTNNESIIDLLRGK-TSIIS 523 
PfMyoA          LEQLFINITNEMLQKNFVDIVFERESKLYKDEGISTAELKYTSNKEVINVLCEKGKSVLS 540 
 ****:***:** ::: :: :*:*:**:***.***   .:***.*:.:*::*  * .*::* 
PfMyoB          ILEDNCLAPGKKDESIVSVYTNKFSKNEHYSVCKKNITESFVIKHTVSDVTYSISNFISK 583 
PfMyoA          YLEDQCLAPGGTDEKFVSSCATNLKENNKFTPAKVASNKNFIIQHTIGPIQYCAESFLLK 600 
 ***:***** .**.:**  :.::.:*:::: .*   .:.*:*:**:. : *. ..*: * 
PfMyoB          NKDILSPNILKLLKVSNNKLIQNLYDDAEVTDS-LGRKNLITYKYLENLKKICSYLKSTN 642 
PfMyoA          NKDVLRGDLVEVIKDSPNPIVQQLFEGQVIEKGKIAKGSLIGSQFLNQLTSLMNLINSTE 660 
 ***:*  ::::::* * * ::*:*::.  : .. :.: .**  ::*::*..: . ::**: 
PfMyoB          IYFIKCIKPNETKEKNNFNPKKVYPQLFSLSIVETLNIKYF-FQYKYTFASFLSYYQYLD 701 
PfMyoA          PHFIRCIKPNENKKPLEWCEPKILIQLHALSILEALVLRQLGYSYRRTFEEFLYQYKFVD 720 
 :**:******.*:  ::   *:  **.:***:*:* :: : :.*: ** .**  *:::* 
PfMyoB          IAVSNDSSLDEKTKVTMLLERN-FDKDSYKVGHTMVFLKKEAVHKIRDIINSNLKCYRNL 760 
PfMyoA          IAAAEDSSVENQNKCVNILKLSGLSESMYKIGKSMVFLKQEGAKILTKIQREKLVEWENC 780 
 **.::***::::.* . :*: . :.:. **:*::*****:*..: : .* ..:*  :.* 
PfMyoB          CCITSALIMKIKKKRIVEENIKNLQLAQAYFRKYKYIKEHE 801 
PfMyoA          VSVIEAAILKHKYKQKVNKNIPSLLRVQAHIRKKMVAQ--- 818 
                                        .: .* *:* * *: *::** .*  .**::**    : 
